Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3037551	p-ca12-5	kU/l (u/ml)	9667	29709	0.02%
3037551	s-ca12-5	kU/L (u/ml)	7396	28960	0.00%
3037551	s-ca12-5	kU/l (u/ml)	5737	12843	0.00%
3037551	s-ca12-5	— (—)	1027	2169	100.00%	Distribution not available
3037551	s-ca12-5	kU/L______ (u/ml)	425	1206	0.00%
3037551	p-ca12-5	— (—)	416	588	100.00%	Distribution not available
3037551	p-ca12-5antigeeni	kU/l (u/ml)	313	689	0.00%
3037551	ca12-5antigeeni	kU/l (u/ml)	173	289	0.00%
3037551	s-ca12-5antigeeni	kU/L______ (u/ml)	170	414	0.00%
3037551	s-ca12-5	kU/l______ (u/ml)	82	186	0.00%
3037551	ca12-5antigeeni	kU/l______ (u/ml)	51	88	0.00%
3037551	-ca12-5	kU/l (u/ml)	14	14	0.00%	Distribution not available
3037551	vertca12-5	kU/l (u/ml)	13	15	0.00%
3037551	s-ca125kj	kU/L (u/ml)	11	12	0.00%	Distribution not available
3037551	ca12-5antigeeni	— (—)	8	9	100.00%	Distribution not available
3037551	s-ca12-5antigeeni	— (—)	8	8	100.00%	Distribution not available
3037551	p-ca-12-5	kU/l (u/ml)	5	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Congenital malformations of ovaries, fallopian tubes and broad ligaments

752

1768

5.74

316.36

2.0

2.9

20.22

48.75

u/ml

3.65

723

1711

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

747

1690

4.82

308.30

8.4

1.5

102.97

24.91

u/ml

10.64

737

1612

Malignant neoplasm, wide definition

5509

10458

3.30

307.65

5.2

1.5

68.31

23.81

u/ml

21.38

5365

10046

Benign neoplasm of ovary

1834

6046

3.69

307.65

2.5

4.1

32.59

72.63

u/ml

7.22

1791

5829

Noninflammatory disorders of female genital tract

2371

4257

2.99

307.65

2.7

5.3

46.65

88.33

u/ml

4.64

2296

4116

Female infertility, cervical, vaginal, other or unspecified origin

1735

3520

3.44

307.65

2.8

5.5

33.00

81.98

u/ml

5.48

1678

3412

Malignant neoplasm of breast, HER-positive

2683

6883

3.27

307.65

3.1

1.5

55.14

22.65

u/ml

9.07

2597

6580

Malignant neoplasm of breast, ER-positive, including Hilmo

2696

6894

3.28

307.65

3.1

1.5

55.29

22.64

u/ml

9.20

2610

6591

Malignant neoplasm

5402

10252

3.32

307.65

5.4

1.5

66.99

23.19

u/ml

20.57

5257

9845

Endometriosis of ovary

1879

3390

6.43

307.65

2.6

5.6

47.83

92.35

u/ml

4.13

1827

3289

Endometriosis ASRM stages 3,4

2169

8450

2.96

307.65

2.6

3.5

45.50

57.66

u/ml

1.57

2107

8160

Malignant neoplasm of breast, HER2-negative

3307

8120

2.91

307.65

3.1

1.5

67.37

22.79

u/ml

4.76

3202

7781

Malignant neoplasm of ovary

1407

968

50.26

307.65

16.9

1.5

168.18

23.59

u/ml

13.99

1384

918

Other symptoms and signs involving the digestive system and abdomen

1822

4401

4.96

307.65

5.4

2.9

74.81

49.69

u/ml

1.73

1785

4259

Solid cancers, including Hilmo

5510

10312

3.36

307.65

5.3

1.5

69.46

23.23

u/ml

22.58

5363

9903

Oxycodone

2164

7153

2.75

307.65

7.4

3.2

127.94

54.55

u/ml

8.04

2116

6906

Endometriosis

2928

4153

4.68

307.65

2.8

5.4

42.93

89.79

u/ml

6.04

2849

4020

Malignant neoplasm, including Hilmo

5485

10458

3.28

307.65

5.2

1.5

68.32

23.80

u/ml

21.24

5342

10046

Ovarian cyst

5647

4193

10.43

307.65

2.2

5.4

27.49

89.11

u/ml

10.46

5466

4059

Malignant neoplasm of ovary, including Hilmo

1854

1318

46.80

307.65

16.0

1.5

162.99

26.30

u/ml

18.93

1828

1255

Postmenopausal bleeding

2081

3413

3.60

307.65

3.5

6.0

56.25

101.70

u/ml

3.28

2013

3302

Polyp of the female genital tract

2177

3883

3.52

307.65

3.1

5.6

46.05

94.38

u/ml

4.18

2116

3759

Malignant neoplasm of corpus uteri, including Hilmo

1955

1825

20.57

307.65

5.0

1.5

44.32

24.81

u/ml

1.90

1926

1731

Ascites

895

1171

10.08

307.65

14.1

2.9

308.82

59.07

u/ml

14.49

885

1127

Any gastric operation

3823

7208

2.78

307.65

3.9

1.6

61.99

25.69

u/ml

11.03

3704

6940

Solid cancers

5419

10095

3.40

307.65

5.5

1.5

67.73

23.14

u/ml

21.15

5275

9694

Female infertility

1834

3568

3.35

307.65

2.9

5.5

32.40

81.26

u/ml

5.61

1777

3459

Other medical care

3115

8998

3.15

307.65

8.9

2.7

157.40

40.61

u/ml

24.04

3053

8671

Family history of malignant neoplasm

1169

3493

4.00

307.65

5.0

3.2

27.78

52.56

u/ml

4.46

1124

3379

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

840

507

85.40

307.65

22.6

1.5

275.82

25.44

u/ml

8.06

834

481

Neoplasms

3568

5435

3.62

307.65

3.2

1.4

47.21

22.06

u/ml

8.29

3465

5186

malignant neoplasm of female genital organs

3923

3382

24.39

307.65

11.2

1.5

117.93

24.35

u/ml

14.56

3867

3214

Unspecified/other endometriosis

942

1572

7.09

307.65

2.2

4.8

36.64

73.54

u/ml

3.13

918

1524

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1568

2249

8.27

307.65

10.6

1.5

171.31

24.03

u/ml

19.21

1538

2143

Endometriosis of pelvic peritoneum

1442

3014

5.07

307.65

2.5

5.5

41.12

89.43

u/ml

3.93

1409

2924

Exclusions for E4_PCOS_CONSORTIUM

5665

14149

2.72

307.65

4.8

2.4

62.17

43.82

u/ml

2.11

5513

13646

Uterine polyps

2196

3816

3.78

307.65

3.1

5.7

41.91

95.30

u/ml

5.24

2138

3699

Serous carcinoma of ovary, including Hilmo

984

640

63.82

307.65

21.9

1.5

188.66

25.18

u/ml

14.10

973

609

GASTRO-related operations

3823

7208

2.78

307.65

3.9

1.6

61.99

25.69

u/ml

11.03

3704

6940

malignant neoplasm of female genital organs, including Hilmo

4373

3846

22.41

307.65

10.6

1.5

119.73

23.79

u/ml

18.29

4311

3657

Malignant neoplasm of breast, HER2-negative, including Hilmo

3356

8279

2.87

307.65

3.1

1.5

66.94

22.79

u/ml

4.80

3252

7935

Medicines for HER+ breast cancer

3088

12874

2.49

307.65

5.0

3.6

58.89

61.05

u/ml

0.14

2996

12426

Malignant neoplasm

5403

10252

3.32

307.65

5.4

1.5

66.97

23.19

u/ml

20.55

5258

9844

Malignant neoplasm of breast

3314

8138

2.91

307.65

3.1

1.5

67.53

22.78

u/ml

4.80

3209

7799

Any event in cancer register

5764

11364

3.18

307.65

4.9

1.5

62.32

27.84

u/ml

15.24

5604

10936

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1780

2811

7.06

307.65

6.4

1.5

104.84

25.46

u/ml

17.17

1748

2680

Malignant neoplasm of corpus uteri

1788

1634

21.27

307.65

5.0

1.5

36.47

25.73

u/ml

2.20

1763

1549

Malignant neoplasm of breast, including Hilmo

3357

8279

2.87

307.65

3.1

1.5

66.92

22.79

u/ml

4.80

3253

7935

L02BG Aromatase inhibitors

2440

11029

2.43

306.86

5.3

3.9

63.67

63.93

u/ml

0.01

2367

10641

Congenital ovarian cysts

650

1414

6.52

303.64

2.0

2.7

19.85

47.80

u/ml

2.56

628

1371

Malignant neoplasm of digestive organs, including Hilmo

1584

4157

2.93

298.30

3.3

1.5

95.44

23.83

u/ml

11.18

1541

3949

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

447

685

7.57

286.06

13.2

1.5

185.93

24.57

u/ml

7.54

438

649

Congenital malformations of genital organs

898

2529

4.19

282.21

2.1

2.8

21.60

45.77

u/ml

4.67

865

2453

Other noninflammatory disorders of uterus, except cervix

1424

3334

3.14

277.56

3.5

6.0

41.80

102.46

u/ml

5.68

1379

3221

Excessive, frequent and irregular menstruation

1979

4249

2.63

273.82

2.6

5.3

43.20

88.40

u/ml

5.07

1897

4108

Complications of surgical and medical care, not elsewhere classified

4674

17905

1.80

267.35

4.0

3.2

49.50

53.46

u/ml

0.23

4522

17321

L02BA Anti-estrogens

1520

6034

2.91

267.30

4.1

3.8

53.69

64.23

u/ml

0.62

1484

5822

Pain and other conditions associated with female genital organs and menstrual cycle

1202

3366

3.21

266.10

2.4

5.2

24.70

83.98

u/ml

7.34

1154

3261

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

365

503

9.95

265.73

3.0

5.9

30.97

93.67

u/ml

1.62

352

487

Complications of procedures, not elsewhere classified

3933

17631

1.86

260.07

3.7

3.2

47.37

53.87

u/ml

0.36

3804

17061

Liquid cancers, including Hilmo

1293

4146

2.88

246.48

6.2

1.5

109.45

24.10

u/ml

3.32

1269

3940

Symptoms and signs involving the digestive system and abdomen

3797

10305

1.90

243.23

4.1

2.6

62.10

43.63

u/ml

2.75

3663

9967

Benign neoplasms

3904

11729

1.86

240.95

2.8

3.6

44.51

53.88

u/ml

1.22

3777

11321

Any death

2659

9232

2.10

240.91

8.1

3.2

188.12

32.06

u/ml

21.04

2594

8882

Endometroid carcinoma of ovary, including Hilmo

209

165

34.44

240.89

13.5

1.5

43.19

25.12

u/ml

0.95

203

159

Malignant neoplasm of digestive organs

1332

3751

2.83

239.06

2.6

1.5

93.43

23.98

u/ml

8.78

1292

3559

Persons encountering health services for specific procedures and health care

4789

16755

1.74

237.47

5.6

2.4

96.46

34.10

u/ml

11.53

4642

16192

Endometriosis diagnosis and infertility diagnosis occurring together

1045

3682

3.35

232.23

2.6

3.0

39.55

43.16

u/ml

0.28

1019

3571

Secondary uncertain malignant neoplasm

573

1337

4.61

226.64

4.3

1.5

157.20

26.92

u/ml

10.30

563

1271

Appendectomy

3260

17282

1.87

222.19

7.0

2.7

54.94

48.61

u/ml

0.81

3178

16715

Hernia of abdominal wall, postoperative

785

2295

3.60

222.05

5.0

1.6

41.72

29.72

u/ml

1.27

760

2204

Menorrhagia

1702

4072

2.46

209.04

2.7

5.5

44.27

91.06

u/ml

5.11

1642

3942

Procreative management

1784

6791

2.29

203.19

5.1

3.2

33.50

52.88

u/ml

4.91

1714

6590

Colorectal cancer, including Hilmo

908

2858

3.10

200.79

3.4

1.5

54.71

24.61

u/ml

6.95

889

2709

Endometriosis ASRM stages 1,2

1479

6576

2.52

200.74

2.5

3.3

40.75

45.40

u/ml

0.49

1442

6366

Torsion of ovary, ovarian pedicle and fallopian tube

267

355

9.93

199.08

2.1

5.3

41.08

94.57

u/ml

0.82

255

344

Abdominal and pelvic pain

3608

10304

1.80

197.55

3.6

2.6

54.63

43.63

u/ml

1.29

3482

9966

Endometriosis of rectovaginal septum and vagina

567

1516

4.29

191.55

2.7

5.7

48.35

116.62

u/ml

2.42

554

1460

Adenomyosis (Endometriosis of uterus)

836

2872

3.20

186.91

3.0

5.7

47.08

98.29

u/ml

3.88

816

2779

Malignant neoplasm of colon, including Hilmo

663

1962

3.55

184.80

3.3

1.5

60.93

25.57

u/ml

5.67

650

1858

Genitourinary diseases

1213

2277

2.72

183.65

2.8

4.7

57.44

81.14

u/ml

1.14

1175

2204

Malignant neoplasm of cervix uteri, including Hilmo

305

521

8.00

182.65

5.4

1.5

103.87

24.69

u/ml

0.94

299

499

Leiomyoma of uterus

4266

14959

1.68

178.27

3.0

3.7

44.26

57.74

u/ml

2.46

4134

14467

Complications of medical and surgical care

3397

18337

1.72

174.81

4.0

3.3

50.77

53.92

u/ml

0.13

3278

17750

Intestinal stricture

1373

6198

2.33

171.43

9.0

3.5

89.30

72.76

u/ml

0.92

1335

5962

Colorectal cancer

764

2487

3.08

168.56

2.7

1.5

52.50

25.13

u/ml

5.22

747

2356

Malignant neoplasm of breast, ER-negative, including Hilmo

1204

4981

2.43

158.41

3.5

1.5

88.73

23.97

u/ml

1.86

1174

4746

Malignant neoplasm of colon

539

1575

3.61

154.55

2.9

1.5

58.80

25.81

u/ml

4.27

529

1486

Malignant neoplasm of breast, HER-negative

1102

4643

2.45

148.55

3.5

1.5

92.24

24.06

u/ml

1.76

1074

4423

Other abnormal uterine and vaginal bleeding

1153

3605

2.44

147.26

3.4

5.6

67.62

97.21

u/ml

1.13

1105

3481

Abnormal findings on diagnostic imaging of other body structures

890

3587

2.71

146.98

3.5

4.0

57.78

65.44

u/ml

0.26

852

3468

Hydronephrosis

607

1991

3.31

146.57

9.8

3.5

114.25

65.56

u/ml

1.99

595

1919

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2715

16052

1.71

139.79

3.7

3.4

51.67

57.31

u/ml

0.20

2621

15527

Paralytic ileus and intestinal obstruction

1133

5150

2.30

138.60

9.0

3.6

90.89

81.12

u/ml

0.38

1101

4980

Dysplasia of cervi uteri

1104

3392

2.41

138.35

2.4

5.3

63.82

84.15

u/ml

0.50

1071

3290

Deep endometriosis

776

3067

2.89

137.28

2.6

3.5

47.47

63.44

u/ml

1.38

757

2957

Inflammatory diseases of female pelvic organs

4058

18570

1.56

130.01

2.9

3.5

38.91

53.99

u/ml

2.64

3904

17993

Other or unspecified ileus, impaction or obstruction

805

3255

2.61

129.00

9.3

3.6

102.92

90.65

u/ml

0.34

779

3135

Anaemias

1023

2824

2.43

128.50

3.6

1.6

46.32

25.19

u/ml

2.48

989

2741

Pleural effusion

593

2087

3.01

124.95

10.6

3.6

194.54

73.79

u/ml

4.18

583

2006

Female infertility, associated with anovulation

397

1105

3.88

123.82

2.3

4.0

25.16

40.96

u/ml

3.48

384

1072

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2522

15387

1.69

123.42

3.6

3.5

49.72

58.49

u/ml

0.32

2435

14877

Nausea and vomiting

1147

5505

2.11

113.67

5.5

2.8

73.90

53.18

u/ml

1.31

1100

5312

Cervical polyps

577

2156

2.93

111.03

3.1

5.9

44.83

102.05

u/ml

2.21

563

2090

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4042

17581

1.48

106.52

3.7

3.3

42.79

53.17

u/ml

1.45

3887

17038

Opioids

3880

13586

1.50

105.71

3.9

2.7

56.54

41.17

u/ml

2.97

3743

13161

Other menopausal disorders

1285

3633

2.07

105.48

2.5

5.8

44.38

94.23

u/ml

3.16

1239

3531

Salpingitis and oophoritis

1238

6611

2.03

102.45

3.1

3.9

48.27

59.34

u/ml

0.41

1209

6403

Other diseases of intestines

4115

15872

1.47

102.32

3.8

3.0

47.87

51.91

u/ml

0.41

3966

15382

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2568

14306

1.60

101.15

3.5

3.8

56.96

61.10

u/ml

0.28

2467

13831

Liquid cancers

797

3373

2.30

99.33

3.2

1.5

115.60

24.75

u/ml

1.70

777

3206

Fever of other and unknown origin

2263

12241

1.64

98.87

5.2

3.2

55.07

50.05

u/ml

0.45

2203

11844

Bacterial infection, other or unspecified

1965

10031

1.70

96.99

5.4

3.5

82.05

60.70

u/ml

0.73

1912

9682

Colorectal adenocarcinoma

526

1952

2.75

96.42

2.6

1.5

57.21

25.22

u/ml

3.87

513

1851

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4214

15756

1.45

95.15

3.9

3.2

45.57

53.24

u/ml

1.25

4085

15224

Personal history of malignant neoplasm

646

2795

2.58

93.46

2.5

3.7

44.11

68.83

u/ml

1.29

625

2701

Malignant neoplasm, without specification of site

151

240

6.91

92.46

4.0

1.5

267.21

30.55

u/ml

4.76

151

230

Bacterial infection, other or unspecified, including avohilmo

2150

11028

1.64

92.17

5.3

3.5

79.07

59.45

u/ml

0.73

2087

10649

Female infertility, tubal origin

312

912

3.82

92.03

3.2

5.8

29.57

73.59

u/ml

2.29

306

883

Pain in joint

2080

7837

1.67

91.38

2.6

3.4

35.62

54.88

u/ml

4.41

1997

7599

Fentanyl

459

1679

2.89

90.07

7.9

3.3

167.15

84.53

u/ml

0.67

446

1606

First line medication for Crohn's disease

4159

15962

1.42

87.14

4.9

2.6

52.24

48.12

u/ml

0.50

4027

15426

Female genital prolapse

1253

3739

1.94

86.92

3.2

5.7

48.77

96.25

u/ml

3.72

1214

3622

Non-Hodgkin lymphoma, all, including Hilmo

373

1279

3.04

82.04

2.9

1.5

78.79

26.06

u/ml

3.35

362

1212

Cystitis

3549

14879

1.45

81.88

3.1

3.3

44.91

51.91

u/ml

0.61

3429

14420

Colon adenocarcinoma

344

1139

3.15

80.39

2.7

1.5

66.77

28.16

u/ml

2.75

336

1076

Agranulocytosis

575

2529

2.45

78.17

8.8

3.7

58.71

63.33

u/ml

0.20

556

2444

Postmenopausal atrophic vaginitis

1173

3480

1.92

78.07

2.6

6.0

31.28

100.08

u/ml

8.59

1129

3371

Other noninflammatory disorders of vulva and perineum

484

1975

2.62

77.18

2.7

5.5

64.72

101.52

u/ml

0.57

473

1902

General symptoms and signs

4053

14695

1.40

77.07

3.9

3.1

61.81

46.75

u/ml

1.07

3916

14239

Drug-induced neutropenia

413

1576

2.89

77.00

9.7

3.7

62.30

71.94

u/ml

0.34

400

1523

Other disorders of urethra and urinary system

3030

14702

1.47

76.46

3.7

3.3

48.81

52.11

u/ml

0.21

2919

14252

Venous thromboembolism

1967

12227

1.59

76.08

5.7

3.5

92.21

61.11

u/ml

2.08

1903

11804

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3776

18467

1.40

74.98

4.5

3.1

57.42

50.63

u/ml

0.61

3644

17875

Follow-up examination after treatment for conditions other than malignant neoplasms

1849

7762

1.63

74.69

3.0

3.5

37.15

57.38

u/ml

4.72

1786

7538

Pulmonary heart disease

1086

6061

1.85

74.29

6.1

3.8

120.38

72.09

u/ml

1.77

1058

5827

Pulmonary embolism

1086

6069

1.85

73.97

6.1

3.8

120.38

71.89

u/ml

1.78

1058

5834

Medical treatment for female infertility

1321

7833

1.77

72.99

2.4

2.5

29.06

32.73

u/ml

0.81

1284

7591

Persons encountering health services in other circumstances, wide

4177

15775

1.38

72.76

3.9

3.2

56.50

53.24

u/ml

0.16

4042

15243

Follow-up examination after treatment for malignant neoplasms

512

2231

2.44

70.66

6.0

4.3

68.28

85.99

u/ml

0.26

490

2158

Other pleural conditions

353

1281

2.90

70.47

11.3

3.5

258.60

74.40

u/ml

2.69

347

1238

Other bacterial diseases

3438

16427

1.41

70.40

4.9

3.3

75.02

50.99

u/ml

1.72

3325

15884

Other bacterial diseases, including avohilmo

3825

17573

1.38

68.59

4.8

3.1

68.40

48.80

u/ml

1.47

3701

16996

Non-invasive ventilation

1161

5807

1.79

68.58

4.6

3.8

37.07

45.66

u/ml

1.16

1076

5657

DVT of lower extremities and pulmonary embolism

1473

9131

1.65

67.03

6.1

3.6

104.43

66.14

u/ml

1.94

1427

8801

Disorders of the thyroid gland

3619

17227

1.39

66.69

3.1

3.4

45.88

50.91

u/ml

0.44

3489

16658

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

519

1863

2.35

66.59

2.7

1.5

74.02

26.46

u/ml

5.19

501

1777

Pulmonary heart disease, diseases of pulmonary circulation

1125

6550

1.77

66.40

5.9

3.7

123.74

71.06

u/ml

2.12

1097

6293

Congenital malformations, deformations and chromosomal abnormalities

2349

15390

1.48

65.23

2.5

3.2

48.26

46.91

u/ml

0.04

2273

14903

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

179

446

4.21

64.83

2.2

1.5

129.04

26.80

u/ml

3.16

173

423

Malignant neoplasm of skin, including Hilmo

1423

5823

1.67

64.58

3.4

1.5

60.24

23.32

u/ml

4.62

1374

5550

Other noninflammatory disorders of vagina

392

1595

2.63

63.16

3.0

5.5

50.76

110.86

u/ml

1.84

377

1534

Malignant neoplasm of skin

1335

5476

1.68

62.66

3.6

1.5

59.11

23.51

u/ml

5.67

1285

5212

Secondary and unspecified malignant neoplasm of lymph nodes

259

844

3.22

62.63

3.2

1.5

95.88

25.72

u/ml

4.12

253

804

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2571

16593

1.44

61.98

2.5

3.3

46.50

48.42

u/ml

0.06

2486

16063

Examination and observation for other reasons

2067

7804

1.52

61.43

3.2

3.5

42.84

57.33

u/ml

1.25

1978

7578

Other diseases of urinary system

3585

14927

1.37

60.03

3.2

3.3

48.33

51.85

u/ml

0.26

3463

14465

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1204

3538

1.74

60.02

3.1

2.3

61.64

30.19

u/ml

2.14

1161

3452

Headache

2659

14667

1.43

59.74

2.7

3.1

35.65

46.77

u/ml

1.72

2559

14213

Tramadol

2893

12502

1.41

59.70

4.0

2.8

53.98

42.37

u/ml

1.50

2787

12122

Parasetamol

2347

8159

1.48

59.19

3.2

2.9

46.58

52.47

u/ml

0.45

2277

7893

Other diseases of blood and blood-forming organs, wide

870

4886

1.85

58.91

6.9

3.7

56.86

61.31

u/ml

0.20

844

4714

Malignant neoplasm of bronchus and lung, including Hilmo

450

1632

2.36

58.44

2.7

1.5

78.30

25.58

u/ml

4.90

432

1554

Hypothyroidism, other/unspecified

3486

17136

1.36

57.27

3.2

3.4

47.64

51.03

u/ml

0.25

3361

16574

Malignant neoplasm of rectum, including Hilmo

287

1041

2.85

56.87

3.5

1.5

38.44

27.50

u/ml

1.01

279

990

Hypothyreosis and Thyroxine purchase for inclusion criteria

3665

18139

1.34

56.06

3.2

3.4

50.52

51.55

u/ml

0.07

3535

17550

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1156

4742

1.68

54.92

3.7

1.5

61.69

24.07

u/ml

5.17

1113

4504

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1207

5005

1.66

53.70

3.7

1.5

67.14

23.85

u/ml

4.58

1164

4759

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

135

314

4.51

53.60

2.0

1.5

147.89

26.34

u/ml

2.62

129

298

Basal cell carcinoma

1120

4613

1.69

53.40

3.7

1.5

62.06

24.19

u/ml

4.80

1078

4385

Any reimbursement code in KELA

2189

7607

1.47

53.29

3.5

1.6

52.05

28.75

u/ml

3.21

2132

7348

Basal cell carcinoma, including Hilmo

1167

4832

1.66

53.01

3.6

1.5

68.03

24.12

u/ml

4.34

1124

4593

All kidney diseases

3688

18870

1.33

52.26

4.5

3.1

75.09

46.28

u/ml

2.58

3579

18242

Malignant neoplasm of pancreas, including Hilmo

226

755

3.12

52.23

2.2

1.5

219.58

25.91

u/ml

2.93

216

714

Irregular menses

2818

15681

1.39

52.06

2.4

3.3

36.25

47.28

u/ml

1.21

2722

15201

Non-small cell lung cancer, including Hilmo

322

1212

2.56

51.34

2.6

1.5

66.72

26.12

u/ml

2.86

309

1150

Other functional intestinal disorders

1728

10735

1.49

50.53

4.2

3.4

55.03

62.48

u/ml

0.54

1657

10404

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

121

273

4.64

49.92

2.0

1.5

132.75

25.24

u/ml

1.95

116

259

Pain in limb

3072

14618

1.35

49.60

3.2

3.4

57.42

53.15

u/ml

0.15

2952

14158

Misadventures to patients during surgical and medical care

599

3181

1.97

48.84

3.8

3.5

41.60

66.50

u/ml

2.25

576

3063

Ventral hernia

913

5490

1.72

48.36

4.5

3.9

42.98

71.48

u/ml

2.64

880

5293

Colectomy operation

577

3035

1.97

48.07

6.0

3.9

74.92

76.07

u/ml

0.03

562

2921

Benign leiomyoma with endometriosis

920

5633

1.73

47.39

3.1

4.0

40.04

71.41

u/ml

3.83

890

5433

Artificial opening status

230

828

2.98

47.36

8.4

3.5

81.19

89.35

u/ml

0.11

224

799

Enlarged lymph nodes

603

3233

1.93

47.33

3.9

3.3

58.78

61.18

u/ml

0.07

587

3129

Amenorrhoea

259

992

2.74

46.81

1.8

4.8

75.48

68.56

u/ml

0.05

251

959

Hypothyroidism, levothyroxine purchases

879

2861

1.76

46.80

2.5

1.6

30.30

25.19

u/ml

0.89

846

2774

Hypothyroidism and >3 levothyroxin purchases

879

2861

1.76

46.80

2.5

1.6

30.30

25.19

u/ml

0.89

846

2774

Malignant neoplasm of respiratory system and intrathoracic organs

412

1575

2.22

46.60

2.2

1.5

74.31

24.64

u/ml

5.05

398

1501

Hypothyroidism (congenital or acquired)

876

2862

1.75

45.84

2.5

1.6

30.26

25.19

u/ml

0.88

842

2775

Depression medications

959

2863

1.72

45.83

2.4

1.6

36.21

25.17

u/ml

1.80

922

2776

Renal tubulo-interstitial diseases

3206

17984

1.32

45.44

4.9

3.2

81.39

47.68

u/ml

2.70

3110

17374

Malignant melanoma, including Hilmo

428

2063

2.13

45.09

2.8

1.5

33.79

24.64

u/ml

0.74

411

1964

Codeine

3274

13523

1.32

44.46

2.9

2.7

47.44

41.25

u/ml

0.54

3151

13100

Low back pain

2886

14717

1.34

44.43

2.7

3.5

43.02

54.25

u/ml

1.12

2774

14266

Diverticular disease of intestine

2385

10888

1.38

44.05

3.2

3.5

41.98

61.90

u/ml

2.84

2294

10560

Malignant neoplasm of pancreas

180

587

3.19

43.46

1.6

1.5

256.36

26.29

u/ml

2.64

170

557

Pain (limb, back, neck, head abdominally)

2178

7839

1.41

43.38

3.4

58.03

54.62

u/ml

0.21

2094

7598

Malignant melanoma

384

1817

2.18

42.54

2.9

1.5

35.66

25.05

u/ml

0.78

369

1728

Malignant neoplasm of bronchus and lung

362

1376

2.25

42.50

2.4

1.5

79.58

25.36

u/ml

4.68

348

1307

Malignant neoplasm of other connective and soft tissue, including Hilmo

145

424

3.64

42.23

3.3

1.5

39.52

25.95

u/ml

0.91

140

404

Lower back pain or/and sciatica

3900

19142

1.28

42.23

2.8

3.4

44.10

52.83

u/ml

1.04

3744

18539

Other diseases of pleura

1165

6612

1.56

42.02

7.9

3.6

158.14

71.93

u/ml

4.39

1134

6353

Other female pelvic inflammatory diseases

912

5752

1.67

41.45

3.3

3.8

41.24

63.54

u/ml

2.44

863

5560

Oligomenorrhoea

165

532

3.35

41.40

2.5

5.1

29.75

79.70

u/ml

1.39

160

511

Intestinal adhesions without obstruction

349

1621

2.27

41.36

8.5

3.7

57.33

80.51

u/ml

0.84

338

1565

Right hemicolectomy

230

891

2.75

41.10

7.5

3.7

98.50

92.99

u/ml

0.06

225

859

Septicaemia

1241

7543

1.53

41.06

4.9

3.5

93.01

66.54

u/ml

0.54

1203

7269

Polycystic ovarian syndrome, consortium definition

4023

18415

1.28

40.79

2.9

3.5

47.53

52.28

u/ml

0.37

3875

17826

Diffuse large B-cell lymphoma

145

434

3.53

40.58

2.0

1.5

117.77

26.74

u/ml

2.32

140

412

Diffuse large B-cell lymphoma, helper endpoint

145

434

3.53

40.58

2.0

1.5

117.77

26.74

u/ml

2.32

140

412

Diffuse large B-cell lymphoma, including Hilmo

145

434

3.53

40.58

2.0

1.5

117.76

26.74

u/ml

2.32

140

412

Malignant neoplasm of urinary organs, including Hilmo

226

864

2.69

40.50

4.0

1.5

47.77

25.05

u/ml

1.93

213

818

Oedema, not elsewhere classified

1193

7760

1.54

40.47

4.3

3.5

77.18

58.61

u/ml

0.65

1154

7512

Hypothyroidism, strict autoimmune

2936

14808

1.32

40.04

3.3

3.4

50.80

50.32

u/ml

0.03

2833

14335

Constipation

3198

16858

1.30

39.70

3.9

3.5

60.18

53.65

u/ml

0.27

3072

16332

Disorders of gallbladder, biliary tract and pancreas

3545

17415

1.28

38.63

3.3

3.4

50.24

52.09

u/ml

0.16

3422

16870

Other complications of surgical and medical care, not elsewhere classified

431

2230

2.03

38.32

7.7

3.4

49.44

66.48

u/ml

0.88

418

2151

Benzodiazepine use

3602

19294

1.27

37.97

3.7

3.3

65.72

49.44

u/ml

1.03

3472

18675

Pain, not elsewhere classified

1116

7449

1.54

37.80

3.0

3.1

46.74

52.44

u/ml

0.18

1060

7205

Other septicaemia, including avohilmo

1114

6948

1.53

37.67

4.8

3.6

98.79

67.93

u/ml

0.58

1077

6694

Other septicaemia

1088

6794

1.54

37.42

4.8

3.6

100.36

66.38

u/ml

0.64

1052

6544

Hernia of abdominal wall

1361

9454

1.47

37.26

4.0

3.5

40.65

64.58

u/ml

3.69

1314

9125

Fistulae involving female genital tract

113

312

4.18

37.08

5.6

5.9

45.67

113.74

u/ml

0.97

108

302

Fenamates

565

2149

1.85

36.37

2.7

3.6

43.91

97.31

u/ml

3.38

548

2084

Other soft tissue disorders, not elsewhere classified

3274

14655

1.29

36.00

3.0

3.4

55.74

53.09

u/ml

0.09

3151

14194

156

536

3.27

35.95

4.7

2.2

35.87

37.72

u/ml

0.05

150

524

Persons encountering health services in circumstances related to reproduction

1914

9432

1.38

35.50

4.3

3.5

37.57

51.62

u/ml

2.99

1843

9143

Hypothyroidism, strict autoimmune, 3 medication purchases required

3386

18091

1.27

35.48

3.3

3.4

53.51

51.72

u/ml

0.11

3270

17504

Malignant neoplasm of rectum

210

828

2.61

35.47

2.1

1.5

35.01

24.30

u/ml

1.19

203

787

Other nutritional deficiencies

2598

18428

1.31

34.48

2.8

3.4

42.53

50.53

u/ml

0.98

2495

17853

Explicit Sepsis, including avohilmo

1397

8952

1.44

34.22

4.6

3.6

85.60

61.92

u/ml

0.55

1355

8661

All chronic kidney diseases

1635

9438

1.40

34.11

5.7

3.4

100.09

58.25

u/ml

1.40

1578

9111

Diseases of peritoneum

383

1980

2.02

34.04

3.4

3.5

69.23

68.54

u/ml

0.02

368

1915

Explicit Sepsis

1359

8722

1.44

33.91

4.6

3.6

87.13

62.09

u/ml

0.57

1318

8438

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

198

776

2.62

33.86

4.0

1.5

50.44

24.65

u/ml

1.95

187

736

Certain infectious and parasitic diseases

3503

13992

1.27

33.76

3.7

3.1

47.90

47.48

u/ml

0.04

3372

13563

Cholelithiasis

3148

17071

1.27

33.24

3.3

3.5

53.25

52.41

u/ml

0.05

3046

16533

Malignant neoplasm of urinary organs

189

736

2.64

32.76

3.7

1.5

48.90

25.05

u/ml

1.69

179

697

Urinary track infection

3341

13387

1.27

32.47

3.3

55.54

48.09

u/ml

0.32

3232

12970

Non-small cell lung cancer

188

725

2.62

32.28

2.1

1.5

78.94

23.37

u/ml

2.32

179

685

Dysphagia

737

4642

1.62

32.24

2.9

48.55

56.31

u/ml

0.27

707

4479

Cholelithiasis, broad definition with cholecystitis

3224

17152

1.27

32.17

3.4

3.5

53.25

52.28

u/ml

0.06

3120

16612

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

204

838

2.50

31.63

2.5

1.5

39.33

24.17

u/ml

1.68

198

795

Abnormalities of breathing

3176

14482

1.27

31.49

3.9

3.2

53.68

51.04

u/ml

0.18

3064

14072

Malignant melanoma of skin, including Hilmo

330

1657

2.04

31.28

2.5

1.5

34.01

25.54

u/ml

0.48

318

1575

Cholecystectomy

2708

18176

1.28

31.01

3.6

3.5

53.88

54.46

u/ml

0.03

2621

17577

Non-small cell lung cancer, adenocarcinoma

146

520

2.91

30.29

2.1

1.5

81.45

25.26

u/ml

1.66

140

494

Gastrointestinal diseases

2087

7938

1.33

29.67

3.2

3.0

49.76

51.06

u/ml

0.07

2017

7705

Diseases of oesophagus, stomach and duodenum

3711

17902

1.24

29.54

2.9

3.5

48.19

53.50

u/ml

0.55

3567

17362

Postprocedural endocrine and metabolic disorders, not elsewhere classified

626

3916

1.67

29.24

3.5

3.6

35.49

57.11

u/ml

2.08

608

3788

Inflammatory disease of uterus

756

4950

1.59

29.13

2.7

3.3

35.03

47.11

u/ml

0.79

729

4802

Other metabolic disorders

655

4154

1.64

28.82

3.5

34.65

56.75

u/ml

2.32

636

4015

Hypothyroidism, drug reimbursement

542

2240

1.74

28.79

2.8

1.6

25.20

24.06

u/ml

0.22

529

2179

Paracetamol or NSAID medication

390

1022

1.95

28.74

2.5

2.9

45.41

63.14

u/ml

0.72

371

990

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3268

16746

1.25

28.39

3.9

3.3

55.26

50.22

u/ml

0.39

3170

16202

Other anaemias

1243

8348

1.41

28.17

4.3

3.7

81.06

72.24

u/ml

0.26

1197

8039

Sequelae of external causes of morbidity and mortality

858

5792

1.52

27.68

3.7

61.64

69.25

u/ml

0.18

836

5587

Sequelae with surgical and medical care as external cause

695

4491

1.59

27.65

3.7

3.8

41.80

68.24

u/ml

3.40

681

4319

Malignant neoplasm of kidney, except renal pelvis

171

690

2.55

27.63

3.9

1.5

46.08

25.50

u/ml

1.38

162

653

Aplastic and other anaemias

1339

8929

1.39

27.56

4.8

3.7

81.30

70.71

u/ml

0.35

1290

8598

Disorders of eyelid, lacrimal system and orbit

3113

18512

1.25

27.51

3.0

3.5

40.64

55.51

u/ml

1.94

3009

17909

Abnormal findings on diagnostic imaging of lung

1375

9550

1.38

27.38

3.5

4.0

56.69

71.72

u/ml

1.32

1328

9228

Medical observation and evaluation for suspected diseases and conditions

2000

7806

1.32

27.25

3.0

3.5

56.39

57.32

u/ml

0.04

1924

7580

Other and unspecified anaemias

1222

8260

1.41

27.15

4.0

3.7

76.44

72.40

u/ml

0.11

1177

7956

Unspecific neurodegenerative disorder

531

5868

0.61

26.74

2.4

4.3

105.95

92.59

u/ml

0.18

504

5651

Adenocarcinoma and papilloma adenocarcinoma of rectum

188

805

2.39

26.66

2.4

1.5

39.39

24.33

u/ml

1.51

183

764

Adenocarcinoma and papillary adenocarcinoma of stomach

157

4.45

26.52

3.3

1.5

53.33

25.52

u/ml

1.34

150

Primary_lymphoid and hematopoietic malignant neoplasms

637

4065

1.60

26.50

2.8

4.1

119.60

78.97

u/ml

0.40

621

3908

Cardiovascular diseases (excluding rheumatic etc)

2417

10929

1.28

26.04

3.2

2.7

47.21

35.57

u/ml

1.25

2337

10599

Acute renal failure

534

3280

1.66

25.95

5.2

4.0

135.75

83.69

u/ml

1.81

510

3151

Malignant melanoma of skin

267

1336

2.05

25.69

2.6

1.5

37.78

23.21

u/ml

0.81

258

1268

Dermatitis and eczema

3836

18898

1.21

25.44

3.1

3.4

40.05

55.04

u/ml

3.82

3700

18282

Gastro-oesophageal reflux disease

2368

15904

1.27

25.42

2.9

3.7

46.99

56.23

u/ml

0.83

2272

15416

Dyspnoea

3108

18348

1.23

25.42

4.4

3.3

64.09

50.47

u/ml

1.19

2991

17758

Obesity

2404

18104

1.27

25.30

2.8

3.4

40.91

50.98

u/ml

1.47

2315

17535

Obesity and other hyperalimentation

2411

18153

1.26

25.09

2.8

3.4

40.83

50.97

u/ml

1.50

2322

17583

Intestinal infectious diseases, including avohilmo, including avohilmo

3955

18394

1.21

24.98

3.2

3.4

48.97

53.48

u/ml

0.42

3811

17801

In situ neoplasms

1521

11528

1.34

24.95

2.9

3.6

63.35

60.21

u/ml

0.06

1465

11137

Other disorders of skin and subcutaneous tissue

2519

17106

1.26

24.71

3.2

3.6

54.23

56.07

u/ml

0.09

2421

16549

Heartburn

376

2142

1.81

24.49

3.0

2.8

40.45

45.40

u/ml

0.22

365

2068

Other noninflammatory disorders of cervix uteri

222

1070

2.21

24.49

3.3

6.2

83.87

128.50

u/ml

0.57

209

1032

Other specific joint derangements/joint disorders

2601

13033

1.26

24.48

2.6

3.4

33.27

52.83

u/ml

5.21

2497

12639

Malignant neoplasm of endocrine gland, including Hilmo

276

1439

1.99

24.01

2.6

1.5

44.95

22.76

u/ml

1.47

269

1375

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2610

16440

1.25

23.96

2.7

3.3

36.58

48.53

u/ml

1.29

2520

15926

Conjunctivitis (acute, non atopic), including avohilmo

3421

17123

1.22

23.78

2.8

3.5

41.83

54.88

u/ml

2.48

3309

16558

Adenocarcinoma and ductal carcinoma of pancreas

317

3.20

23.67

1.7

1.5

155.39

24.60

u/ml

3.23

299

Degenerative diseases of the nervous system

417

4972

0.59

23.63

2.4

4.2

159.96

92.90

u/ml

0.89

392

4779

Other noninfective disorders of lymphatic vessels and lymph nodes

183

832

2.36

23.54

6.0

3.6

42.94

73.39

u/ml

1.00

178

804

Disorders of thyroid, IBD co-morbidities

722

3292

1.54

23.52

2.9

4.0

37.65

54.96

u/ml

1.54

695

3228

Obesity due to excess calories

1805

14129

1.30

23.19

2.9

3.3

41.70

49.37

u/ml

0.75

1734

13688

Major coronary heart disease event excluding revascularizations

973

8939

0.71

23.05

3.5

4.2

80.07

72.43

u/ml

0.18

932

8628

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

202

936

2.17

23.02

3.2

1.5

54.34

26.72

u/ml

1.17

195

876

Persons encountering health services in other circumstances

1388

10380

1.34

22.94

3.4

3.2

57.00

54.93

u/ml

0.10

1342

10025

Symptoms and signs involving the circulatory and respiratory systems

3475

14482

1.21

22.64

3.4

3.2

41.22

51.04

u/ml

1.73

3345

14072

Malaise and fatigue

1700

10374

1.31

22.53

4.0

3.4

83.42

52.68

u/ml

2.11

1625

10036

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

314

1749

1.88

22.53

4.2

3.4

45.04

65.61

u/ml

0.84

304

1690

Alzheimer disease, including avohilmo

462

5117

0.62

22.53

2.6

4.3

142.96

95.40

u/ml

0.64

436

4924

Malignant neoplasm of thyroid gland, including Hilmo

253

1315

2.00

22.30

2.4

1.5

40.96

23.27

u/ml

1.15

247

1258

Anxiety disorders, excluding more controls

3034

16017

1.22

22.18

3.3

3.5

51.98

50.26

u/ml

0.06

2919

15537

Follow-up care involving plastic surgery

202

980

2.21

22.16

2.6

51.50

50.67

u/ml

0.01

197

948

Other diseases of intestine

468

2903

1.65

22.16

4.3

3.7

54.35

67.43

u/ml

0.47

451

2804

Need for other prophylactic measures

200

959

2.18

22.10

7.1

3.5

39.46

74.47

u/ml

1.54

189

928

Dementia

615

6300

0.66

22.03

2.7

4.4

82.78

88.66

u/ml

0.09

588

6064

Myocardial infarction, strict

578

6192

0.65

21.79

3.7

4.3

94.82

81.45

u/ml

0.21

552

5964

Myocardial infarction

673

6891

0.67

21.50

3.6

4.3

93.07

77.29

u/ml

0.31

644

6642

Phlebitis and thrombophlebitis (not including DVT)

775

5407

1.47

21.29

4.5

3.5

74.75

68.15

u/ml

0.14

754

5210

Alzheimer disease

377

4457

0.60

21.22

2.5

4.2

173.55

97.69

u/ml

0.92

354

4277

Disorders of breast

2630

19105

1.23

21.13

3.3

3.5

55.99

51.85

u/ml

0.13

2551

18491

Mesothelioma

7.87

21.08

1.9

1.6

87.70

38.17

u/ml

0.41

Anxiety disorders

3278

18838

1.20

20.93

3.3

3.4

50.18

51.55

u/ml

0.05

3158

18239

Neurotic, stress-related and somatoform disorders

3255

18774

1.21

20.92

3.3

3.4

50.41

51.16

u/ml

0.03

3136

18177

Cardiovascular diseases

2200

9358

1.26

20.86

2.9

2.7

42.81

36.42

u/ml

0.51

2124

9091

Dementia, including avohilmo

676

6702

0.68

20.70

2.8

4.3

84.56

87.28

u/ml

0.04

644

6452

Codeine or tramadol medication

3865

17796

1.19

20.66

2.9

3.4

51.38

52.49

u/ml

0.06

3723

17231

Migraine

2268

14328

1.25

20.65

2.5

3.5

32.65

46.97

u/ml

3.58

2183

13909

Acute tubulo-interstitial nephritis

2189

14948

1.25

20.55

4.0

3.2

77.61

50.54

u/ml

1.06

2126

14433

543

3569

1.56

20.26

5.0

3.1

97.35

55.03

u/ml

0.35

525

3468

N06DA Anticholinesterases

431

5231

0.63

19.78

2.3

4.3

100.13

101.57

u/ml

0.01

408

5029

Use of anticholinesterases

431

5231

0.63

19.78

2.3

4.3

100.13

101.57

u/ml

0.01

408

5029

Benign neoplasm of colon, rectum, anus and anal canal

1922

13014

1.26

19.75

3.1

4.0

46.15

67.18

u/ml

3.23

1850

12570

Migraine, single triptan purchase ok & required. ICD-code if available is included

3011

17064

1.21

19.66

2.7

3.5

33.50

50.92

u/ml

4.75

2924

16522

Triptan medication for migraine, single purchase ok

3011

17064

1.21

19.66

2.7

3.5

33.50

50.92

u/ml

4.75

2924

16522

Malignant neoplasm of endocrine gland

235

1245

1.96

19.60

2.3

1.5

35.58

23.66

u/ml

0.81

229

1191

Non-follicular lymphoma

259

1413

1.89

19.60

2.8

3.8

99.13

82.03

u/ml

0.33

250

1361

Colon adenocarcinoma, helper endpoint

344

2039

1.73

19.51

2.7

4.3

66.77

93.59

u/ml

1.09

336

1954

Acute upper respiratory infections

3641

18535

1.19

19.37

3.2

3.4

45.48

54.50

u/ml

0.52

3508

17945

Any dementia

522

5441

0.65

19.36

2.8

4.2

113.57

94.34

u/ml

0.27

499

5238

Other antidepressants

3220

13789

1.20

19.20

3.2

3.5

57.44

53.21

u/ml

0.16

3103

13358

Other diseases of peritoneum

202

1033

2.08

19.14

2.8

3.5

45.79

69.91

u/ml

0.84

194

999

Contraceptive management

1412

7633

1.31

19.01

2.8

3.3

30.44

44.86

u/ml

3.07

1362

7411

Metabolic disorders

3167

15989

1.20

18.81

4.0

3.3

53.89

52.58

u/ml

0.10

3060

15488

Alzheimer’s disease, strict definition

276

3852

0.57

18.79

2.6

4.2

194.51

96.12

u/ml

0.92

260

3685

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3425

18637

1.19

18.65

2.9

3.4

47.89

53.15

u/ml

0.46

3304

18035

Dorsalgia

3299

14749

1.19

18.60

3.0

3.5

46.19

54.19

u/ml

0.72

3173

14296

Organic, including symptomatic, mental disorders

800

7786

0.71

18.48

2.9

4.2

85.82

79.91

u/ml

0.11

769

7498

Benign neoplasm: Colon

1584

11760

1.28

18.41

3.1

4.1

47.49

69.24

u/ml

2.74

1522

11358

Unspecified misadventure during surgical and medical care

202

1042

2.03

18.40

2.7

3.5

36.35

68.12

u/ml

1.50

190

1005

Atrophic disorders of skin

738

5287

1.44

17.98

2.9

4.0

51.36

67.79

u/ml

0.38

708

5103

Coxibs

655

2341

1.48

17.94

2.8

3.5

49.66

93.14

u/ml

2.55

630

2268

Disorders of conjunctiva

3051

19996

1.19

17.84

2.8

3.4

48.43

52.19

u/ml

0.15

2944

19346

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3052

20092

1.19

17.84

3.0

3.4

36.05

54.38

u/ml

6.41

2946

19435

Asthma, unspecified (mode)

1911

11153

1.25

17.72

3.2

47.62

47.22

u/ml

0.02

1833

10810

Acute peritonitis

179

896

2.07

17.59

4.0

3.3

94.84

78.70

u/ml

0.33

172

866

Malignant neoplasm of thyroid gland

222

1203

1.92

17.36

2.3

1.5

36.78

23.88

u/ml

0.84

217

1149

Asthma, unspecified (mode), excluding more controls

1864

10783

1.25

17.33

3.2

46.95

45.41

u/ml

0.07

1792

10458

Pain in throat and chest

2845

14167

1.20

17.01

3.2

40.56

51.58

u/ml

1.82

2729

13771

Symptoms and signs involving the skin and subcutaneous tissue

2510

19848

1.21

16.94

3.0

3.4

41.81

54.09

u/ml

2.25

2419

19215

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

321

1956

1.69

16.65

4.5

3.5

56.78

67.93

u/ml

0.30

309

1885

Alzheimer’s disease (Late onset)

248

3510

0.57

16.61

2.5

4.3

156.88

98.58

u/ml

0.74

234

3358

General examination and investigation of persons without complaint and reported diagnosis

1863

7805

1.25

16.59

3.4

3.5

60.52

57.32

u/ml

0.07

1817

7579

Hypertension, essential

2652

12558

1.20

16.59

3.5

3.3

40.33

48.80

u/ml

1.48

2580

12161

Other disorders of fluid, electrolyte and acid-base balance

926

6521

1.36

16.57

4.7

3.9

88.10

75.63

u/ml

0.50

888

6290

Any dementia, excluding more controls

501

5031

0.67

16.03

2.9

4.3

106.35

84.80

u/ml

0.31

478

4858

Sleep disorders

3204

18907

1.18

15.80

2.5

3.6

37.92

54.86

u/ml

2.56

3104

18288

Other diseases of anus and rectum

915

6869

1.35

15.69

3.7

3.5

43.28

72.54

u/ml

2.82

884

6640

Hypertensive diseases (excluding secondary)

1884

8942

1.24

15.68

3.5

2.9

43.61

37.22

u/ml

0.76

1830

8682

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

324

2012

1.66

15.67

8.0

3.3

50.80

69.11

u/ml

0.77

317

1943

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1706

8701

1.25

15.60

3.9

2.9

48.51

37.53

u/ml

1.59

1655

8443

Bacterial Sepsis

1211

7812

1.29

15.50

4.3

3.8

74.25

68.41

u/ml

0.33

1159

7548

Adenocarcinoma of pancreas

238

3.02

15.45

1.6

1.5

133.83

27.01

u/ml

4.28

230

Other reaction to severe stress, and adjustment disorders

1414

11308

1.27

15.32

3.9

3.1

68.46

43.96

u/ml

0.59

1369

10955

Malignant neoplasm of bladder, including Hilmo

106

445

2.38

15.31

3.9

1.4

46.19

24.84

u/ml

1.54

100

419

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

906

6880

1.35

15.26

2.5

3.3

27.85

47.60

u/ml

5.90

870

6661

Other special examinations and investigations of persons without complaint or reported diagnosis

1889

7807

1.24

15.15

2.8

3.5

40.81

57.35

u/ml

2.94

1826

7581

Factors influencing health status and contact with health services

603

2097

1.46

15.05

3.2

2.6

63.65

52.29

u/ml

0.40

580

2039

Coronary atherosclerosis

1241

9906

0.78

14.98

3.4

4.3

66.81

68.71

u/ml

0.05

1195

9570

Depression

3298

19011

1.17

14.95

2.8

3.5

53.48

51.10

u/ml

0.09

3180

18405

Insomnia

3198

19152

1.17

14.94

2.4

3.5

38.00

54.61

u/ml

2.47

3098

18522

Ovarian dysfunction

372

2423

1.60

14.93

2.6

2.4

25.38

41.30

u/ml

1.98

360

2353

Dental caries

726

5016

1.39

14.93

3.6

3.8

50.08

67.50

u/ml

1.05

704

4888

Behavioural syndromes associated with physiological disturbances and physical factors

3247

18936

1.17

14.81

2.5

3.5

38.96

54.89

u/ml

2.31

3140

18316

Disorders of calcium metabolism

237

1378

1.79

14.81

3.1

3.8

56.21

80.85

u/ml

0.81

230

1328

Other and unspecified drugs and medicaments

307

1915

1.66

14.66

8.3

3.5

52.31

66.56

u/ml

0.53

300

1850

Lung cancer and mesothelioma

471

2714

1.50

14.54

2.8

3.9

76.74

71.06

u/ml

0.17

453

2615

Neurological diseases, wide definition

940

3553

1.34

14.52

2.2

3.8

34.05

52.56

u/ml

2.21

902

3474

COPD/asthma/ILD related infections

3632

15787

1.16

14.45

3.6

3.3

55.62

51.53

u/ml

0.19

3506

15290

COPD/asthma related infections

3632

15787

1.16

14.45

3.6

3.3

55.62

51.53

u/ml

0.19

3506

15290

Polycystic ovarian syndrome, broad definition

529

3722

1.47

14.41

2.2

2.3

23.62

32.19

u/ml

3.79

512

3606

Alzheimer’s disease (Late onset), excluding more controls

183

2132

0.55

14.26

2.6

5.1

86.74

86.73

u/ml

0.00

174

2077

Renal failure

1063

7037

1.30

14.12

4.6

3.9

107.33

78.44

u/ml

1.31

1017

6771

Benign neoplasm of other and ill-defined parts of digestive system

587

4209

1.43

14.11

2.8

4.0

59.95

68.83

u/ml

0.13

558

4057

Caries of dentine

632

4407

1.40

14.11

3.6

3.8

52.35

68.57

u/ml

0.80

610

4292

Selective serotonin reuptake inhibitors

3088

13796

1.17

14.02

3.1

3.5

57.58

53.20

u/ml

0.16

2974

13365

Acetic acid derivatives and related substances

635

2333

1.42

13.99

3.0

3.5

47.41

93.41

u/ml

2.79

617

2260

Oxicams

540

2126

1.46

13.94

3.1

3.7

56.37

99.17

u/ml

2.00

517

2061

Other embolism and thrombosis

386

2565

1.54

13.80

5.0

3.8

66.57

68.39

u/ml

0.05

374

2464

Infections of the skin and subcutaneous tissue

1691

13709

1.22

13.70

3.4

3.3

41.59

53.62

u/ml

1.59

1629

13252

Major coronary heart disease event

1939

13876

0.83

13.51

3.4

3.9

64.69

59.25

u/ml

0.26

1878

13422

Use of memantine

330

4057

0.65

13.42

2.3

4.2

154.70

104.06

u/ml

0.46

304

3890

Use of other anti-dementia drugs

330

4057

0.65

13.42

2.3

4.2

154.70

104.06

u/ml

0.46

304

3890

Other dorsopathies, not elsewhere classified

3279

14754

1.16

13.42

3.0

3.5

43.85

54.18

u/ml

1.10

3153

14301

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

186

3.11

13.40

3.0

1.5

140.13

25.81

u/ml

0.74

179

Chronic lymphocytic leukaemia, helper endpoint

186

3.11

13.40

3.0

1.5

140.13

25.81

u/ml

0.74

179

Chronic lymphocytic leukaemia

186

3.11

13.40

3.0

1.5

140.13

25.81

u/ml

0.74

179

Excluding asthma or asthma-COPD overlap

2691

11508

1.18

13.34

3.6

3.2

53.16

46.75

u/ml

0.72

2597

11151

Mood [affective] disorders

3437

19196

1.15

13.30

2.9

3.5

55.38

51.43

u/ml

0.16

3309

18582

3923

17456

1.15

13.25

3.3

3.4

52.20

53.22

u/ml

0.04

3776

16906

Other diseases of biliary tract

277

1728

1.65

13.18

5.4

4.2

86.67

80.15

u/ml

0.10

266

1666

Dementia in Alzheimer disease

176

2600

0.56

13.17

2.1

4.3

211.29

107.52

u/ml

0.97

163

2478

Depression or dysthymia

2011

9164

1.21

13.14

3.0

3.8

70.32

57.76

u/ml

0.35

1933

8903

Injuries to the head

2929

20065

0.86

13.11

3.1

3.4

44.34

52.91

u/ml

1.12

2819

19416

Recurrent or chronic depression

1424

8008

1.25

13.07

2.8

3.8

53.32

52.62

u/ml

0.01

1379

7787

Mood disorders

3438

19198

1.15

13.01

2.9

3.5

55.36

51.44

u/ml

0.16

3310

18583

Iron deficiency anaemia

1393

11118

1.24

12.94

2.9

3.6

69.95

63.35

u/ml

0.17

1339

10738

Other degenerative diseases of the nervous system

536

5421

0.71

12.91

2.3

4.3

91.65

63.81

u/ml

0.49

510

5272

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2553

16143

1.18

12.87

2.7

3.3

36.21

47.47

u/ml

1.15

2466

15645

Other pulmonary diagnosis

2681

11508

1.18

12.72

3.7

3.2

53.47

46.75

u/ml

0.76

2590

11151

Anosmia

328

2.51

12.66

4.1

1.5

43.47

32.16

u/ml

0.33

321

Implicit bacterial Sepsis, including avohilmo

1146

7586

1.27

12.61

4.1

3.9

73.24

69.71

u/ml

0.18

1092

7328

Other symptoms and signs involving the urinary system

233

1403

1.69

12.61

3.9

3.5

54.10

78.92

u/ml

0.49

226

1358

Osteopathies and chondropathies

1904

14625

1.20

12.53

3.3

3.7

51.54

61.20

u/ml

0.90

1833

14140

Nutritional anaemias

1570

12366

1.22

12.47

3.1

3.6

72.07

62.21

u/ml

0.31

1512

11948

Faecal incontinence

347

2313

1.54

12.45

3.5

3.0

82.99

68.92

u/ml

0.14

333

2228

Endocrine, nutritional and metabolic diseases

2541

10969

1.18

12.34

3.1

3.3

43.10

47.80

u/ml

0.47

2454

10640

Irritable bowel syndrome

1053

8369

1.28

12.32

2.5

3.2

32.61

59.68

u/ml

4.04

997

8114

Explicit bacterial Sepsis

260

1620

1.64

12.30

4.9

3.5

58.96

71.67

u/ml

0.40

255

1561

COPD differential diagnosis

2669

11487

1.17

12.28

3.6

3.2

53.47

46.81

u/ml

0.75

2577

11134

Brain meningioma, including Hilmo

152

820

1.92

12.21

2.5

1.5

66.31

22.88

u/ml

0.60

145

782

Other noninfective gastroenteritis and colitis

762

5808

1.33

12.20

3.1

3.6

67.31

68.37

u/ml

0.02

742

5606

Lichen sclerosus et atrophicus

529

3842

1.42

12.16

3.0

4.0

56.27

66.23

u/ml

0.15

514

3708

ILD differential diagnosis

2667

11486

1.17

12.16

3.6

3.2

53.50

46.81

u/ml

0.75

2575

11133

Papillary adenocarcinoma of thyroid gland

167

931

1.86

12.12

2.3

1.5

36.60

23.34

u/ml

0.62

162

890

Brain meningioma

149

801

1.93

12.11

2.6

1.5

65.56

23.02

u/ml

0.57

142

765

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

143

756

1.93

12.04

3.0

1.5

48.01

23.94

u/ml

1.90

137

723

Other diseases of the digestive system

701

5288

1.34

11.99

3.1

3.7

51.49

82.73

u/ml

3.03

681

5068

Implicit bacterial Sepsis

1007

6820

1.28

11.88

4.2

3.9

76.94

71.99

u/ml

0.23

959

6583

Sciatica+with lumbago

1792

13326

1.20

11.87

2.6

3.7

51.40

56.77

u/ml

0.22

1710

12922

Disorders of mineral metabolism

276

1767

1.61

11.85

3.2

3.7

55.01

80.51

u/ml

1.00

266

1710

Cough

1398

10714

1.23

11.84

3.5

46.11

58.23

u/ml

1.15

1335

10406

Covid-19 confirmed case

1022

8109

1.27

11.81

3.9

3.4

51.34

68.97

u/ml

1.49

983

7815

Asthma (diagnoses ohter than nonallergic)

2875

20237

1.15

11.66

2.9

3.4

45.63

52.88

u/ml

0.61

2768

19580

Explicit bacterial Sepsis, including avohilmo

264

1675

1.61

11.61

4.9

3.4

58.32

72.52

u/ml

0.47

259

1615

Persons with potential health hazards related to communicable diseases

1238

9983

1.24

11.60

3.1

2.8

28.05

42.55

u/ml

6.11

1196

9653

Other chronic obstructive pulmonary disease, including avohilmo

841

8840

0.77

11.56

2.8

4.0

67.71

71.12

u/ml

0.13

798

8533

DVT of lower extremities

524

3812

1.40

11.54

6.0

3.8

68.22

72.38

u/ml

0.14

505

3660

Hypertension

2638

12852

1.17

11.54

3.4

3.3

43.27

48.23

u/ml

0.61

2563

12452

Care involving use of rehabilitation procedures

1901

14460

1.19

11.53

3.3

2.6

65.53

35.12

u/ml

1.06

1811

13962

Alzheimer disease, excluding more controls

267

2673

0.64

11.52

2.5

5.0

149.45

82.47

u/ml

0.63

252

2601

Hypertensive diseases

2637

12858

1.16

11.43

3.4

3.3

43.27

48.22

u/ml

0.61

2563

12458

Erysipelas

1415

10054

1.22

11.32

3.6

3.5

68.18

61.28

u/ml

0.28

1361

9701

Angina pectoris

1065

8793

0.80

11.31

3.3

4.3

68.11

72.56

u/ml

0.11

1019

8489

Haemorrhoids and perianal venous thrombosis

1002

7933

1.27

11.26

3.0

3.5

42.64

71.46

u/ml

3.09

966

7678

Other and unspecified iron deficiency

1099

8854

1.25

11.15

2.7

3.6

69.00

66.99

u/ml

0.04

1056

8547

Ischaemic heart disease, wide definition

1683

12320

0.83

11.13

3.5

4.1

66.47

63.15

u/ml

0.12

1621

11904

Use of hypnotics and sedatives

3411

17188

1.14

11.08

3.6

3.3

48.92

51.39

u/ml

0.24

3290

16646

Certain infectious and parasitic diseases, including avohilmo

2357

10132

1.17

11.05

3.6

3.3

50.66

52.40

u/ml

0.13

2263

9828

Stroke, including SAH

1174

10344

0.81

11.05

3.1

4.0

118.55

65.18

u/ml

1.11

1118

9996

COPD

645

6894

0.75

10.99

2.7

4.2

64.80

77.42

u/ml

0.55

611

6656

Inguinal hernia

639

5617

0.75

10.96

3.1

3.5

49.16

73.34

u/ml

0.94

618

5417

Renal cell carcinoma of kidney

226

2.68

10.92

5.1

1.5

52.61

28.06

u/ml

0.71

219

Episodal and paroxysmal disorders

3615

16230

1.14

10.84

2.7

3.5

54.47

52.97

u/ml

0.06

3478

15733

Benign thyroid growths and nodules

1370

10552

1.22

10.84

3.0

3.9

56.50

61.83

u/ml

0.15

1325

10196

Asthma (mode)

2527

11486

1.16

10.70

3.0

3.2

44.37

46.81

u/ml

0.14

2438

11133

Other bacterial intestinal infections

509

3738

1.38

10.61

3.8

3.7

65.96

71.92

u/ml

0.21

487

3609

Coronary revascularization (ANGIO or CABG)

1856

13242

0.84

10.60

3.2

4.0

60.60

59.61

u/ml

0.04

1792

12810

Other chronic obstructive pulmonary disease

610

6582

0.75

10.57

2.7

4.2

66.84

78.94

u/ml

0.49

578

6349

Conjunctivitis

2817

19888

1.15

10.56

2.9

3.4

48.13

51.99

u/ml

0.14

2722

19241

Percutaneous Coronary Intervention

1856

13239

0.85

10.42

3.2

4.0

59.66

59.62

u/ml

0.00

1790

12807

Codes for special purposes

1646

13785

1.19

10.39

3.6

3.2

42.91

57.90

u/ml

2.30

1587

13325

Provisional assignment of new diseases of uncertain etiology

1644

13773

1.19

10.35

3.6

3.3

42.85

57.91

u/ml

2.31

1585

13313

Other disorders of breast

669

5165

1.33

10.30

2.7

3.6

35.63

55.84

u/ml

3.36

649

4993

Functional dyspepsia

981

7907

1.26

10.25

3.0

3.7

43.27

62.86

u/ml

1.64

942

7663

Other CVD

467

3407

1.39

10.10

3.0

4.0

80.25

93.17

u/ml

0.17

457

3256

Infections, IBD-co-morbidities

492

2527

1.39

10.06

3.8

4.4

54.63

63.58

u/ml

0.35

470

2474

Diseases of the digestive system

1171

9550

1.23

9.95

3.8

3.6

50.03

68.08

u/ml

2.12

1136

9207

Use of rivastigmine

171

2800

0.60

9.95

2.3

4.1

49.13

108.26

u/ml

3.79

163

2663

Follicular adenocarcinoma of thyroid gland, including Hilmo

143

3.16

9.95

1.6

1.4

38.20

28.18

u/ml

0.33

138

Diseases of arteries, arterioles and capillaries

1216

10787

0.82

9.91

3.0

3.9

52.53

70.84

u/ml

1.79

1173

10410

Mood disorders, excluding more controls

3091

16046

1.14

9.89

2.9

3.5

57.81

50.39

u/ml

0.31

2974

15564

GI-bleeding

670

5165

1.31

9.88

3.2

3.7

52.37

83.86

u/ml

2.93

650

4950

Other diseases of pancreas

229

1467

1.60

9.85

2.8

4.0

33.08

80.22

u/ml

3.73

222

1413

Other/unspecified dorsalgia

1288

10576

1.22

9.81

3.3

3.7

58.20

61.04

u/ml

0.08

1240

10235

Coronary artery bypass grafting

153

1922

0.58

9.77

3.3

4.1

189.70

111.83

u/ml

0.42

145

1826

Other postsurgical states

205

1284

1.64

9.76

4.1

3.5

27.77

77.04

u/ml

3.73

197

1239

Coagulation defects, purpura and other haemorrhagic conditions

556

4196

1.35

9.74

5.5

3.4

62.66

61.25

u/ml

0.04

539

4045

Carcinoma in situ of cervix uteri, endocervix

369

2.33

9.65

1.8

2.5

19.55

36.64

u/ml

1.54

358

Benign neoplasm: Adrenal gland

249

1640

1.56

9.57

2.8

3.8

35.56

74.55

u/ml

3.07

241

1583

Emergency coronary revascularization (for ACS)

1977

13833

0.86

9.52

3.2

4.0

60.98

60.74

u/ml

0.01

1905

13375

Asthma (only as main-diagnosis)

2350

11420

1.16

9.51

2.7

3.2

43.63

46.82

u/ml

0.19

2261

11068

Benign neoplasm: Colon, unspecified

613

4706

1.32

9.47

3.0

4.2

39.61

79.41

u/ml

3.84

587

4527

Use of donepezil

251

3570

0.66

9.39

2.0

4.1

98.92

100.81

u/ml

0.01

237

3408

Erosion and ectropion of cervix uteri

105

555

1.98

9.23

3.6

6.0

100.00

111.13

u/ml

0.08

535

Cirrhosis of liver, NAS

133

753

1.82

9.21

2.8

3.8

205.36

90.11

u/ml

2.54

127

731

Asthma (only as main-diagnosis), excluding more controls

2297

11048

1.16

9.21

2.7

3.2

43.64

45.05

u/ml

0.07

2216

10714

Stroke, excluding SAH

1081

9469

0.82

9.16

3.1

4.1

122.78

67.77

u/ml

1.03

1025

9150

Other headache syndromes

1654

14111

1.18

9.11

2.5

3.6

35.88

53.94

u/ml

4.67

1581

13689

Hypokalaemia

389

2814

1.41

9.08

4.4

3.8

61.89

81.01

u/ml

0.88

377

2711

Persons encountering health services for examination and investigation

1821

7807

1.18

9.03

3.1

3.5

47.63

57.35

u/ml

1.07

1764

7581

All anxiety disorders

2218

15018

1.15

9.02

2.8

3.2

49.46

47.43

u/ml

0.05

2146

14557

Ischemic heart diseases

2038

13968

0.86

9.00

3.4

3.9

62.78

57.97

u/ml

0.23

1970

13517

Implicit viral Sepsis, including avohilmo

831

6653

1.26

8.98

3.3

3.7

55.76

64.90

u/ml

0.49

788

6424

Other bacterial intestinal infections, including avohilmo

687

5398

1.29

8.93

3.5

3.6

57.06

71.73

u/ml

0.75

659

5218

Cutaneous abscess, furuncle and carbuncle

701

5520

1.28

8.91

3.2

3.3

35.48

53.06

u/ml

2.91

679

5344

Spondylopathies in diseases classified elsewhere

176

2.78

8.81

1.8

3.7

201.96

153.30

u/ml

0.15

169

Other gastritis (incl. Duodenitis)

594

4589

1.31

8.81

2.8

4.0

51.13

77.59

u/ml

1.40

572

4434

Unspecified lump in breast

743

5941

1.28

8.70

4.0

3.8

81.53

61.32

u/ml

0.21

730

5731

Abnormalities of heart beat

1197

9698

1.21

8.69

3.3

3.4

48.34

59.84

u/ml

0.45

1163

9411

Sleep disorders (combined)

3597

16867

1.12

8.64

2.7

3.6

45.52

56.63

u/ml

1.29

3471

16323

Cardiac arrhythmias

2191

12263

1.15

8.63

2.9

3.3

41.19

39.70

u/ml

0.13

2094

11912

Convalescence

192

1224

1.62

8.63

3.4

2.6

43.08

45.88

u/ml

0.06

185

1177

Dorsopathies

3266

14769

1.13

8.57

2.9

3.5

46.10

54.18

u/ml

0.73

3147

14316

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

125

3.31

8.57

4.3

2.3

47.54

40.83

u/ml

0.15

119

Acute pharyngitis

384

2764

1.39

8.57

2.4

2.7

31.81

49.25

u/ml

1.48

370

2680

Bacterial intestinal infections, IBD co-morbidities

500

3796

1.34

8.47

3.8

3.6

67.41

71.53

u/ml

0.13

477

3656

Substance abuse, excluding more controls

979

9931

0.82

8.44

2.7

3.4

52.04

46.27

u/ml

0.30

943

9640

Unstable angina pectoris

495

5107

0.75

8.43

2.6

4.3

88.24

88.05

u/ml

0.00

471

4904

Dentofacial anomalies [including malocclusion]

2626

18217

1.14

8.41

2.4

3.5

33.79

49.69

u/ml

3.74

2534

17649

Purpura and other haemorrhagic conditions

353

2543

1.41

8.41

7.3

3.4

82.25

66.09

u/ml

0.40

344

2457

Noninfectious colitis NAS

415

3076

1.37

8.34

3.3

3.6

83.94

64.89

u/ml

0.24

405

2966

COPD, early/later onset

610

6531

0.78

8.32

2.7

4.1

66.84

75.18

u/ml

0.30

578

6293

Peripheral artery disease

559

5698

0.77

8.31

3.0

4.1

54.47

87.44

u/ml

2.38

539

5469

Carcinoma in situ of breast, intraductal

407

3032

1.39

8.28

2.7

4.2

114.58

65.83

u/ml

0.29

391

2928

Colonic or urogenital fistula

747

5989

1.26

8.23

3.4

3.6

38.99

56.13

u/ml

2.38

717

5787

Diseases of the skin and subcutaneous tissue

3098

13881

1.13

8.15

3.1

3.5

52.09

55.46

u/ml

0.22

3002

13424

Asthma

2510

11420

1.14

8.14

2.9

3.2

43.39

46.82

u/ml

0.21

2416

11068

All dysplastic lesions of the cervix uteri, vagina or vulva

1420

11848

1.19

8.13

2.5

3.0

39.39

41.51

u/ml

0.08

1379

11488

Chronic diseases of tonsils and adenoids

2686

15043

1.13

8.12

2.8

3.6

34.22

53.29

u/ml

5.45

2583

14580

Polycystic ovarian syndrome

252

1730

1.50

8.10

1.8

2.3

21.28

32.45

u/ml

3.03

243

1677

Other heart diseases, wide

3098

16781

1.12

8.09

3.1

3.4

46.58

48.89

u/ml

0.21

2967

16289

Sulfonylureas

398

4256

0.74

8.07

3.0

4.4

111.12

90.32

u/ml

0.25

379

4091

912

9647

0.82

8.04

2.6

3.4

62.59

51.39

u/ml

0.57

877

9330

Varicose veins

2005

13234

1.15

8.02

3.7

77.64

55.61

u/ml

1.02

1938

12791

Ischaemic Stroke, excluding all haemorrhages

988

8779

0.82

8.01

3.0

4.1

99.45

70.87

u/ml

0.87

935

8481

COPD, hospital admissions

605

6468

0.78

7.94

2.7

4.1

67.18

75.42

u/ml

0.30

574

6232

Implicit Sepsis

2178

14104

1.14

7.88

3.8

3.6

74.40

55.55

u/ml

1.45

2070

13654

Asthma, excluding more controls

2438

11048

1.14

7.86

2.9

3.2

43.57

45.05

u/ml

0.08

2351

10714

Autoimmune diseases related-to ILD

2692

20044

1.13

7.86

2.6

3.4

45.78

53.01

u/ml

0.83

2599

19392

Fissure and fistula of anal and rectal regions

658

5228

1.27

7.85

3.2

36.79

64.93

u/ml

2.88

629

5058

Oral corticosteroids

3428

18117

1.11

7.81

3.0

3.5

46.03

53.87

u/ml

1.11

3312

17542

Certain disorders involving the immune mechanism

525

4067

1.31

7.74

3.2

3.7

47.59

62.43

u/ml

0.99

502

3931

Diseases of liver

917

7562

1.22

7.73

3.3

3.8

84.63

59.86

u/ml

1.56

876

7315

Symptoms and signs concerning food and fluid intake

292

2064

1.44

7.72

2.8

3.6

82.60

63.79

u/ml

0.26

279

1987

Cerebrovascular diseases

1557

12508

0.86

7.70

3.1

4.0

102.34

60.72

u/ml

1.13

1494

12079

Other disorders of the genitourinary system

503

3899

1.32

7.60

3.7

4.0

47.23

65.89

u/ml

0.75

490

3758

Atherosclerosis, excluding cerebral and coronary sclerosis

509

5153

0.77

7.54

2.9

4.1

56.02

91.04

u/ml

2.27

492

4940

Sequelae of cerebrovascular disease

524

5737

0.77

7.51

2.5

4.1

157.37

73.93

u/ml

0.75

503

5519

Nontoxic goitre/thyroid nodule

1168

9902

1.20

7.49

2.9

4.0

49.37

68.61

u/ml

0.90

1129

9568

COPD (mode)

458

4654

0.76

7.43

2.6

3.9

71.18

62.64

u/ml

0.29

433

4493

Candidiasis, including avohilmo

1113

9398

1.20

7.40

2.8

3.5

42.39

59.15

u/ml

1.41

1073

9086

Hard cardiovascular diseases

2149

14362

0.88

7.37

3.3

3.8

76.37

53.45

u/ml

0.87

2080

13910

Propionic acid derivatives

601

2360

1.29

7.36

2.8

3.5

54.00

92.69

u/ml

1.92

581

2287

Spondylosis

1653

11211

1.16

7.36

2.7

4.0

37.04

61.53

u/ml

5.83

1594

10858

Chronic kidney disease

598

4550

1.27

7.31

3.6

3.8

77.59

84.55

u/ml

0.16

571

4360

Soft tissue disorders

3179

14660

1.12

7.28

3.1

3.4

49.81

53.09

u/ml

0.23

3060

14199

Other intervertebral disc disorders

2612

13895

1.13

7.26

3.0

3.6

45.44

55.88

u/ml

1.26

2512

13480

Other heart diseases

1539

8631

1.17

7.26

3.0

2.9

49.17

37.83

u/ml

1.28

1480

8373

ILD medications: prednisolone, methylprednisolone, prednisone

3485

17541

1.11

7.25

3.0

3.5

43.23

53.23

u/ml

1.90

3366

16977

Status post-ami

219

2422

0.68

7.22

2.7

4.1

143.94

104.31

u/ml

0.28

208

2307

Umbilical hernia

559

4399

1.28

7.21

2.8

3.3

36.93

57.52

u/ml

2.75

541

4246

Vulvovaginal ulceration/inflammation in other diseases

302

2191

1.42

7.21

2.4

3.1

40.96

50.41

u/ml

0.21

291

2120

Complications following infusion, transfusion and therapeutic injection

259

2.29

7.18

9.2

2.8

67.46

100.13

u/ml

0.27

248

Nerve, nerve root and plexus disorders

3412

18560

1.11

7.16

2.8

3.5

48.70

54.07

u/ml

0.46

3267

17990

Diarrhoea and gastroenteritis of presumed infectious origin

2144

16952

1.13

7.13

3.1

3.3

57.81

51.93

u/ml

0.33

2069

16399

Benign neoplasm of other and unspecified endocrine glands

396

2992

1.35

7.11

2.8

3.8

107.48

64.45

u/ml

0.24

380

2885

Anxiety (asthma-related co-morbidities)

2163

14567

1.14

7.07

2.8

3.3

50.11

47.40

u/ml

0.07

2094

14131

Caries of enamel

3166

18723

1.11

7.03

2.9

3.5

34.33

52.81

u/ml

4.30

3059

18119

Other disorders of kidney and ureter

304

2207

1.40

7.00

3.1

3.8

41.10

79.31

u/ml

3.52

293

2129

Placenta praevia

227

1579

1.49

6.99

2.7

2.4

36.24

36.51

u/ml

0.02

218

1530

Heart failure and coronary heart disease

615

5379

0.79

6.98

2.9

4.3

106.99

89.48

u/ml

0.32

598

5179

Single delivery by forceps and vacuum extractor

471

3605

0.76

6.92

2.4

2.8

25.99

36.92

u/ml

2.36

463

3508

Melanocytic naevi, other sites/unspecified

260

1847

1.44

6.91

2.3

3.2

34.66

54.34

u/ml

1.21

252

1783

Noninfective enteritis and colitis

1358

11690

1.17

6.90

2.8

3.5

57.75

56.15

u/ml

0.05

1318

11288

Other benign neoplasms of uterus

226

1575

1.49

6.89

3.4

4.1

96.64

85.75

u/ml

0.07

219

1513

HSIL lesion of the cervix uteri, vagina or vulva

937

7864

1.21

6.88

2.3

3.0

43.99

40.22

u/ml

0.10

911

7612

Melanocytic naevi

1022

8622

1.20

6.87

2.4

3.3

37.29

53.95

u/ml

1.58

1000

8333

Benign neoplasm: Rectum

434

3334

1.32

6.86

3.0

4.2

47.35

71.74

u/ml

1.71

418

3209

Nontoxic multinodular goitre

781

6442

1.23

6.85

3.0

4.1

54.87

70.73

u/ml

0.41

752

6219

Glucosamine medication

1427

9851

1.17

6.80

3.8

4.3

54.60

76.36

u/ml

2.01

1367

9507

Other diseases of upper respiratory tract

3436

16253

1.11

6.75

3.1

3.5

44.55

58.01

u/ml

1.74

3315

15733

Implicit viral Sepsis

510

4008

1.29

6.73

3.2

3.7

48.14

76.11

u/ml

1.82

483

3853

Viral Sepsis

511

4017

1.29

6.73

3.2

3.7

48.08

75.97

u/ml

1.81

484

3862

Antihypertensive medication - note that there are other indications

2036

9387

1.14

6.72

2.7

2.9

37.31

43.71

u/ml

0.88

1969

9117

Other joint disorders

2786

13055

1.12

6.72

2.7

3.4

44.00

52.86

u/ml

0.79

2673

12659

Transplanted organ and tissue status

211

1449

1.48

6.65

2.0

3.6

62.81

66.95

u/ml

0.09

199

1396

Benign neoplasm: Rectum, anus and anal canal

487

3814

1.29

6.64

2.9

4.1

47.32

72.37

u/ml

2.04

468

3666

Implicit fungal Sepsis, including avohilmo

223

1553

1.47

6.64

3.4

3.7

75.60

70.09

u/ml

0.07

216

1503

Insulin medication

1174

11375

0.85

6.63

2.7

3.7

64.37

59.36

u/ml

0.16

1126

10991

Benign lipomatous neoplasm

851

7089

1.21

6.59

2.8

3.8

42.20

66.70

u/ml

1.52

824

6845

Injuries to the shoulder and upper arm

2070

17942

0.88

6.59

3.0

3.6

57.77

55.25

u/ml

0.11

1998

17344

Other obstructive and reflux uropathy

126

776

1.67

6.58

5.6

2.4

52.24

60.14

u/ml

0.16

120

745

Adjustment and management of implanted device

315

2320

1.37

6.58

3.1

2.8

58.05

52.81

u/ml

0.17

299

2203

Implicit Sepsis, including avohilmo

2438

15593

1.12

6.58

3.7

3.5

71.40

52.33

u/ml

1.69

2328

15097

Special screening examination for infectious and parasitic diseases

695

4121

1.24

6.52

2.5

2.8

28.82

46.39

u/ml

2.41

665

3994

Heart failure, not strict

2047

12198

1.13

6.51

3.7

4.0

86.14

58.85

u/ml

1.77

1974

11799

Intestinal infectious diseases

2957

19904

1.11

6.50

3.2

3.4

54.47

51.94

u/ml

0.16

2847

19255

Ulcer of vagina/vulva

130

816

1.67

6.50

2.8

3.4

24.50

71.68

u/ml

2.21

119

788

Nephropathy related operations

220

1530

1.46

6.47

2.6

3.7

73.81

71.72

u/ml

0.04

211

1477

Scar conditions and fibrosis of skin

165

1092

1.56

6.46

2.6

3.3

36.43

65.69

u/ml

1.16

152

1063

Endometriosis in cutaneous scar

4.08

6.46

2.6

3.8

26.21

60.82

u/ml

0.39

Other anxiety disorders

1637

12216

1.15

6.44

2.7

3.0

49.31

45.19

u/ml

0.08

1578

11840

Personal history of other diseases and conditions

387

2948

1.33

6.39

3.0

2.7

46.27

45.60

u/ml

0.02

376

2857

Benign neoplasm: Sigmoid colon

458

3579

1.30

6.38

2.8

4.1

57.05

70.70

u/ml

0.42

441

3443

Retention of urine

537

3443

1.27

6.33

3.5

3.7

40.99

80.79

u/ml

5.11

519

3305

COPD related to multimorbidity

486

5196

0.78

6.32

2.6

4.2

73.68

82.90

u/ml

0.26

461

5003

Disorders of lacrimal system

1642

14220

1.15

6.28

3.0

3.8

42.99

61.94

u/ml

1.39

1581

13748

Fibrosis and cirrhosis of liver

204

1412

1.47

6.27

2.6

3.8

170.78

77.83

u/ml

2.11

193

1358

Malignant neoplasm of gallbladder

4.03

6.25

2.8

1.6

60.94

35.61

u/ml

0.47

Pain in thoracic spine

539

4316

1.27

6.22

2.6

3.8

30.68

61.67

u/ml

5.94

520

4167

Anti-inflammatory and antirheumatic products, non-steroids

589

2360

1.26

6.21

2.4

3.5

58.75

92.69

u/ml

1.42

566

2287

Benign mammary dysplasia

613

4997

1.25

6.18

3.5

4.1

66.43

70.33

u/ml

0.09

596

4815

Diaphragmatic hernia

1081

9248

1.18

6.17

3.2

3.9

44.85

71.34

u/ml

2.61

1043

8935

Care involving dialysis

139

889

1.59

6.14

2.5

2.8

60.83

57.27

u/ml

0.07

133

859

Enterocolitis due to Clostridium difficile

269

1960

1.39

6.14

4.1

3.5

78.12

83.10

u/ml

0.10

257

1896

Non-small cell lung cancer, adenocarcinoma, helper endpoint

146

947

1.57

6.12

2.1

4.2

81.45

84.69

u/ml

0.04

140

912

Chronic gastritis

753

6250

1.22

6.08

3.0

4.2

47.78

79.37

u/ml

2.96

716

6042

Exposure to other specified factors

2093

20051

0.89

6.05

2.9

3.4

34.20

52.12

u/ml

5.57

2018

19398

Pain associated with micturition

373

2865

1.32

6.03

2.4

3.7

35.42

67.63

u/ml

3.98

358

2762

Temporomandibular joint disorders, including avohilmo

1803

15517

1.13

5.97

2.4

3.2

35.65

47.96

u/ml

1.63

1731

15037

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2781

17014

1.11

5.95

3.6

3.4

72.03

47.97

u/ml

2.18

2680

16472

Polyneuropathies and other disorders of the peripheral nervous system

439

3443

1.29

5.94

4.8

3.9

161.64

75.95

u/ml

0.59

427

3310

853

9030

0.84

5.86

2.6

3.4

62.27

52.60

u/ml

0.45

818

8727

Other infectious diseases, including avohilmo

216

1531

1.43

5.83

3.8

3.3

65.70

71.58

u/ml

0.09

210

1475

Dialysis, with operation codes

224

1596

1.42

5.81

2.6

3.7

75.49

70.16

u/ml

0.12

214

1541

Injuries to the wrist and hand

2757

20093

0.90

5.81

2.7

3.4

39.00

52.24

u/ml

2.51

2651

19451

Pure hypercholesterolaemia

2147

12206

1.12

5.78

4.4

3.7

55.93

59.95

u/ml

0.30

2067

11813

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2968

15787

1.10

5.77

4.0

3.3

58.41

51.53

u/ml

0.57

2880

15290

2968

15787

1.10

5.77

4.0

3.3

58.41

51.53

u/ml

0.57

2880

15290

Any event in hilmo or specialist outpatient

+∞

5.77

1.1

0.0

9.57

—

u/ml

—

Disorders of skin appendages

1611

14169

1.14

5.76

2.5

3.3

39.91

51.42

u/ml

1.32

1552

13708

Single spontaneous delivery

1472

8842

0.87

5.74

3.5

3.7

75.67

59.80

u/ml

0.73

1415

8549

Phobic anxiety disorders

393

3050

1.30

5.74

3.1

2.6

40.06

43.22

u/ml

0.14

385

2956

Other disorders of lacrimal gland

1366

11968

1.15

5.73

2.9

3.8

41.63

62.00

u/ml

1.30

1314

11574

Gout, FINNGEN

401

3100

1.29

5.71

3.3

4.1

65.03

93.26

u/ml

0.87

390

2972

Iron deficiency anaemia secondary to blood loss (chronic)

441

3488

1.28

5.66

3.2

3.8

95.61

79.64

u/ml

0.19

424

3349

Acute pancreatitis

408

3192

1.29

5.65

3.0

4.0

55.19

64.92

u/ml

0.30

390

3083

Localized swelling, mass and lump of skin and subcutaneous tissue

956

8167

1.18

5.61

3.2

3.7

42.77

61.34

u/ml

1.79

924

7898

Inflammatory bowel disease treatment related agents

3605

18387

1.09

5.51

2.9

3.4

41.93

53.44

u/ml

2.48

3484

17800

Migraine without aura

834

7064

1.19

5.51

2.2

3.1

27.33

42.71

u/ml

4.62

808

6856

Abnormal results of function studies

247

1811

1.39

5.51

3.1

3.4

64.58

63.91

u/ml

0.01

234

1753

Disturbances of skin sensation

954

8168

1.18

5.50

2.4

3.3

37.44

52.16

u/ml

1.35

918

7896

HSIL lesion of the cervix uteri

836

7098

1.20

5.48

2.3

2.8

46.94

39.28

u/ml

0.19

812

6871

Erysipelas, including avohilmo

2002

13288

1.12

5.47

3.7

3.4

62.21

55.42

u/ml

0.39

1935

12831

Triptan medication for migraine, min. 3 purchases

2338

15806

1.11

5.46

2.4

3.3

30.11

45.26

u/ml

3.72

2260

15319

Disorders of synovium and tendon

1787

13517

1.13

5.45

2.9

3.6

57.53

54.46

u/ml

0.07

1732

13104

Collagenous colitis

296

2242

1.35

5.38

2.9

3.7

46.33

70.93

u/ml

1.25

288

2163

Dermatitis

2008

17655

1.12

5.38

3.3

3.5

50.82

56.42

u/ml

0.47

1941

17081

Fibromyalgia

430

3428

1.28

5.37

2.3

3.6

54.34

51.66

u/ml

0.05

409

3321

Migraine without aura and triptan purchases

688

5752

1.21

5.33

1.9

2.9

25.83

42.09

u/ml

4.61

669

5557

COPD, hospital admissions 1, only main diagnosis

404

4388

0.79

5.30

2.3

4.2

70.09

82.85

u/ml

0.40

382

4222

Benign lipomatous neoplasm of other sites/unspecified

229

1671

1.40

5.29

2.8

3.8

32.81

78.87

u/ml

4.22

224

1617

Other problems related to primary support group, including family circumstances

359

2718

1.30

5.29

2.5

2.8

115.67

45.02

u/ml

0.41

353

2634

Androgenic alopecia

289

2.06

5.29

2.3

2.9

23.83

76.04

u/ml

0.69

277

All dysplastic lesions of the cervix uteri

1203

10359

1.16

5.29

2.3

2.9

41.96

38.94

u/ml

0.10

1167

10043

All influenza

605

4987

1.22

5.27

4.0

3.5

70.47

67.17

u/ml

0.05

588

4804

Gout, idiopatic and unspecified

327

2509

1.31

5.24

3.5

3.9

71.37

92.49

u/ml

0.46

319

2408

Sequelae of other external causes

159

1090

1.49

5.23

4.0

3.5

146.80

71.61

u/ml

0.43

152

1055

Other viral diseases

786

6626

1.19

5.19

2.7

3.0

41.61

47.58

u/ml

0.29

753

6408

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

249

1843

1.36

5.17

2.9

4.0

154.35

77.21

u/ml

3.01

240

1777

Polyuria

445

3567

1.26

5.08

2.4

3.9

46.37

68.85

u/ml

0.79

423

3443

Obesity, other/unspecified

1202

10533

1.15

5.07

2.5

3.2

38.63

47.56

u/ml

1.02

1155

10198

Unspecified haematuria

783

5385

1.19

5.07

3.4

3.9

58.63

77.10

u/ml

0.84

751

5197

Inflammatory disease of cervix uteri

261

1970

1.36

5.03

3.0

3.9

62.44

70.93

u/ml

0.17

253

1904

Migraine with aura

1006

8715

1.17

5.01

2.5

3.3

25.46

47.30

u/ml

8.10

962

8444

Sarcoidosis

351

2746

1.30

5.00

3.5

3.7

52.77

64.74

u/ml

0.47

336

2647

COPD, hospital admission 2, with asthma infections

369

4024

0.78

4.97

2.5

4.1

53.66

85.33

u/ml

1.80

353

3876

Symptoms and signs involving the urinary system

2157

14728

1.11

4.91

3.2

3.7

47.57

61.47

u/ml

1.62

2074

14244

Diseases of the respiratory system

2195

9942

1.11

4.90

3.7

3.3

58.44

49.93

u/ml

0.85

2117

9646

Acute pancreatitis (for exclusion)

408

3257

1.26

4.86

3.0

3.7

55.19

69.68

u/ml

0.49

390

3142

Somatoform disorder

551

4553

1.23

4.84

2.6

3.4

23.76

54.35

u/ml

9.41

526

4409

Benign neoplasm of breast

513

4222

1.24

4.83

3.2

3.8

53.05

60.95

u/ml

0.14

501

4070

Urolithiasis

567

4686

1.22

4.83

2.7

3.6

68.27

59.27

u/ml

0.27

548

4524

Oter anti-inflammatory and antirheumatic agents, non-steroids

433

1894

1.26

4.80

3.3

3.9

58.18

107.50

u/ml

2.06

419

1836

Gastroduodenal ulcer

523

4279

1.23

4.79

2.9

4.1

50.10

86.05

u/ml

3.01

501

4119

Viral infections characterized by skin and mucous membrane lesions

1188

10430

1.15

4.78

3.2

3.5

35.37

61.53

u/ml

6.08

1151

10073

Other diseases of liver

518

4258

1.23

4.77

2.9

3.8

69.14

58.77

u/ml

0.38

489

4115

Diagnoses used for exclusion with ILD

556

4596

1.22

4.77

3.5

3.8

57.18

67.98

u/ml

0.53

535

4432

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

208

1524

1.39

4.74

2.9

3.9

61.44

88.09

u/ml

0.81

202

1470

Complications of other internal prosthetic devices, implants and grafts

120

795

1.55

4.73

5.5

3.5

70.07

90.06

u/ml

0.21

120

769

Gout, strict definition

214

1570

1.37

4.71

3.4

4.0

78.74

99.68

u/ml

0.31

209

1511

Delivery

1499

8853

0.88

4.69

3.5

3.7

74.72

59.76

u/ml

0.69

1442

8558

Calculus of kidney and ureter

541

4469

1.22

4.66

2.8

3.6

66.81

59.05

u/ml

0.22

522

4317

LSIL lesion of the cervix uteri, vagina or vulva

639

5387

1.21

4.65

2.7

3.0

30.02

43.51

u/ml

2.46

613

5230

Other disorders of bladder

204

1491

1.38

4.64

2.3

3.9

61.74

66.66

u/ml

0.08

194

1448

Malignant neoplasm of brain, including Hilmo

520

1.66

4.63

3.4

1.5

46.36

24.19

u/ml

0.94

496

Other infectious diseases

171

1217

1.43

4.61

4.1

3.3

74.47

69.21

u/ml

0.06

166

1174

Bronchitis

3515

19533

1.08

4.61

3.3

3.4

45.68

53.23

u/ml

0.85

3390

18899

Atrial fibrillation and flutter

843

4656

1.18

4.61

3.7

3.6

62.34

45.82

u/ml

0.94

814

4507

Other arthrosis

1568

9381

1.13

4.61

2.9

3.9

52.83

61.64

u/ml

0.43

1507

9090

ILD medications

3538

17660

1.08

4.61

2.9

3.5

44.21

53.04

u/ml

1.55

3412

17091

Post-traumatic stress disorder

298

2314

1.31

4.58

2.1

2.4

22.36

40.74

u/ml

2.71

282

2245

Supervision of high-risk pregnancy

891

4616

1.17

4.57

2.4

2.8

23.33

38.95

u/ml

6.33

867

4491

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

4.99

4.55

2.8

1.5

36.80

48.61

u/ml

0.13

Contact with and exposure to communicable diseases

960

8310

1.16

4.54

2.5

2.7

26.48

40.66

u/ml

4.91

931

8035

Gestational diabetes (for exclusion)

1396

10764

0.88

4.54

2.3

2.7

25.34

34.97

u/ml

4.50

1347

10454

Mental and behavioural disorders due to psychoactive substance use

1015

10639

0.87

4.53

2.7

3.4

51.91

50.54

u/ml

0.06

977

10289

Other specified/unspecified bacterial intestinal infections

180

1299

1.41

4.53

3.8

3.5

65.40

79.33

u/ml

0.29

171

1255

Myocardial infarction, without ST-elevation

486

5331

0.82

4.52

3.0

4.0

71.94

88.22

u/ml

0.56

464

5117

Other and unspecified local infections of skin and subcutaneous tissue

242

1831

1.34

4.46

4.2

3.3

46.60

64.21

u/ml

0.76

232

1765

Symptoms and signs involving cognition, perception, emotional state and behaviour

3039

18760

1.09

4.38

2.8

3.5

53.01

51.30

u/ml

0.09

2922

18173

Use of galantamine

1249

0.62

4.37

2.3

4.2

179.05

114.35

u/ml

0.38

1202

Other viral diseases, including avohilmo

1134

9900

1.14

4.37

2.6

3.0

37.19

44.29

u/ml

0.55

1090

9580

Shoulder lesions

2316

12671

1.10

4.36

3.3

3.7

54.78

56.71

u/ml

0.05

2239

12277

Other inflammation of eyelid, including avohilmo

1594

14348

1.12

4.35

2.6

3.3

33.11

53.45

u/ml

3.77

1527

13898

Acute upper respiratory infections of multiple and unspecified sites

2486

16633

1.09

4.33

3.2

3.3

37.08

53.32

u/ml

5.52

2403

16105

Dislocation, sprain and strain of joints and ligaments of knee

1600

16046

0.90

4.32

2.9

3.3

34.31

48.43

u/ml

3.01

1530

15549

Other viral diseases, not elsewhere classified

464

3798

1.23

4.32

3.2

47.47

52.47

u/ml

0.14

447

3678

Gout, unspecified

256

1956

1.32

4.32

3.2

3.9

78.58

99.60

u/ml

0.33

249

1880

Haemorrhage from respiratory passages

812

6186

1.17

4.32

3.5

3.7

65.57

72.75

u/ml

0.24

775

5999

Covid-19 suspected case

665

5651

1.19

4.31

3.0

29.28

48.64

u/ml

4.01

643

5473

Nontraumatic intracranial haemmorrhage

283

3619

0.78

4.28

3.4

4.1

198.03

79.54

u/ml

0.56

272

3467

Chronic rhinitis, nasopharyngitis and pharyngitis

1076

9477

1.14

4.26

2.9

3.6

34.16

56.55

u/ml

3.88

1037

9177

Other diseases of appendix

244

1.99

4.25

2.4

2.6

25.41

65.39

u/ml

1.22

235

Kela-code for severe mental illness

736

8565

0.85

4.24

2.5

3.4

42.08

51.45

u/ml

0.80

700

8281

Spondylopathies

2337

12642

1.10

4.21

2.9

3.8

39.70

58.06

u/ml

3.47

2256

12257

Syncope and collapse

1154

8509

1.14

4.21

2.9

3.4

56.90

56.65

u/ml

0.01

1107

8236

Other benign neoplasm of uterus: Cervix uteri

228

2.07

4.16

2.4

3.1

20.08

51.79

u/ml

1.07

217

Vascular disorders of the intestines

142

997

1.44

4.15

2.8

3.3

82.95

96.93

u/ml

0.14

136

955

Condition for Implicit Sepsis (Organ dysfunction codes)

2510

15984

1.09

4.13

3.7

3.5

80.79

49.96

u/ml

2.73

2404

15473

Abnormal findings on examination of blood, without diagnosis

877

6897

1.16

4.10

3.0

3.7

46.48

67.44

u/ml

1.73

848

6651

Thrombocytopenia, unspecified

161

1160

1.41

4.09

7.7

3.4

74.00

70.99

u/ml

0.05

156

1120

Secondary hypertension

174

1250

1.39

4.08

5.5

3.6

47.56

60.24

u/ml

0.35

161

1205

Other local infections of skin and subcutaneous tissue

250

1928

1.31

4.05

4.1

3.3

46.55

62.78

u/ml

0.71

239

1860

All dysplastic lesions of the vagina

127

887

1.49

4.05

2.9

3.3

25.52

67.62

u/ml

2.03

121

856

Cellulitis

510

4256

1.21

4.05

3.2

3.6

51.52

62.25

u/ml

0.42

490

4110

Carpal tunnel syndrome

2097

16628

1.10

4.02

2.9

3.7

51.13

56.50

u/ml

0.30

2023

16112

Disorders of other endocrine glands

1396

12338

1.12

3.99

2.9

3.4

43.93

61.03

u/ml

0.94

1341

11909

Injury, poisoning and certain other consequences of external causes

1815

8241

1.11

3.99

3.3

49.00

56.73

u/ml

0.70

1752

8001

Benign neoplasm: Ascending colon

333

2670

1.26

3.95

3.5

4.3

48.04

80.62

u/ml

1.97

321

2570

Diabetes mellitus in pregnancy

1242

8830

0.89

3.94

2.3

2.6

25.11

34.66

u/ml

3.76

1199

8591

Candidiasis

457

3795

1.22

3.91

3.2

3.5

51.88

58.86

u/ml

0.20

437

3662

External causes of morbidity and mortality

2177

9979

1.10

3.90

3.5

3.4

43.12

54.98

u/ml

1.80

2100

9697

Urticaria

1023

9042

1.14

3.90

3.1

3.3

43.49

52.88

u/ml

0.69

977

8744

Hypo-osmolality and hyponatraemia

464

3826

1.21

3.88

4.7

4.0

103.78

92.71

u/ml

0.21

445

3676

Weight loss

258

2015

1.30

3.84

2.7

3.7

79.67

75.50

u/ml

0.04

247

1939

Immunodeficiencies

140

1000

1.43

3.84

3.4

3.3

39.70

72.81

u/ml

1.41

134

965

Asthma, including avohilmo

3658

18820

1.07

3.84

2.8

3.5

42.60

54.29

u/ml

1.56

3522

18218

Dizziness and giddiness

2380

17055

1.09

3.82

2.8

3.6

59.87

53.27

u/ml

0.30

2291

16513

Acute bronchitis

1085

9442

1.13

3.81

2.8

3.5

48.56

62.92

u/ml

1.23

1037

9112

Unspecified mental disorder

878

10001

0.87

3.81

2.5

3.3

75.17

50.21

u/ml

0.33

839

9678

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1154

10294

1.13

3.81

2.9

3.6

77.15

57.43

u/ml

0.31

1114

9960

Volume depletion

193

1452

1.34

3.74

4.4

3.6

61.90

100.49

u/ml

1.38

188

1397

Urticaria and erythema

1239

11108

1.12

3.72

3.0

3.4

45.31

53.67

u/ml

0.68

1185

10745

Nonorganic sleeping disorders, excluding more controls

646

5554

1.17

3.68

2.8

3.1

34.22

44.84

u/ml

1.39

628

5385

Neurological diseases

2741

12745

1.08

3.68

2.8

3.6

45.05

48.51

u/ml

0.35

2643

12395

Prolonged pregnancy

505

5091

0.84

3.66

3.0

2.6

27.41

35.31

u/ml

1.85

492

4949

Other benign neoplasms of skin

1100

9806

1.13

3.66

2.9

3.7

45.13

65.43

u/ml

2.53

1068

9466

Alzheimer’s disease (Atypical or mixed), excluding more controls

107

1156

0.68

3.65

1.9

5.1

113.08

106.55

u/ml

0.05

1115

Myocardial infarction, unclassifiable

186

2197

0.75

3.63

3.4

3.8

100.44

102.68

u/ml

0.03

176

2098

Melanocytic naevi of other and unspecified parts of face

187

1413

1.35

3.63

2.4

3.3

75.97

58.28

u/ml

0.24

180

1367

Migraine with aura and triptan purchases

634

5460

1.17

3.61

2.2

3.0

27.56

43.28

u/ml

2.61

602

5275

Other viral diseases, not elsewhere classified, including avohilmo

771

6681

1.15

3.61

2.8

3.1

38.54

45.86

u/ml

0.39

745

6460

Abnormal serum enzyme levels

287

2201

1.26

3.59

2.9

3.4

56.26

71.22

u/ml

0.38

277

2123

Type 1 diabetes, wide definition

346

4229

0.81

3.59

2.5

3.4

79.33

56.77

u/ml

0.26

336

4091

Vascular dementia (undefined)

464

0.44

3.59

2.8

3.2

27.81

138.66

u/ml

3.11

447

Mycoses, including avohilmo

2855

20223

1.08

3.57

2.8

3.4

48.60

52.32

u/ml

0.24

2761

19559

Chronic pancreatitis

210

1612

1.31

3.55

2.2

4.0

43.51

78.40

u/ml

2.16

199

1552

Osteoporosis

907

7358

1.14

3.54

3.8

4.2

62.07

80.75

u/ml

1.05

871

7082

Benign neoplasm: Stomach

277

2214

1.27

3.48

2.9

4.1

94.79

72.33

u/ml

0.17

262

2136

Diseases of tongue

200

1535

1.33

3.47

3.4

4.2

31.19

85.81

u/ml

5.47

192

1494

HSIL lesion of the vulva

536

1.58

3.45

2.6

3.1

184.53

81.50

u/ml

0.28

517

Benign neoplasm: Caecum

258

2048

1.28

3.41

3.6

4.1

67.40

79.05

u/ml

0.19

247

1975

Alcohol use disorder, Swedish definition

803

8305

0.88

3.41

2.6

3.4

60.38

49.12

u/ml

0.74

773

8029

Adenocarcinoma of small intestine

4.68

3.40

6.2

1.7

61.00

15.80

u/ml

—

Tonsillectomy and adenotomy

1829

11660

1.10

3.39

2.4

2.8

25.45

40.79

u/ml

10.53

1763

11313

Diseases of salivary glands

1040

9290

1.13

3.39

3.0

3.6

51.87

58.50

u/ml

0.20

1009

8981

Substance abuse

979

10213

0.89

3.37

2.7

3.4

52.04

51.46

u/ml

0.02

943

9876

Tongue abnormality

184

1404

1.34

3.37

3.6

3.9

30.86

75.11

u/ml

3.02

177

1354

Abnormal weight loss

228

1787

1.29

3.35

2.7

3.8

82.79

78.87

u/ml

0.04

217

1719

Generalized anxiety disorder

523

4456

1.18

3.33

2.2

2.8

39.24

43.02

u/ml

0.20

509

4314

Nonorganic sleeping disorders

646

5602

1.16

3.33

2.8

3.1

34.22

48.95

u/ml

2.22

628

5430

Hyperkalaemia

109

764

1.45

3.30

6.4

3.6

96.05

108.07

u/ml

0.17

103

741

Benign neoplasm: Transverse colon

231

1817

1.29

3.30

2.6

4.0

40.57

82.34

u/ml

2.21

223

1751

Viral and other specified intestinal infections, including avohilmo

729

6133

1.15

3.29

2.7

2.9

45.72

49.37

u/ml

0.16

694

5933

Sub-endpoint used in defining T1D endpoints

431

5037

0.84

3.29

2.9

3.3

79.79

62.70

u/ml

0.23

414

4867

Visual disturbances and blindness

1591

14529

1.10

3.28

3.2

3.6

43.84

58.45

u/ml

1.42

1529

14039

Mental and behavioural disorders due to alcohol

740

8036

0.87

3.27

2.6

3.3

58.60

48.88

u/ml

0.42

711

7766

Disorders of vitreous body and globe

1574

13597

1.10

3.26

3.3

4.0

40.73

63.16

u/ml

4.28

1528

13134

Injuries to the abdomen, lower back, lumbar spine and pelvis

1070

9450

1.12

3.25

2.7

3.5

40.99

66.06

u/ml

2.16

1024

9120

COPD, hospital admissions 3, with asthma pneumonia sepsis

289

3057

0.81

3.25

2.5

4.2

57.65

81.33

u/ml

1.16

274

2946

Zoster [herpes zoster], including avohilmo

1592

14054

1.10

3.22

3.3

3.8

38.98

64.15

u/ml

5.67

1537

13585

Other and unspecified glaucoma

168

1272

1.34

3.22

4.6

4.1

107.01

99.18

u/ml

0.06

161

1227

Pruritus

392

3278

1.21

3.21

2.3

3.7

44.84

62.26

u/ml

0.72

383

3169

Primary gonarthrosis, bilateral

1465

11168

1.10

3.21

3.3

4.2

59.64

68.44

u/ml

0.33

1403

10791

Disorders of lipoprotein metabolism and other lipidaemias

2351

13250

1.08

3.21

4.2

3.6

51.48

57.51

u/ml

0.56

2268

12827

Malignant neoplasm of eye, brain and central nervous system

451

1.57

3.20

1.6

1.5

49.43

24.94

u/ml

0.88

427

Chronic apical periodontitis

3524

18571

1.07

3.19

3.4

3.3

42.85

54.32

u/ml

2.01

3379

17984

Other acute lower respiratory infections

1382

11959

1.10

3.19

3.1

3.4

46.66

58.56

u/ml

1.26

1322

11550

Hypertrophy of breast

783

6920

1.15

3.18

2.7

3.4

35.47

49.16

u/ml

1.50

749

6702

Other mental disorders due to brain damage and dysfunction and to physical disease

167

2185

0.76

3.16

3.2

4.0

89.92

99.99

u/ml

0.12

158

2084

Zoster [herpes zoster]

501

4283

1.18

3.14

3.8

3.9

32.90

82.22

u/ml

6.25

488

4120

Other and unspecified urticaria

630

5484

1.16

3.13

3.1

3.4

43.28

52.39

u/ml

0.53

598

5309

Viral and other specified intestinal infections

471

3905

1.18

3.13

2.6

2.7

39.44

53.28

u/ml

1.12

446

3777

Hypertrophy of breast in women and men

785

6942

1.14

3.13

2.7

3.4

35.51

49.52

u/ml

1.56

751

6723

Congenital absence, atresia and stenosis of large intestine

6.51

3.13

1.3

13.86

13.43

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

366

3049

1.21

3.12

2.3

3.8

48.86

62.77

u/ml

0.27

353

2943

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

5.29

3.11

2.5

1.2

75.88

74.53

u/ml

—

Long labour

895

8496

0.88

3.11

2.7

3.0

35.97

38.93

u/ml

0.23

876

8246

Cyclic neutropenia

3.66

3.11

7.1

2.9

18.33

43.74

u/ml

0.50

Panic disorder

458

3892

1.19

3.11

3.0

2.8

39.12

45.68

u/ml

0.41

443

3767

Seborrhoeic keratosis

722

6348

1.15

3.09

3.3

4.1

48.57

74.65

u/ml

1.57

693

6122

Malignant neoplasm of oral cavity, including Hilmo

384

1.61

3.08

4.3

1.5

42.89

24.84

u/ml

0.63

364

Nonalcoholic fatty liver disease

270

2185

1.25

3.07

2.6

3.6

62.34

60.22

u/ml

0.04

258

2109

Rheumatoid arthritis, including avohilmo

1005

11179

0.89

3.04

3.2

3.8

50.08

63.62

u/ml

1.06

970

10801

Haemorrhage, not elsewhere classified

588

1.49

3.02

2.5

3.3

85.33

101.22

u/ml

0.16

572

Alzheimer’s disease (Atypical or mixed)

122

1637

0.73

3.01

1.8

3.9

106.18

118.21

u/ml

0.12

110

1562

Other arrhythmias

2069

14311

1.08

3.01

3.1

3.6

51.02

51.63

u/ml

0.02

1968

13880

Seborrhoeic dermatitis

208

1637

1.28

2.99

2.3

3.6

30.23

70.41

u/ml

3.56

199

1583

Other congenital malformations

239

1916

1.26

2.96

2.1

2.9

28.53

53.68

u/ml

2.61

233

1851

Disorders of vitreous body

1538

13425

1.09

2.94

3.3

4.0

40.88

63.42

u/ml

4.19

1492

12971

Exclusions for E4_PCOS_BROAD

437

3715

1.18

2.92

3.0

3.4

94.86

56.21

u/ml

0.24

418

3597

Nontoxic single thyroid nodule

261

2123

1.25

2.91

2.9

4.0

96.82

64.77

u/ml

0.29

252

2059

Benign neoplasm: Pancreas

521

1.52

2.91

2.3

4.0

27.07

105.20

u/ml

2.50

506

Other and unspecified dermatitis

1698

15662

1.09

2.90

3.3

3.6

49.34

57.13

u/ml

0.64

1637

15153

Rash and other nonspecific skin eruption

279

2283

1.24

2.89

3.5

3.7

59.94

57.92

u/ml

0.04

267

2205

Intracranial trauma

1565

11504

0.91

2.89

2.7

3.7

44.07

48.54

u/ml

0.32

1508

11196

Schizophrenia

225

2803

0.80

2.87

3.0

3.4

53.74

53.70

u/ml

0.00

212

2713

Other disorders of eyelid

1317

11341

1.10

2.85

3.0

4.1

42.64

69.79

u/ml

3.39

1268

10943

Carcinoma in situ of cervix uteri

406

3452

1.19

2.84

2.2

2.6

27.92

42.37

u/ml

2.20

392

3346

Kidney transplant status

679

1.43

2.84

2.0

3.3

44.40

76.58

u/ml

0.81

656

Acne vulgaris

199

1567

1.28

2.83

2.3

2.2

27.40

32.09

u/ml

0.44

191

1514

LSIL lesion of the cervix uteri

484

4178

1.17

2.81

2.4

2.9

30.36

40.51

u/ml

1.22

462

4053

Use of levodopa decarboxylase inhibitor

157

2037

0.76

2.81

2.7

4.3

75.41

92.43

u/ml

0.25

152

1954

Crohn's disease of small intestine

177

1379

1.30

2.81

2.1

3.1

36.86

60.63

u/ml

0.94

169

1332

Osteonecrosis

164

1266

1.32

2.80

4.5

4.1

67.01

75.35

u/ml

0.13

157

1220

STROKE

1484

10873

0.91

2.79

3.3

4.0

101.20

54.99

u/ml

1.25

1424

10537

Crohn disease

319

2654

1.21

2.78

2.0

3.3

42.81

56.76

u/ml

0.70

308

2559

Visual disturbances

1475

13557

1.09

2.78

3.2

3.6

39.49

58.96

u/ml

2.37

1420

13099

Vitamin deficiency

126

938

1.37

2.77

3.1

3.4

106.64

74.31

u/ml

0.26

121

909

Vitamin deficiency, wide

126

938

1.37

2.77

3.1

3.4

106.64

74.31

u/ml

0.26

121

909

Obesity related asthma

1036

9370

1.11

2.76

2.7

3.7

35.52

60.35

u/ml

3.58

992

9070

Disorders of continuity of bone

294

2432

1.22

2.75

2.8

3.6

32.64

60.86

u/ml

3.06

277

2344

Transient ischemic attack

1089

9564

0.90

2.75

3.3

4.1

78.78

69.01

u/ml

0.25

1042

9248

Subjective visual disturbances

794

7089

1.13

2.71

3.2

3.6

33.85

61.57

u/ml

2.91

753

6845

Insulin, combination of fast acting with intermediate-acting or long-acting

1174

11684

0.91

2.71

2.7

3.6

64.37

61.36

u/ml

0.09

1126

11281

Early onset COPD

292

3519

0.82

2.70

2.4

4.0

45.96

65.99

u/ml

1.09

277

3393

Herpesviral [herpes simplex] infections

346

2912

1.20

2.70

2.9

3.4

42.08

63.24

u/ml

1.28

337

2816

Exposure to other specified electric current

388

0.48

2.68

1.5

2.3

17.68

36.66

u/ml

1.79

372

Superficial injury of abdomen, lower back and pelvis

387

3290

1.19

2.66

1.9

3.3

33.05

60.76

u/ml

3.37

370

3180

Other general symptoms and signs

152

1160

1.32

2.65

2.6

2.8

68.92

57.86

u/ml

0.12

146

1125

Inflammatory bowel disease

805

7199

1.12

2.65

2.3

3.4

48.19

55.54

u/ml

0.38

781

6964

HSIL lesion of the vagina

446

1.55

2.64

2.7

22.23

44.64

u/ml

1.32

427

Unspecified dementia

122

1457

0.75

2.63

3.1

4.0

85.61

115.17

u/ml

0.52

115

1387

Seropositive rheumatoid arthritis

671

7517

0.88

2.61

3.2

4.2

54.33

70.97

u/ml

0.89

649

7267

Chronic sinusitis

1357

12449

1.09

2.61

2.7

3.6

33.15

57.52

u/ml

4.47

1306

12060

Type 1 diabetes, wide definition, subgroup 1

337

3990

0.84

2.61

2.5

3.4

81.05

51.73

u/ml

0.35

327

3862

Heart failure and antihypertensive medication

577

3273

1.15

2.61

3.2

4.1

83.69

67.15

u/ml

0.59

554

3172

Oesophageal varices

491

1.49

2.61

2.7

3.6

153.21

99.70

u/ml

0.64

474

Paroxysmal tachycardia

639

4681

1.14

2.60

2.8

3.3

69.29

45.37

u/ml

0.55

614

4530

Mycoses

743

6625

1.13

2.59

3.1

3.6

67.73

60.71

u/ml

0.13

717

6403

Familial hypercholesterolemia

285

2363

1.21

2.58

4.1

4.0

104.70

98.16

u/ml

0.05

279

2272

Intracerebral haemorrhage

147

1899

0.77

2.58

3.8

4.0

278.35

90.77

u/ml

0.45

142

1826

Adverse effects, not elsewhere classified

614

5416

1.14

2.58

3.1

3.3

39.40

50.70

u/ml

0.96

594

5246

Gonarthrosis, primary, with knee surgery

1579

11354

1.09

2.55

3.1

4.2

52.09

68.75

u/ml

1.23

1524

10964

Systemic connective tissue disorders

1146

10469

1.10

2.54

2.9

3.7

42.22

65.25

u/ml

2.88

1109

10109

Crohn disease (strict definition, all UC cases excluded)

127

961

1.34

2.54

2.1

2.8

43.87

64.85

u/ml

0.50

120

927

Presence of cardiac and vascular implants and grafts

614

5118

0.88

2.52

2.6

4.1

106.68

92.30

u/ml

0.18

584

4930

Pregnancy examination and test

637

3486

1.14

2.52

1.9

2.6

30.89

37.91

u/ml

0.44

619

3390

Congenital malformation of biliary tract

3.36

2.52

1.8

3.2

111.80

35.58

u/ml

—

Congenital absence of the vagina

4.25

2.52

3.4

1.4

133.62

26.87

u/ml

—

Diseases of appendix

2185

18280

1.07

2.51

2.9

3.4

40.80

50.40

u/ml

1.18

2116

17701

Insulin, fast-acting (human)

206

2547

0.80

2.51

2.7

2.9

40.70

54.22

u/ml

0.72

200

2469

L04AD Calcineurin inhibitors

230

1877

1.24

2.48

2.8

3.4

60.17

60.29

u/ml

0.00

219

1816

Soft tissue disorders related to use, overuse and pressure

839

7557

1.12

2.47

2.8

4.0

66.48

63.73

u/ml

0.04

803

7310

Acute lymphadenitis

147

1140

1.31

2.47

2.9

3.0

48.72

59.23

u/ml

0.20

141

1104

Other shoulder lesions

285

2380

1.21

2.46

2.9

3.7

76.86

58.41

u/ml

0.16

280

2305

Rhabdomyosarcoma

7.05

2.45

2.0

1.6

15.00

16.75

u/ml

—

Malignant neoplasm of oral cavity

280

1.63

2.45

5.3

1.5

51.38

24.03

u/ml

0.74

266

Diplopia

321

2710

1.19

2.44

3.1

3.6

70.42

66.96

u/ml

0.05

313

2609

Pneumocystosis, including avohilmo

274

1.65

2.44

4.5

3.4

49.75

111.24

u/ml

0.66

265

Pneumocystosis

274

1.65

2.44

4.5

3.4

49.75

111.24

u/ml

0.66

265

Later onset COPD

319

3035

0.84

2.43

2.9

4.4

86.39

109.82

u/ml

0.53

302

2916

Gastric ulcer

353

3003

1.18

2.42

2.6

4.2

51.85

95.49

u/ml

2.52

339

2901

Vascular diseases of the intestine

583

1.43

2.41

2.5

4.0

89.48

102.83

u/ml

0.08

562

Abnormal findings on diagnostic imaging of central nervous system

139

1076

1.31

2.39

3.2

53.69

65.00

u/ml

0.22

130

1047

Influenza and pneumonia

3320

19415

1.06

2.39

4.0

3.2

59.90

49.91

u/ml

0.85

3221

18775

L04AX Other immunosuppressants

1514

16311

0.92

2.39

2.5

3.6

40.56

54.60

u/ml

2.45

1453

15789

590

0.61

2.37

1.5

3.5

196.69

91.73

u/ml

0.78

566

Other inflammation of eyelid

423

3663

1.17

2.37

2.8

4.0

29.07

66.61

u/ml

6.84

406

3535

Flatulence and related conditions

155

1.86

2.36

1.7

2.3

29.57

127.79

u/ml

0.69

148

Other/unspecified seropositive rheumatoid arthritis

660

7389

0.89

2.35

3.2

3.9

54.62

71.64

u/ml

0.91

639

7134

Disorders of muscles

260

2162

1.21

2.35

3.7

3.5

89.98

65.85

u/ml

0.20

255

2087

Other neurological diseases

1742

14488

0.93

2.34

3.1

3.7

79.74

59.21

u/ml

0.51

1671

14004

Used for control exclusion in common control thyroid runs

3018

14385

1.06

2.34

3.0

3.4

47.12

50.29

u/ml

0.29

2917

13919

Diseases of the musculoskeletal system and connective tissue

1608

7467

1.08

2.34

2.7

3.5

45.78

52.55

u/ml

0.59

1545

7261

Labour and delivery complicated by fetal stress [distress]

886

6355

0.90

2.34

2.3

2.5

26.68

33.05

u/ml

1.81

855

6174

Cholecystitis

293

2464

1.20

2.32

3.1

3.9

48.03

76.28

u/ml

1.32

283

2373

Other disorders of bone

520

4573

1.14

2.32

2.7

3.5

33.94

52.40

u/ml

2.19

508

4416

Benign neoplasm: Descending colon

149

1168

1.29

2.31

2.5

4.0

36.97

78.27

u/ml

2.30

142

1128

Myelodysplastic syndrome

2.26

2.30

5.7

1.5

35.69

34.22

u/ml

0.03

Other disorders of eye and adnexa

418

3628

1.16

2.28

2.7

3.4

55.34

57.58

u/ml

0.05

401

3506

Myalgia

827

7488

1.11

2.26

2.6

3.6

43.14

57.08

u/ml

1.19

798

7248

Benign neoplasm of urinary organs

118

901

1.33

2.26

3.4

3.7

38.19

81.04

u/ml

1.73

112

873

Other and unspecified polyneuropathies, also in other diseases

339

2897

1.18

2.23

3.1

4.0

152.16

74.31

u/ml

0.41

329

2787

Other CVD (FINNGEN)

260

1653

1.21

2.22

3.2

4.0

50.29

60.79

u/ml

0.29

253

1600

Second line medication for Crohn's disease

1567

16798

0.93

2.22

2.5

3.6

44.26

53.78

u/ml

1.03

1504

16255

Cervicobrachial syndrome

739

6660

1.12

2.22

2.7

3.9

27.47

60.21

u/ml

6.56

707

6447

Schizophrenia or delusion, excluding more controls

639

7050

0.89

2.20

2.5

3.4

52.53

52.89

u/ml

0.01

607

6836

Other skin changes

509

4489

1.14

2.20

3.0

3.9

41.00

78.45

u/ml

3.03

492

4320

Asthma/COPD (KELA code 203)

2962

18762

1.06

2.19

2.8

3.4

37.15

53.48

u/ml

4.14

2847

18174

Stomatitis and related lesions

554

4914

1.13

2.19

3.6

3.5

41.65

57.54

u/ml

0.87

525

4748

Malignant neoplasm of other and unspecified urinary organs

4.45

2.18

3.0

1.2

31.73

80.46

u/ml

—

Bacterial, viral and other infectious agents, including avohilmo

181

1463

1.25

2.18

2.4

3.0

32.98

57.31

u/ml

1.50

173

1419

Acute appendicitis, no complications

1590

14728

1.08

2.17

2.7

3.3

40.58

48.02

u/ml

0.65

1538

14268

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

655

7296

0.89

2.17

3.2

3.9

54.93

70.78

u/ml

0.81

634

7046

Maternal care for other conditions predominantly related to pregnancy

763

8209

0.90

2.17

2.3

2.9

27.01

37.62

u/ml

2.24

737

7977

Hernia

2840

17877

1.06

2.16

3.6

3.5

45.22

55.98

u/ml

1.33

2740

17292

Crohn's disease NAS

152

1207

1.27

2.16

1.6

2.9

49.02

63.04

u/ml

0.36

145

1163

Seropositive rheumatoid arthritis, wide

671

7461

0.89

2.15

3.2

3.9

54.33

73.15

u/ml

1.05

649

7203

Open wound of head

1036

10604

0.91

2.14

3.2

3.6

53.63

66.10

u/ml

0.76

999

10245

Glucagon-like peptide-1 (GLP-1) analogues

832

7556

1.11

2.14

2.6

3.8

39.01

55.07

u/ml

1.15

802

7313

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

832

7556

1.11

2.14

2.6

3.8

39.01

55.07

u/ml

1.15

802

7313

Type 1 diabetes

412

4716

0.87

2.14

2.8

3.4

80.82

55.45

u/ml

0.36

399

4566

Cyst of Bartholin Gland

152

1214

1.28

2.13

1.9

3.3

21.32

59.29

u/ml

2.97

145

1178

Anogenital herpesviral [herpes simplex] infection, including avohilmo

353

3045

1.17

2.13

2.2

2.6

19.12

41.62

u/ml

5.80

343

2964

Superficial injury of forearm

252

2112

1.20

2.13

2.3

3.0

40.54

56.50

u/ml

0.65

243

2037

Ocular pain

265

2234

1.20

2.13

2.5

3.3

29.88

59.63

u/ml

2.44

253

2152

Melanoma in situ

103

779

1.34

2.13

3.5

3.8

30.42

80.87

u/ml

2.14

755

Hypotension

320

2734

1.18

2.13

3.0

4.0

60.57

102.28

u/ml

1.50

312

2602

Glomerulonephritis

189

1540

1.24

2.12

2.7

3.4

198.76

64.72

u/ml

0.40

181

1488

Delivery, wide proxy

1259

7223

0.92

2.11

3.5

3.6

85.37

62.72

u/ml

0.94

1206

6977

Sicca syndrome [Sjögren]

305

2608

1.19

2.10

2.6

4.0

30.45

71.76

u/ml

5.90

294

2515

Subarachnoid haemorrhage

156

1942

0.80

2.10

2.9

4.1

100.31

77.57

u/ml

0.21

150

1876

Obstructed labour due to malposition and malpresentation of fetus

842

8550

0.90

2.10

2.2

2.9

24.73

37.14

u/ml

5.04

814

8304

Other disorders of veins

1404

12843

1.08

2.10

2.9

3.6

60.12

55.66

u/ml

0.12

1359

12405

Glomerular diseases

322

2758

1.17

2.09

2.6

3.6

131.75

66.87

u/ml

0.31

308

2662

Other congenital malformations of respiratory system

3.08

2.09

7.9

3.6

29.26

84.72

u/ml

—

Schizophrenia, schizotypal and delusional disorders

640

7124

0.89

2.07

2.5

3.4

54.20

51.11

u/ml

0.12

608

6894

Transport accidents

1268

11388

0.92

2.07

2.8

3.4

34.69

56.71

u/ml

3.93

1222

11052

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

371

3121

1.16

2.07

2.6

3.3

39.85

55.77

u/ml

1.21

362

3012

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2089

18849

1.07

2.07

2.9

3.4

48.29

50.85

u/ml

0.07

2025

18248

Metabolic disorder, other/unspecified

2.79

2.06

1.7

3.5

17.85

22.94

u/ml

—

Rosacea

420

3680

1.15

2.06

2.2

3.7

35.57

57.73

u/ml

2.43

403

3562

Type 1 diabetes, wide definition, subgroup 2

178

0.39

2.05

2.9

2.8

19.14

59.17

u/ml

—

172

Atrial fibrillation and flutter with reimbursement

620

3490

1.12

2.05

3.2

3.9

55.08

51.97

u/ml

0.11

597

3375

Follicular cysts of skin and subcutaneous tissue

433

3799

1.15

2.05

3.1

3.7

39.17

59.88

u/ml

1.90

416

3677

Spondyloarthritis

414

3620

1.15

2.04

2.8

3.5

63.28

58.93

u/ml

0.10

396

3503

Neuroendocrine tumor and carcinoma of pancreas

2.22

2.03

2.1

1.5

44.53

38.39

u/ml

0.08

Unspecified acute lower respiratory infection

292

2489

1.18

2.02

4.1

3.2

43.98

61.78

u/ml

1.15

282

2410

Ethmoidectomy

312

2677

1.17

2.02

2.5

3.4

31.43

55.07

u/ml

1.77

303

2583

Asthma, hospital admission 2, infections

1752

16014

1.07

2.02

2.8

3.5

41.92

57.42

u/ml

1.20

1682

15488

Asthma-related infections

1752

16014

1.07

2.02

2.8

3.5

41.92

57.42

u/ml

1.20

1682

15488

Undetermined asthma, excluding more controls

378

3289

1.16

2.01

2.6

3.5

77.16

57.04

u/ml

0.23

365

3186

Presbyopia

228

1909

1.21

2.00

4.1

3.6

25.73

55.77

u/ml

2.83

223

1846

Polyarthrosis

730

5955

1.11

2.00

3.0

4.6

52.38

77.43

u/ml

1.68

701

5760

Non-ischemic cardiomyopathy

720

5160

1.11

1.99

3.2

4.4

91.43

85.11

u/ml

0.19

686

4975

Seropositive rheumatoid arthritis, strict definition

355

4078

0.86

1.98

3.1

3.9

61.65

63.20

u/ml

0.03

343

3929

Other appendicitis

215

1791

1.21

1.98

2.4

3.6

36.44

63.21

u/ml

1.52

205

1733

Acute alcohol intoxication

282

3304

0.85

1.98

2.7

3.4

53.68

54.50

u/ml

0.01

270

3186

Sacroiliitis, not elsewhere classified

137

1090

1.27

1.96

2.6

3.0

23.28

58.68

u/ml

2.30

129

1060

Asthma, hospital admissions , main diagnosis only

2498

20595

1.06

1.96

2.6

3.4

44.03

52.86

u/ml

0.73

2402

19929

Malignant neoplasm of other and ill-defined sites

3.88

1.96

1.2

1.8

249.00

79.97

u/ml

—

Bacterial, viral and other infectious agents

159

1285

1.25

1.95

2.1

3.2

32.16

60.70

u/ml

1.65

151

1245

Chronic iridocyclitis

125

984

1.29

1.95

2.9

3.4

34.04

74.52

u/ml

2.05

120

951

Other coagulation defects

209

1740

1.21

1.95

2.2

3.1

28.25

57.75

u/ml

2.67

201

1682

Arthropathies

2725

13061

1.06

1.95

2.9

3.4

46.78

52.85

u/ml

0.60

2627

12665

Acne

252

2119

1.19

1.95

2.2

2.3

40.11

31.96

u/ml

0.22

244

2041

Spirochaetal infections, other/unspecified

231

1941

1.20

1.95

3.2

3.8

44.01

65.80

u/ml

0.54

223

1874

Appendicitis, broad definition

2147

18188

1.06

1.95

2.9

3.4

41.08

49.57

u/ml

0.97

2078

17613

Isolated growth hormone deficiency

2.31

1.94

2.4

3.2

46.35

23.01

u/ml

0.62

Benign neoplasm of bone and articular cartilage

214

1786

1.21

1.94

2.9

3.2

30.01

57.31

u/ml

2.29

206

1723

Nonspecific lymphadenitis

168

1370

1.24

1.94

3.4

3.3

22.83

58.80

u/ml

2.83

162

1321

Radiculopathy

405

3554

1.15

1.93

3.1

4.1

55.34

82.28

u/ml

0.86

390

3418

Schizophrenia or delusion

639

7075

0.90

1.91

2.5

3.4

52.53

51.11

u/ml

0.05

607

6847

Other congenital malformations, including avohilmo

349

3035

1.16

1.90

2.5

3.1

47.62

49.49

u/ml

0.03

339

2939

Undetermined asthma

378

3304

1.15

1.90

2.6

3.5

77.16

55.34

u/ml

0.25

365

3200

Rheumatism, unspecified

547

4906

1.13

1.90

2.7

4.1

53.04

66.34

u/ml

0.41

527

4740

Extreme obesity with alveolar hypoventilation

101

777

1.32

1.89

2.2

3.6

33.51

82.88

u/ml

2.03

755

Rhabdomyosarcoma, including Hilmo

3.77

1.88

3.0

1.4

21.00

70.85

u/ml

—

Trochanteric bursitis

574

5163

1.12

1.88

2.9

4.1

81.83

68.24

u/ml

0.17

549

4984

Other maternal disorders predominantly related to pregnancy

2433

16023

0.95

1.87

2.8

3.5

30.72

48.93

u/ml

5.63

2364

15529

Presence of other devices

555

4898

1.12

1.85

2.9

3.8

48.75

88.84

u/ml

2.85

535

4719

Rickettsioses, including avohilmo

2.94

1.84

3.0

1.8

37.45

77.08

u/ml

—

Injuries to the elbow and forearm

2272

18452

1.06

1.84

3.4

3.5

48.63

54.58

u/ml

0.56

2194

17829

Hyperhidrosis

100

773

1.32

1.83

2.5

2.8

16.24

65.23

u/ml

2.50

751

Hereditary motor and sensory neuropathy

150

0.39

1.82

1.5

3.0

20.83

37.22

u/ml

—

143

Dermatographic urticaria

220

1856

1.20

1.82

2.8

3.2

40.54

54.25

u/ml

0.54

215

1793

Benign neoplasm of other and unspecified female genital organs

170

1404

1.23

1.81

2.1

3.8

43.57

72.34

u/ml

0.72

165

1360

Dislocation, sprain and strain of joints and ligaments at neck level

411

3630

1.14

1.81

2.5

3.0

29.99

45.50

u/ml

2.11

400

3522

Later onset COPD, excluding more controls

316

2774

0.86

1.78

2.9

4.0

86.53

77.69

u/ml

0.18

299

2678

Other symptoms and signs involving the circulatory and respiratory systems

161

1319

1.23

1.78

2.4

3.5

37.83

71.50

u/ml

1.89

155

1276

Rickettsioses

3.14

1.78

1.1

2.0

35.66

90.63

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

180

1466

1.22

1.77

2.6

2.4

29.67

42.79

u/ml

0.78

175

1417

Reimbursement for rheumatic diseases

1622

17122

0.94

1.77

3.0

3.6

47.08

57.23

u/ml

0.99

1558

16563

Allergic conjunctivitis

2152

19630

1.06

1.77

2.9

3.4

47.65

50.36

u/ml

0.07

2084

18994

FESS (DNB20)

301

2608

1.16

1.76

2.5

3.4

32.02

55.20

u/ml

1.63

292

2515

Gout

401

3032

1.14

1.76

3.3

4.4

65.03

100.16

u/ml

1.02

390

2915

Thyrotoxicosis, other and/or unspecified

707

6449

1.10

1.76

3.4

3.7

59.81

63.87

u/ml

0.10

681

6248

Lymphoid leukaemia

688

1.32

1.76

2.6

3.8

407.98

86.59

u/ml

0.49

667

Other systemic involvement of connective tissue

891

8209

1.09

1.76

3.1

3.7

37.78

70.50

u/ml

5.34

864

7919

Undefined dementia

124

1430

0.80

1.76

3.1

3.9

84.54

125.13

u/ml

0.79

117

1368

Moderate visual impairment, binocular

508

1.38

1.75

3.3

3.1

158.41

118.87

u/ml

0.21

490

Special screening examination for neoplasms

136

1096

1.25

1.75

2.7

4.1

29.90

76.50

u/ml

2.59

131

1059

Smoking dependency

199

1668

1.20

1.75

3.1

3.4

47.59

58.52

u/ml

0.33

194

1613

Mental and behavioural disorders due to tobacco

199

1668

1.20

1.75

3.1

3.4

47.59

58.56

u/ml

0.34

194

1613

Other inflammatory liver diseases

161

1323

1.23

1.75

4.5

3.7

37.53

67.73

u/ml

1.82

152

1275

All influenza (not pneumonia)

281

2423

1.17

1.73

3.3

3.2

88.86

63.87

u/ml

0.24

275

2343

Type of accident

720

6572

1.10

1.73

2.8

3.5

49.01

65.62

u/ml

0.66

690

6349

Other and unspecified degenerative diseases of nervous system

370

0.59

1.72

1.4

3.4

37.91

114.59

u/ml

1.24

361

Supplementary factors related to causes of morbidity and mortality classified elsewhere

771

7062

1.10

1.72

2.8

3.5

53.55

63.89

u/ml

0.37

740

6821

Postmenopausal osteoporosis with pathological fracture

238

2035

1.19

1.72

4.1

4.4

50.10

102.44

u/ml

2.60

230

1954

Other and unspecified rosacea

272

2348

1.17

1.71

2.4

3.5

39.16

62.05

u/ml

1.45

261

2266

Other benign neoplasm of uterus: Other parts/unspecified

137

1114

1.25

1.70

3.9

4.3

130.59

101.50

u/ml

0.12

132

1074

Benign neoplasm: Skin of eyelid, including canthus

424

3771

1.13

1.70

2.9

4.0

49.00

68.54

u/ml

1.53

414

3634

Diseases of pulp and periapical tissues, including avohilmo

3186

15755

1.05

1.69

3.2

3.4

45.55

57.03

u/ml

1.63

3055

15277

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

2.97

1.69

1.3

3.8

33.71

34.31

u/ml

—

Peripheral artery operations in Hilmo

110

1384

0.79

1.68

3.3

3.9

35.81

90.32

u/ml

3.95

105

1331

Lactose intolerance

678

1.32

1.68

2.1

3.2

23.82

81.83

u/ml

2.36

650

Otitis externa

591

5357

1.11

1.67

3.1

3.5

52.90

55.36

u/ml

0.08

560

5180

Mantle cell lymphoma

2.62

1.67

4.5

1.6

14.82

44.31

u/ml

—

Multiple gestation

391

3472

1.14

1.67

2.4

2.8

26.14

34.45

u/ml

1.59

379

3365

Benign neoplasm: Kidney

696

1.31

1.67

3.4

3.7

33.41

86.17

u/ml

1.75

672

Fracture of rib(s), sternum and thoracic spine

582

5270

1.11

1.66

3.2

3.8

45.24

73.45

u/ml

3.53

557

5065

Infections with a predominantly sexual mode of transmission, including avohilmo

1301

11141

1.07

1.65

2.2

2.9

28.62

41.28

u/ml

4.49

1255

10795

Spinal stenosis

1291

8893

1.07

1.65

3.0

4.3

46.16

69.44

u/ml

2.74

1236

8595

Viral warts, including avohilmo

569

5151

1.11

1.65

2.6

3.3

24.96

52.93

u/ml

9.49

550

4983

Aneurysms, operations, SAH

326

3712

0.87

1.64

2.8

4.1

65.98

68.23

u/ml

0.04

319

3581

Disorders of choroid and retina

1972

14556

0.95

1.64

3.4

3.8

59.16

60.32

u/ml

0.05

1899

14063

Infections with a predominantly sexual mode of transmission

1003

9293

1.08

1.64

2.4

3.0

30.29

42.09

u/ml

3.34

969

9004

Unspecified urinary incontinence

287

2498

1.16

1.63

2.8

4.2

55.51

79.50

u/ml

0.72

275

2405

Conduction disorders

533

4730

0.90

1.63

3.1

4.3

46.98

78.54

u/ml

2.13

509

4574

Diabetic retinopathy

556

3818

0.90

1.63

2.9

3.2

79.55

57.59

u/ml

0.40

534

3672

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

742

8080

0.91

1.63

2.3

3.0

31.65

42.86

u/ml

1.71

716

7820

Injuries to the thorax

982

9101

1.08

1.62

3.1

3.5

42.90

65.94

u/ml

3.16

941

8772

Psoriatic arthropathies

194

2292

0.84

1.61

2.6

4.0

30.66

60.78

u/ml

2.03

189

2211

Primary biliary cholangitis, wide definition

605

1.33

1.61

1.8

3.6

119.02

87.11

u/ml

0.19

589

Any mental disorder

3348

16073

1.04

1.61

3.2

3.5

61.64

50.52

u/ml

0.56

3206

15589

Monoamine oxidase A inhibitors

306

2677

1.15

1.60

3.1

4.0

39.93

62.89

u/ml

1.35

296

2588

Congenital malformations and deformations of the musculoskeletal system

215

1821

1.18

1.60

2.4

2.8

20.01

49.43

u/ml

3.88

208

1761

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

337

2874

1.14

1.60

2.5

3.3

40.26

57.64

u/ml

1.24

330

2775

Hallux valgus (acquired)

1275

8537

1.07

1.60

3.5

4.1

43.48

64.02

u/ml

1.16

1214

8272

Carbimazole or st.post thyroidectomy, condition for graves disease

735

6754

1.10

1.59

3.1

3.6

54.52

59.89

u/ml

0.15

713

6531

Missing teeth due to accident, extraction or parodontitis

1700

14345

1.06

1.59

3.3

3.8

42.93

63.85

u/ml

4.05

1619

13876

Diabetic maculopathy

145

1659

0.82

1.58

2.2

2.8

120.77

63.12

u/ml

0.28

137

1587

Fracture of skull and facial bones

434

3881

1.12

1.58

2.8

3.7

64.98

62.45

u/ml

0.06

423

3743

1340

12484

1.07

1.57

2.6

3.4

32.30

57.31

u/ml

7.95

1284

12072

Ulcerative enterocolitis

527

1.35

1.57

1.9

2.8

22.09

69.81

u/ml

1.36

509

Communicating hydrocephalus

347

0.59

1.57

4.5

2.9

41.55

109.04

u/ml

1.03

331

Malignant neoplasm of other and unspecified major salivary glands

2.52

1.56

1.6

19.11

42.95

u/ml

—

Childhood asthma (age<16), excluding more controls

296

2017

1.15

1.55

1.8

2.1

26.03

30.47

u/ml

0.69

284

1949

Congenital malformations of heart and great arteries

254

2132

1.16

1.54

2.9

3.2

39.59

55.55

u/ml

0.88

247

2053

Malignant neoplasm of ureter

3.44

1.54

1.4

1.7

17.00

76.60

u/ml

—

Explosion of other materials

3.43

1.54

1.2

5.9

19.60

159.16

u/ml

—

Congenital malformations of the circulatory system

296

2515

1.15

1.54

2.7

3.2

136.17

58.37

u/ml

0.36

289

2426

Duodenal ulcer

155

1286

1.21

1.53

3.2

4.0

51.88

91.14

u/ml

1.96

150

1246

Burn and corrosion of ankle and foot

182

0.49

1.53

2.1

2.5

85.14

48.29

u/ml

—

177

Superficial injury of wrist and hand

553

5022

1.11

1.53

2.4

3.3

36.45

52.08

u/ml

1.24

535

4861

Asthma, hospital admissions 3, pneumonia

930

8606

1.08

1.52

3.2

3.7

52.51

70.89

u/ml

0.65

897

8316

Asthma-related pneumonia or sepsis

930

8606

1.08

1.52

3.2

3.7

52.51

70.89

u/ml

0.65

897

8316

Other follicular disorders

175

1472

1.20

1.52

2.3

2.9

20.90

53.77

u/ml

3.13

170

1417

Vocal cord dysfunction

447

3532

1.12

1.52

2.7

4.1

42.75

56.79

u/ml

0.61

429

3438

Injury of muscle and tendon at shoulder and upper arm level

565

6210

0.91

1.52

3.2

4.0

83.82

66.23

u/ml

0.26

544

5994

Childhood asthma (age<16)

296

2021

1.15

1.52

1.8

2.1

26.03

30.55

u/ml

0.70

284

1953

Malignant neoplasm of tongue

154

1.64

1.51

3.4

1.5

38.84

25.88

u/ml

0.34

148

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

283

2459

1.15

1.51

2.4

3.0

37.59

49.74

u/ml

0.34

272

2377

Infection of intervertebral disc (pyogenic)

139

1.68

1.51

3.4

2.6

44.96

179.23

u/ml

0.83

132

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

213

1826

1.18

1.50

3.2

3.8

30.23

67.58

u/ml

3.48

203

1764

Acute alcohol intoxication, ICD10

237

2741

0.86

1.50

2.4

3.1

56.02

54.73

u/ml

0.02

225

2647

Primary angle-closure glaucoma

104

833

1.26

1.48

3.2

4.0

41.31

101.38

u/ml

2.53

805

Leisure time condition

418

3749

1.12

1.48

3.0

3.5

40.01

64.14

u/ml

2.11

402

3610

Pilonidal cyst

142

1174

1.22

1.48

3.7

2.4

23.08

40.48

u/ml

2.17

134

1128

Asthma-related pneumonia

927

8591

1.08

1.47

3.2

3.7

52.65

70.97

u/ml

0.65

894

8301

Idiopathic pulmonary fibrosis

902

0.76

1.47

3.7

3.9

95.65

100.11

u/ml

0.04

871

Diseases of the ear and mastoid process

3584

17279

1.04

1.47

3.1

3.4

45.86

50.88

u/ml

0.44

3443

16751

Other and unspecified coagulation defects

144

1196

1.22

1.47

2.0

2.8

29.85

60.96

u/ml

1.72

139

1157

Adhesive capsulitis of shoulder

481

4351

1.11

1.47

3.2

4.0

40.06

65.59

u/ml

1.77

470

4208

Perineal laceration during delivery

583

5150

0.91

1.47

2.1

2.6

29.28

37.27

u/ml

1.29

565

5006

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

386

3446

1.13

1.47

2.9

3.6

52.17

62.48

u/ml

0.29

377

3322

Coxarthrosis, primary, with hip surgery

1032

10239

0.93

1.46

3.3

4.2

63.24

74.38

u/ml

0.34

994

9871

Carcinoma in situ of other/unspecified female genital organs

3.60

1.46

3.4

4.6

46.80

76.51

u/ml

—

Scoliosis

250

2175

1.16

1.46

3.2

3.7

31.95

68.23

u/ml

3.71

243

2106

Finngen Rheumatological endpoints

2938

15990

1.04

1.45

3.0

3.4

43.93

52.02

u/ml

0.98

2837

15490

Problems related to lifestyle

202

1728

1.18

1.44

2.3

2.8

33.81

54.89

u/ml

1.44

195

1676

Psoas tendinitis

111

1.78

1.44

1.3

2.3

15.42

51.25

u/ml

1.05

106

Sleep apnoea, including avohilmo

3070

17822

1.04

1.43

2.7

3.6

36.70

54.47

u/ml

4.48

2956

17272

Postprocedural disorders of nervous system

216

1863

1.17

1.43

2.1

2.7

21.01

49.71

u/ml

3.54

204

1807

Voice disturbances

838

7784

1.08

1.42

3.3

3.6

48.29

60.17

u/ml

0.72

800

7529

Speech therapy

693

6389

1.09

1.41

2.9

3.8

61.78

70.15

u/ml

0.15

672

6161

Acute appendicitis

1987

17565

1.05

1.41

2.9

3.3

41.63

49.70

u/ml

0.83

1926

17017

Astigmatism

137

1135

1.22

1.41

2.7

3.1

34.87

67.90

u/ml

1.59

129

1098

Osteoporosis with pathological fracture (FG)

268

2354

1.15

1.40

3.9

4.5

49.76

104.59

u/ml

2.38

258

2254

Infectious mononucleosis, including avohilmo

191

1633

1.18

1.40

1.8

2.3

29.18

32.27

u/ml

0.14

183

1577

Infectious mononucleosis

191

1633

1.18

1.40

1.8

2.3

29.18

32.27

u/ml

0.14

183

1577

Acute laryngitis and tracheitis

269

2321

1.15

1.39

2.4

2.7

31.70

49.10

u/ml

1.54

256

2250

Other and/or unspecified nontoxic goitre

284

2505

1.15

1.39

2.1

4.2

71.38

69.13

u/ml

0.02

278

2417

Arthropathy in hypersensitivity reactions classified elsewhere

3.15

1.39

1.2

2.5

41.40

89.00

u/ml

—

Haemangioma and lymphangioma, any site

238

2072

1.16

1.39

2.3

3.5

202.96

61.06

u/ml

0.53

231

2002

Lumbar disc prolapse

1903

13412

1.05

1.38

2.8

3.7

39.02

56.47

u/ml

3.36

1823

13010

Acne, including avohilmo

589

4361

1.10

1.38

2.0

2.3

33.30

37.00

u/ml

0.20

567

4208

Traumatic subdural haemorrhage

167

1841

0.84

1.37

3.2

4.4

59.65

82.24

u/ml

0.76

160

1773

Heterophoria

217

1878

1.17

1.37

2.3

3.1

29.07

54.95

u/ml

2.17

208

1813

Other disorders of patella

540

4934

1.10

1.37

2.8

3.6

31.54

57.71

u/ml

2.32

514

4784

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

882

8123

1.08

1.36

2.5

2.7

65.59

40.01

u/ml

0.35

857

7857

Iron deficiency

104

844

1.25

1.36

1.9

2.4

27.73

39.00

u/ml

0.92

820

Hydrocephalus

105

1289

0.81

1.36

3.0

3.7

321.39

82.96

u/ml

0.39

100

1246

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

349

3115

1.13

1.36

2.8

3.6

54.13

63.84

u/ml

0.24

340

3007

Injury of unspecified body region

172

1463

1.18

1.35

2.9

3.4

42.59

69.60

u/ml

0.80

163

1415

Other retinal disorders

1462

11727

0.94

1.35

3.4

3.9

67.11

66.22

u/ml

0.03

1401

11324

Tubulo-interstitial nephritis, not specified as acute or chronic

165

1399

1.19

1.35

3.8

3.1

48.46

78.93

u/ml

0.81

160

1343

Guttate psoriasis

295

0.60

1.35

2.7

2.5

51.94

55.54

u/ml

0.03

285

Cervicalgia

626

5761

1.09

1.35

3.0

3.8

54.21

67.80

u/ml

0.45

604

5558

Malignant neoplasm of lip, including Hilmo

2.15

1.34

3.8

1.5

33.70

36.33

u/ml

—

Carcinoma in situ of breast, other/unspecified

431

1.36

1.34

2.5

3.7

45.24

92.35

u/ml

0.67

417

Methotrexate

348

3885

0.89

1.34

2.6

4.0

46.76

71.64

u/ml

1.25

336

3753

Benign neoplasm of mouth and pharynx

245

2143

1.15

1.34

3.0

3.8

39.57

73.68

u/ml

1.63

239

2070

Multiple delivery

300

3369

0.88

1.34

2.4

3.6

24.58

46.93

u/ml

4.98

293

3268

Deforming dorsopathies

865

8062

1.08

1.33

2.8

3.9

40.39

62.76

u/ml

2.55

829

7802

Twin gestation

371

3338

1.12

1.33

2.5

2.7

25.11

34.56

u/ml

2.10

359

3237

Thyrotoxicosis

882

8235

1.08

1.33

3.4

3.7

67.66

63.06

u/ml

0.09

851

7965

Spondylopathies (FG)

340

3038

1.13

1.33

2.8

3.5

34.98

53.13

u/ml

1.62

322

2940

Impotence

0.00

1.32

0.0

1.5

—

188.91

—

KRA_PSY_EATING, excluding more controls

258

2246

1.15

1.32

1.8

2.2

21.10

39.41

u/ml

2.57

249

2171

Pneumonia due to other infectious organisms, not elsewhere classified

543

1.30

1.32

3.1

3.2

206.15

69.87

u/ml

0.35

522

Diseases of inner ear

1599

14529

1.06

1.32

3.3

3.8

63.45

60.73

u/ml

0.09

1549

14031

Symptoms and signs involving speech and voice

994

9320

1.07

1.31

3.3

3.6

52.19

60.72

u/ml

0.45

947

9018

Malignant neoplasm of tongue, including Hilmo

201

1.51

1.31

3.1

1.5

35.67

25.49

u/ml

0.32

194

Use of disulfiram, acamprosate or naltrexone

1041

0.79

1.31

3.2

3.0

63.41

63.04

u/ml

0.00

1005

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

789

7337

1.08

1.31

2.5

3.3

40.96

49.78

u/ml

0.51

760

7098

Car occupant injured in other and unspecified transport accidents

469

4268

1.10

1.30

2.9

3.2

28.76

50.72

u/ml

4.37

453

4131

Sequelae of poliomyelitis, including avohilmo

130

1.66

1.30

5.6

3.7

27.62

131.17

u/ml

0.61

125

Other epidermal thickening

103

839

1.24

1.30

2.4

3.4

19.28

74.92

u/ml

3.27

815

Lesion of ulnar nerve

293

2600

1.13

1.29

2.4

3.8

50.11

59.15

u/ml

0.23

277

2516

Carcinoma in situ, bladder

243

1.45

1.28

5.1

3.2

27.83

115.08

u/ml

1.02

233

Morphin

277

1.43

1.28

6.7

2.9

88.49

86.69

u/ml

0.01

271

Vitamin B12 deficiency anaemia

213

1851

1.16

1.28

4.3

3.9

77.42

84.17

u/ml

0.08

207

1780

Injury of cranial nerves

119

0.41

1.28

1.4

2.4

13.40

160.35

u/ml

—

114

Suicide or other Intentional self-harm

535

5831

0.91

1.27

2.4

3.2

36.36

47.65

u/ml

1.06

515

5646

Dislocation, sprain and strain of joints and ligaments of head

106

869

1.23

1.27

2.7

3.1

54.34

69.09

u/ml

0.20

101

837

Haemophilus septicemia

2.51

1.27

12.2

2.1

84.83

23.53

u/ml

—

Primary coxarthrosis, bilateral

595

6455

0.92

1.27

3.3

4.3

78.05

81.35

u/ml

0.05

561

6214

Other and unspecified effects of external causes

771

7175

1.08

1.26

2.8

3.2

36.81

49.11

u/ml

1.47

745

6942

Alcohol dependence

289

3253

0.89

1.26

2.5

3.6

43.14

56.01

u/ml

0.70

277

3140

Other eccrine sweat disorders

2.92

1.26

7.4

1.7

14.42

29.79

u/ml

—

Hypothermia

190

0.52

1.25

1.7

2.6

91.68

48.48

u/ml

—

181

Unspecified privation

232

2033

1.15

1.25

4.0

3.4

50.93

61.73

u/ml

0.24

225

1969

Autoimmune diseases

3208

15692

1.04

1.25

3.0

3.4

49.19

51.37

u/ml

0.14

3092

15186

Disorders of refraction and accommodation

830

7718

1.08

1.25

2.9

3.2

70.99

47.73

u/ml

0.28

805

7471

Pyogenic arthritis

122

1015

1.21

1.24

3.8

3.9

117.26

93.17

u/ml

0.22

117

979

Recurrent aphthous stomatitis , including avohilmo

389

3518

1.11

1.24

3.7

3.5

44.70

61.60

u/ml

0.61

371

3388

Other sleep disorders

243

2137

1.14

1.24

2.6

3.6

57.56

63.87

u/ml

0.11

235

2070

Synovial cyst of popliteal space [Baker]

199

1728

1.16

1.24

2.8

4.1

27.29

76.93

u/ml

4.72

191

1668

Perforation of tympanic membrane

228

1998

1.15

1.24

3.7

3.6

50.27

73.19

u/ml

0.81

215

1932

Cytomegaloviral pneumonitis

2.76

1.24

6.8

2.2

65.20

62.72

u/ml

—

Acute sinusitis

1668

14444

1.05

1.23

2.6

3.2

35.21

50.75

u/ml

3.51

1592

14006

Dental pulpitis, including avohilmo

2816

17355

1.04

1.23

2.5

3.4

32.66

50.64

u/ml

5.83

2712

16814

Benign neoplasm of brain and other parts of central nervous system

148

1256

1.19

1.23

2.5

3.7

44.56

73.21

u/ml

1.16

143

1211

Other and unspecified nonorganic psychotic disorders

368

4075

0.90

1.23

2.6

3.2

44.52

48.60

u/ml

0.15

347

3944

Asthma and allergy, excluding more controls

395

3532

1.11

1.22

1.9

2.8

29.83

42.96

u/ml

1.09

382

3418

Early onset COPD, excluding more controls

292

3272

0.89

1.22

2.4

3.6

45.96

58.08

u/ml

0.53

277

3164

Other congenital malformations of upper alimentary tract

109

1.70

1.22

2.6

2.8

20.44

66.10

u/ml

1.17

103

Other infective otitis externa

138

1165

1.19

1.22

3.8

3.3

83.07

68.51

u/ml

0.17

130

1127

Viral warts

237

2085

1.14

1.22

2.5

3.1

26.86

55.04

u/ml

3.28

227

2011

Other bursitis of hip

525

1.30

1.21

2.7

3.8

28.49

76.26

u/ml

1.16

510

Convulsions, not elsewhere classified

439

3947

1.10

1.21

3.1

3.0

107.88

53.52

u/ml

0.37

426

3816

Calcific aortic valvular stenosis

394

4182

0.90

1.21

3.1

4.0

60.58

100.84

u/ml

2.34

371

4003

Calcific aortic valvular stenosis, operated

394

4182

0.90

1.21

3.1

4.0

60.58

100.84

u/ml

2.34

371

4003

Disorders of vestibular function (Vertigo)

1441

13336

1.06

1.21

3.2

3.8

59.94

62.76

u/ml

0.09

1399

12877

Diabetic nephropathy, excluding more controls

202

1888

0.87

1.20

2.8

3.1

65.98

60.05

u/ml

0.11

190

1807

Foreign body on external eye

147

1247

1.18

1.20

3.1

2.9

29.66

61.79

u/ml

1.89

141

1201

Mantle cell lymphoma, including Hilmo

1.85

1.20

4.4

1.6

15.74

28.61

u/ml

0.48

Allergic rhinitis

842

8876

0.93

1.20

2.5

3.1

34.24

45.36

u/ml

1.48

816

8585

Drug-induced systemic lupus erythematosus

183

1.53

1.19

1.6

2.9

47.86

54.36

u/ml

0.13

177

Assault

238

2097

1.14

1.19

1.8

2.8

32.12

49.65

u/ml

1.05

233

2029

Other deformity of hallux (acquired)

191

1.51

1.19

3.0

3.8

19.73

152.50

u/ml

1.37

185

Asthma and allergy

395

3538

1.11

1.19

1.9

2.8

29.83

42.96

u/ml

1.09

382

3422

Congenital malformations of the urinary system, including avohilmo

128

1077

1.20

1.18

2.4

3.0

42.44

67.04

u/ml

0.89

123

1041

Cervical disc disorders

965

9077

1.07

1.18

3.2

4.0

40.65

63.21

u/ml

2.10

928

8791

Diabetes, insulin treatment (Kela reimbursement)

2849

17568

0.96

1.17

3.2

3.6

60.44

53.16

u/ml

0.55

2746

17003

Benign neoplasm: Skin of other and unspecified parts of face

251

2225

1.14

1.16

2.6

3.7

41.00

71.01

u/ml

1.59

241

2147

Other systemic involvement of connective tissue (FG)

874

8050

1.07

1.16

3.1

4.0

37.99

66.37

u/ml

4.40

847

7778

Unknown and unspecified causes of morbidity

159

1365

1.17

1.16

4.0

3.1

42.07

71.40

u/ml

0.93

154

1323

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

166

1.52

1.16

3.2

1.5

39.36

27.17

u/ml

0.32

160

Ulcerative colitis

573

5295

1.09

1.15

2.4

3.4

50.91

52.78

u/ml

0.07

558

5125

Other specified/unspecified inflammatory spondylopathies

127

1072

1.20

1.15

2.2

3.2

18.58

63.61

u/ml

3.25

122

1038

Calcific aortic valvular stenosis, diagnosis (helper)

394

4167

0.91

1.14

3.1

4.0

60.58

101.06

u/ml

2.35

371

3988

Operations 2 for CAVS

394

4167

0.91

1.14

3.1

4.0

60.58

101.06

u/ml

2.35

371

3988

Congenital malformations of great veins

2.40

1.14

2.4

1.9

24.73

32.02

u/ml

—

Ptosis of eyelid

272

2428

1.13

3.6

4.2

60.04

81.25

u/ml

0.42

261

2338

Other obstructed labour

300

2699

1.12

1.13

3.2

3.5

39.78

50.04

u/ml

0.47

289

2617

Diabetic retinopathy, strict definition

230

2308

0.88

1.12

2.5

2.9

35.34

58.24

u/ml

3.71

223

2211

Alcohol abuse, main dg

185

2122

0.87

1.12

2.2

2.9

61.35

53.19

u/ml

0.10

175

2051

Crohn disease (strict definition, require KELA, min 2 HDR)

145

1240

1.18

1.12

2.0

2.9

56.70

59.76

u/ml

0.05

138

1198

Ulcerative colitis, NAS

313

2817

1.12

2.4

3.3

57.63

56.18

u/ml

0.03

304

2721

Chronic laryngitis and laryngotracheitis

380

3456

1.11

1.12

2.5

3.9

55.87

66.60

u/ml

0.30

357

3352

Gonarthrosis [arthrosis of knee](FG)

2038

12221

0.96

1.12

3.2

3.8

44.22

58.61

u/ml

1.16

1961

11832

Abscess of Bartholin gland

100

830

1.22

1.12

2.1

3.0

25.46

60.21

u/ml

1.43

100

803

Nonhereditary hypogammaglobulinemia

244

1.43

1.12

2.0

2.7

65.15

45.17

u/ml

0.44

237

Sulfasalazine

725

7758

0.93

1.12

3.0

3.7

40.22

59.39

u/ml

2.12

694

7507

Pneumonias (Asthma/COPD co-morbidities)

3088

19483

1.04

1.12

4.0

3.3

59.08

50.80

u/ml

0.76

2992

18846

Effects of foreign body entering through natural orifice

385

3501

1.10

1.11

3.1

3.3

28.31

58.72

u/ml

5.89

368

3380

Scleritis and episcleritis

175

1522

1.16

1.11

1.8

3.1

19.44

56.50

u/ml

3.99

168

1468

Elevated blood glucose level

171

1483

1.16

1.10

2.4

3.5

27.94

69.49

u/ml

3.42

164

1433

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

155

1335

1.17

1.10

2.0

2.9

54.66

57.31

u/ml

0.05

147

1291

Other diseases of stomach and duodenum

150

1289

1.17

1.10

3.2

3.9

55.23

83.08

u/ml

0.74

140

1250

Transient global amnesia

187

2135

0.87

1.10

3.9

4.5

29.43

93.45

u/ml

5.75

179

2058

Psoriatic arthropathies, ICD10

192

2188

0.87

1.09

2.5

3.5

30.81

57.66

u/ml

1.68

187

2109

Disorders of myoneural junction and muscle in diseases classified elsewhere

212

1.46

1.09

2.2

3.0

55.50

99.08

u/ml

0.33

206

Excessive attrition of teeth

1881

17854

1.04

1.08

2.6

3.3

32.65

49.25

u/ml

4.47

1801

17305

Diseases of external ear

871

8193

1.07

1.08

3.3

3.5

47.46

63.83

u/ml

1.10

826

7917

Primary hyperparathyroidism

341

3096

1.11

1.07

2.8

4.3

77.50

74.93

u/ml

0.02

330

2982

Mucosal proctocolitis

264

2361

1.12

1.07

2.1

3.1

50.07

55.75

u/ml

0.11

255

2273

Autoimmune hyperthyroidism

218

1931

1.14

1.07

3.0

3.6

66.55

61.98

u/ml

0.08

211

1870

Viral conjunctivitis, including avohilmo

108

906

1.21

1.07

3.0

2.9

30.69

59.86

u/ml

0.94

101

873

Cervicocranial syndrome

326

2952

1.11

1.07

2.5

4.0

26.80

66.06

u/ml

5.71

314

2855

Malignant neoplasm of other and unspecified parts of tongue

129

1.57

1.07

3.6

1.5

45.65

23.50

u/ml

0.52

123

Diseases of the eye and adnexa

2333

11245

1.04

1.06

2.9

3.3

34.01

50.77

u/ml

5.08

2264

10901

Conjunctivitis (acute, non atopic)

801

7489

1.07

1.06

2.6

3.4

46.05

53.46

u/ml

0.51

768

7244

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2702

16587

0.96

1.06

3.1

3.6

59.76

52.32

u/ml

0.53

2603

16064

Benign neoplasm: Short bones of lower limb

196

1.46

1.05

3.0

2.7

25.37

45.96

u/ml

0.73

190

Fitting and adjustment of other devices

762

6286

1.07

1.05

3.1

2.7

66.66

43.51

u/ml

1.36

735

6037

Other specified/unspecified soft tissue disorders

134

1147

1.18

1.05

2.0

3.7

28.62

74.68

u/ml

2.77

127

1110

Shoulder region

255

1.40

1.05

3.4

2.9

41.11

59.12

u/ml

0.32

248

Injuries to unspecified part of trunk, limb or body region

222

1968

1.13

1.05

2.8

3.4

42.15

68.42

u/ml

1.08

213

1902

Preparatory care for dialysis

508

1.27

1.05

3.5

52.00

87.85

u/ml

0.71

487

Hypoparathyroidism

952

0.81

1.05

2.3

3.6

45.24

80.21

u/ml

0.80

923

Benign neoplasm: Oesophagus

213

1.44

1.05

5.0

3.1

18.78

90.53

u/ml

0.74

207

1.99

1.05

1.7

3.4

18.72

37.13

u/ml

—

Superficial injury of ankle and foot

301

2717

1.11

1.04

2.4

3.0

47.63

47.38

u/ml

0.01

290

2632

Malignant neoplasm of palate

2.33

1.04

1.8

10.00

63.75

u/ml

—

Calcific aortic valvular stenosis, including rheumatic fever

398

4179

0.91

1.04

3.0

4.0

60.22

100.97

u/ml

2.40

374

4001

Peritonsillar abscess

519

4804

1.08

1.04

2.6

3.1

34.92

47.40

u/ml

0.97

505

4656

Malignant neoplasm of hypopharynx, including Hilmo

2.30

1.04

1.6

1.4

21.20

18.01

u/ml

—

Allergic urticaria

231

2057

1.13

1.03

3.5

3.1

53.81

52.80

u/ml

0.02

221

1980

Lack of expected normal physiological development

156

1.47

1.03

1.8

2.2

33.83

30.61

u/ml

0.06

151

Diseases of middle ear and mastoid

1503

12834

0.95

1.03

2.6

3.1

45.93

51.97

u/ml

0.26

1440

12410

Intermittent heterotropia

129

1100

1.18

1.03

1.9

2.8

33.56

57.98

u/ml

1.08

124

1061

Myopia

356

3244

1.10

1.03

2.4

2.9

117.39

45.75

u/ml

0.41

348

3145

Visual impairment including blindness (binocular or monocular)

150

1297

1.16

1.03

3.2

3.6

86.46

78.11

u/ml

0.09

141

1253

Lichen planus, including avohilmo

552

5127

1.08

1.03

2.9

4.1

35.33

69.98

u/ml

3.74

527

4945

Maternal care for known or suspected fetal abnormality and damage

571

5195

0.93

1.03

2.0

2.6

26.32

34.69

u/ml

2.18

548

5047

Glaucoma suspect

902

9545

0.94

1.02

3.6

4.0

69.99

68.32

u/ml

0.02

868

9214

Brachial plexus disorders

281

2534

1.12

1.02

2.5

3.5

25.41

50.32

u/ml

3.99

267

2467

Inflammatory disorders of breast

239

2138

1.13

1.02

2.7

3.1

29.40

52.13

u/ml

2.45

232

2065

Episcleritis

149

1291

1.17

1.01

1.8

3.1

18.84

58.26

u/ml

3.47

142

1249

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1384

12733

1.05

1.01

2.9

3.6

38.30

56.51

u/ml

2.31

1335

12339

General autosomal fish scale disease

0.00

1.01

0.0

4.2

—

79.40

—

Other complications of labour and delivery, not elsewhere classified

373

3610

0.91

1.01

1.8

2.3

25.43

32.81

u/ml

1.99

364

3503

Thyrotoxicosis with toxic multinodular goitre

188

1657

1.15

1.01

3.4

3.9

100.94

78.97

u/ml

0.13

183

1598

Extrapyramidal and movement disorders

889

9415

0.94

1.01

2.7

3.8

55.59

69.12

u/ml

0.69

849

9091

Hypopituitarism

101

845

1.20

1.01

3.3

2.7

36.83

70.79

u/ml

1.22

818

Other diseases of hard tissues of teeth

1520

7517

1.05

1.01

3.3

3.9

54.94

70.93

u/ml

0.85

1452

7317

Biomechanical lesions, not elsewhere classified

119

1013

1.19

1.01

2.6

3.6

27.93

69.92

u/ml

2.32

114

976

Neuromuscular dysfunction of bladder

177

1552

1.15

1.00

2.5

3.6

39.32

63.14

u/ml

1.89

170

1505

Crohn disease (strict definition, require KELA)

145

1254

1.16

1.00

2.0

2.9

56.70

59.31

u/ml

0.04

138

1212

Primary biliary cholangitis (PBC)

604

1.25

1.00

2.1

3.7

114.90

85.50

u/ml

0.16

587

Congenital myopathies

0.00

0.99

0.0

4.0

—

28.43

—

Other sexually transmitted chlamydial diseases, including avohilmo

226

2015

1.13

0.99

1.6

2.1

26.33

30.07

u/ml

0.29

212

1954

Pneumonia, organism unspecified

2743

18188

1.03

0.98

4.0

3.3

58.53

51.60

u/ml

0.80

2661

17585

Otitis externa, unspecified

273

2462

1.11

0.98

2.6

3.2

52.90

54.83

u/ml

0.04

258

2375

Concussion

1399

11344

0.95

0.98

2.6

3.7

37.43

48.77

u/ml

1.65

1351

11044

Lesion of lateral popliteal nerve

758

1.21

0.98

3.3

3.5

40.22

75.42

u/ml

0.98

729

Diabetic retinopathy, excluding more controls

488

2952

0.92

0.98

2.9

3.2

83.74

54.34

u/ml

0.50

471

2836

Peripheral arterial reconstruction

167

1905

0.87

0.97

3.0

4.0

59.77

103.67

u/ml

1.25

160

1827

Eating disorders

299

2707

1.11

0.97

1.9

2.5

32.87

40.65

u/ml

0.41

289

2620

Biological medication for rheuma

390

4244

0.92

0.97

2.1

3.3

38.66

47.58

u/ml

0.56

375

4117

Other/unspecified enthesopathies, not elsewhere classified

210

1868

1.13

0.97

4.4

3.9

54.76

68.39

u/ml

0.19

203

1806

Postviral fatigue syndrome

200

1.44

0.97

2.1

1.9

22.65

35.84

u/ml

0.69

192

Fall on same level

3323

18239

0.97

0.96

3.1

3.4

45.51

51.62

u/ml

0.68

3196

17687

Diseases of pulp and periapical tissues and dental caries

1842

9069

1.04

0.96

3.4

3.8

56.85

68.44

u/ml

0.61

1755

8823

conjunctival haemorrhage

172

1512

1.15

0.96

2.3

3.9

48.76

84.89

u/ml

1.27

162

1462

Other disorders of amniotic fluid and membranes

480

4991

0.92

0.96

2.2

2.6

25.47

35.97

u/ml

1.96

469

4846

Injuries to the neck

555

5172

1.08

0.95

2.6

3.1

29.78

50.59

u/ml

4.44

537

5010

Thyroiditis

226

2025

1.13

0.95

2.7

3.5

51.97

58.00

u/ml

0.12

218

1953

Tumor necrosis factor alpha inhibitors

350

3820

0.91

0.94

2.1

3.3

38.09

48.11

u/ml

0.59

338

3700

Psoriasis

616

6579

0.93

0.94

2.6

3.6

34.24

61.33

u/ml

3.61

597

6354

Haemangioma, any site

219

1958

1.13

0.94

2.2

3.5

218.49

58.04

u/ml

0.56

212

1890

All pneumoniae

3098

19516

1.03

0.94

4.0

3.2

59.06

50.74

u/ml

0.76

3003

18878

Patellar tendinitis

226

1.39

0.94

2.3

1.9

17.77

40.30

u/ml

1.44

219

Overexertion and strenuous or repetitive movements

201

1788

1.13

0.93

3.9

3.3

33.48

62.18

u/ml

2.46

191

1726

Otosclerosis

145

1660

0.87

0.93

4.1

3.8

105.08

72.65

u/ml

0.40

139

1604

Benign neoplasm of meninges

307

2798

1.10

0.93

3.0

4.1

79.42

71.32

u/ml

0.11

297

2699

Other psoriatic arthropathies

188

2117

0.88

0.93

2.5

3.5

31.19

58.39

u/ml

1.65

183

2041

Other congenital malformations of skull and face bones

2.20

0.93

3.7

2.7

52.17

67.39

u/ml

—

Other disorders of binocular vision

290

0.68

0.92

1.8

2.4

31.34

40.13

u/ml

0.22

276

Mental and behavioural disorders due to alcohol, excluding acute intoxication

612

6476

0.93

0.92

2.6

3.3

54.58

50.65

u/ml

0.17

588

6269

Amputation of thigh

291

0.68

0.92

1.7

2.9

33.54

128.97

u/ml

1.54

283

Periapical abscess

1192

11378

1.05

0.92

3.3

3.6

49.87

52.20

u/ml

0.14

1141

11017

Diabetic maculopathy, excluding more controls

145

1660

0.87

0.91

2.2

3.6

120.77

73.28

u/ml

0.22

137

1602

Other disorders of skin and subcutaneous tissue, not elsewhere classified

328

2999

1.10

0.91

3.2

3.8

69.96

72.24

u/ml

0.04

314

2888

Other condition

317

2894

1.10

0.91

2.4

3.3

59.71

61.95

u/ml

0.03

302

2796

Radiodermatitis

1.82

0.91

2.9

3.1

15.18

32.67

u/ml

0.61

Other congenital malformations of female genitalia

220

1.40

0.91

2.9

1.9

55.74

42.22

u/ml

0.19

209

Contact with other sharp object(s)

125

1079

1.17

0.90

2.0

2.6

19.84

57.05

u/ml

2.47

116

1040

Other and unspecified disorders of vitreous body

1299

12152

1.05

0.90

3.5

4.1

40.00

63.99

u/ml

4.22

1264

11738

Fibroblastic disorders

506

4711

1.08

0.90

2.9

4.0

70.55

66.52

u/ml

0.05

484

4548

Other diseases of lip and oral mucosa

1297

12413

1.05

0.90

3.0

3.7

32.87

59.14

u/ml

6.30

1249

12016

Bronchitis, not specified as acute or chronic

167

1472

1.14

0.90

3.2

3.5

68.19

77.48

u/ml

0.14

157

1429

Other disorders of electrolyte and fluid balance, not elsewhere classified

169

1.45

0.90

7.1

3.4

98.58

140.95

u/ml

0.22

163

False labour

1285

7622

1.05

0.90

2.2

2.7

25.66

37.05

u/ml

3.75

1241

7406

Congenital malformations of the urinary system

116

997

1.17

0.89

2.5

2.9

44.74

66.98

u/ml

0.69

111

963

Cellulitis of external ear

229

0.64

0.89

5.3

2.4

26.22

32.36

u/ml

0.25

221

Bipolar affective disorders

435

4692

0.92

0.89

2.3

3.2

34.80

43.36

u/ml

0.52

421

4562

Gestational [pregnancy-induced] hypertension

994

10416

0.95

0.89

2.4

3.0

33.84

41.65

u/ml

0.92

962

10096

Excessive vomiting in pregnancy

306

2797

1.10

0.89

2.3

2.9

23.80

47.62

u/ml

4.12

298

2711

Psychiatric diseases

2895

14059

1.03

0.89

3.0

3.7

61.11

52.74

u/ml

0.33

2775

13630

Ectopic pregnancy

729

6885

1.06

0.89

2.6

3.6

30.17

51.90

u/ml

3.43

705

6671

Examination and encounter for administrative purposes

135

1174

1.16

0.89

3.6

4.4

35.83

91.31

u/ml

2.73

126

1130

Lung diseases due to external agents

191

1699

1.13

0.89

3.5

3.7

68.94

78.31

u/ml

0.21

185

1638

Foreign body in ear

357

0.72

0.88

2.4

2.7

15.79

81.78

u/ml

1.25

345

Chondropathies

355

3264

1.09

0.88

2.3

3.4

33.43

57.20

u/ml

2.18

349

3153

Benign neoplasm: Cerebral meninges

277

2521

1.11

0.88

3.2

4.0

75.25

72.55

u/ml

0.03

268

2431

Accessory breast

205

1.41

0.88

1.8

2.3

39.46

30.82

u/ml

0.23

197

Lactose intolerance, other/unspecified

595

1.22

0.88

2.2

3.1

25.16

84.98

u/ml

2.05

573

Other acquired deformities of musculoskeletal system and connective tissue

759

1.20

0.88

2.6

3.3

188.47

81.32

u/ml

0.34

733

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1823

11082

0.96

0.87

2.7

3.3

28.41

42.00

u/ml

5.59

1772

10753

Disorders of ocular muscles, binocular movement, accommodation and refraction

1439

13689

1.04

0.87

2.8

3.3

64.24

49.13

u/ml

0.32

1391

13247

Disorder of mineral metabolism, other/unspecified

1.86

0.87

1.3

2.8

23.02

58.85

u/ml

—

Other benign neoplasms of connective and other soft tissue

237

2140

1.11

0.87

3.6

3.4

103.58

66.39

u/ml

0.29

225

2067

Embedded teeth, including avohilmo

215

1931

1.12

0.87

2.4

34.94

42.18

u/ml

0.33

209

1868

Macular pucker

283

3103

0.91

0.86

4.0

4.5

39.75

88.07

u/ml

2.94

272

2986

Embedded and impacted teeth

659

5030

1.07

0.86

2.1

2.4

27.32

38.62

u/ml

2.27

635

4861

Mandibular retrognathia

155

1362

1.14

0.86

2.5

2.7

25.44

48.81

u/ml

1.57

147

1321

Other/unspecified rheumatoid arthritis

274

3006

0.91

0.86

3.0

4.0

30.08

79.89

u/ml

7.57

264

2894

Other bursopathies

315

2886

1.10

0.86

3.0

4.1

34.06

68.87

u/ml

4.02

306

2791

Benign paroxysmal vertigo

901

8563

1.06

0.86

3.2

3.8

64.56

70.61

u/ml

0.13

869

8256

Nonalcoholic steatohepatitis

188

1.41

0.86

3.2

2.6

27.30

48.56

u/ml

0.77

181

Other puerperal infections

282

2574

1.10

0.85

1.9

2.3

40.88

38.89

u/ml

0.07

273

2486

Hyperlipidaemia, other/unspecified

819

6970

1.06

0.85

3.3

4.0

65.79

79.66

u/ml

0.57

783

6725

Herpesviral [herpes simplex] infections, including avohilmo

853

8099

1.06

0.85

2.5

3.2

35.96

53.50

u/ml

1.99

822

7828

Supervision of normal pregnancy

775

4673

0.94

0.85

2.3

2.7

23.66

38.22

u/ml

5.22

756

4546

Chronic ulcer of skin, not elsewhere classified

128

1114

1.16

0.85

3.4

3.9

50.02

81.22

u/ml

1.15

122

1076

Exclusion endpoint for supernumerary teeth

188

1.40

0.85

5.7

2.2

54.80

43.42

u/ml

0.14

181

Ankylosing spondylitis

169

1499

1.13

0.84

3.1

3.5

51.70

65.75

u/ml

0.46

161

1451

473

4112

1.08

0.84

3.6

4.2

98.27

99.00

u/ml

0.01

452

3945

Anomalies of dental arch relationship, including avohilmo

524

4431

1.07

0.84

2.3

3.3

34.17

46.94

u/ml

0.85

501

4293

Seronegative rheumatoid arthritis

297

3241

0.91

0.84

3.4

4.2

48.20

79.19

u/ml

1.45

282

3115

Heart failure,strict

1072

7131

1.05

0.84

3.3

4.3

96.58

73.90

u/ml

0.80

1035

6876

Recurrent and persistent haematuria

138

1.48

0.83

2.5

2.6

32.35

49.43

u/ml

0.35

133

Postpartum haemorrhage

1002

8662

0.95

0.83

2.4

2.9

28.69

38.18

u/ml

2.85

972

8407

Corns and callosities

153

1351

1.14

0.83

4.2

3.7

42.16

76.22

u/ml

1.51

142

1306

Other deformities of toe(s)

110

951

1.17

0.82

3.3

4.2

18.95

86.95

u/ml

4.57

104

921

Other rupture of muscle

122

1.51

0.82

4.0

2.1

23.01

63.57

u/ml

1.19

116

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3006

19453

1.03

0.82

4.0

3.3

55.91

51.53

u/ml

0.46

2913

18817

Alcohol abuse counselling and surveillance

189

0.63

0.82

2.3

2.2

31.75

50.02

u/ml

0.58

184

Use of teriflunomide

247

0.67

0.82

1.6

2.2

15.21

38.10

u/ml

1.57

236

Spondylolisthesis/Spondylolysis

532

4987

1.07

0.82

2.9

4.1

35.60

70.62

u/ml

3.84

505

4814

Personal history of allergy to analgesic agent

148

0.59

0.82

1.2

2.3

16.67

48.92

u/ml

—

143

Puerperal sepsis

444

4757

0.93

0.82

3.7

3.9

33.62

53.40

u/ml

2.44

433

4603

Other degenerative diseases of the basal ganglia

236

0.67

0.82

2.0

3.4

144.63

135.67

u/ml

0.02

228

Gonarthrosis,primary

2364

14696

0.97

0.81

3.3

3.8

52.78

59.90

u/ml

0.42

2282

14217

Labour and delivery complicated by umbilical cord complications

187

1678

1.13

0.81

2.7

3.2

36.35

49.04

u/ml

0.60

180

1626

Hypotony of eye

0.00

0.81

0.0

3.7

—

48.70

—

Carcinoma in situ of rectum

164

1.42

0.81

1.6

3.2

43.65

36.41

u/ml

0.12

159

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

742

7731

0.94

0.81

2.3

3.0

31.65

42.67

u/ml

1.61

716

7497

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

149

0.59

0.81

6.9

3.1

32.04

32.75

u/ml

—

143

Striae atrophicae

269

1.33

0.80

3.0

2.4

21.81

40.35

u/ml

1.08

260

Other arthritis (FG)

884

8416

1.05

0.80

3.3

3.8

46.65

60.88

u/ml

0.96

851

8139

Pedestrian injured in transport accident

153

1356

1.13

0.79

2.5

3.4

60.84

67.71

u/ml

0.12

147

1312

Alcohol use disorder, ICD-based

567

6031

0.94

0.79

2.6

3.4

55.26

50.57

u/ml

0.19

545

5838

Hyperprolactinaemia, drug-induced

161

0.60

0.79

1.3

2.9

18.10

54.51

u/ml

—

154

Adhesive middle ear disease

257

0.69

0.78

1.7

2.8

21.61

35.27

u/ml

1.10

248

Tinnitus

615

5803

1.06

0.78

3.2

3.8

56.85

65.30

u/ml

0.15

593

5602

Diseases of arteries, arterioles and capillaries (FINNGEN)

525

3393

1.07

0.78

3.2

3.8

55.65

52.14

u/ml

0.13

510

3287

Postpartum care and examination

527

3102

1.07

0.77

2.3

2.5

23.65

38.76

u/ml

4.27

513

3015

Agoraphobia

687

1.19

0.77

2.0

2.4

33.75

36.20

u/ml

0.07

665

Other and unspecified syphilis, including avohilmo

1.80

0.77

1.0

3.4

26.67

52.76

u/ml

—

Insulin, intermediate and long-acting

1043

10513

0.96

0.77

2.8

3.6

66.99

63.11

u/ml

0.11

1000

10148

Nail disorders

196

1768

1.11

0.76

2.4

3.7

48.17

60.00

u/ml

0.30

187

1711

Other autoimmune haemolytic anaemias

201

1.36

0.76

2.6

3.0

19.30

58.37

u/ml

1.28

195

Eating disorder

258

2356

1.10

0.76

1.8

2.3

21.10

36.41

u/ml

2.17

249

2275

Atopic dermatitis

1960

15107

1.03

0.76

2.6

3.2

27.63

49.16

u/ml

9.76

1879

14634

Pigmented purpuric dermatosis

184

1.38

0.76

6.7

2.8

24.53

58.19

u/ml

1.05

178

Other specified/unspecified dorsopathies

763

1.18

0.75

2.2

3.8

41.15

84.94

u/ml

1.24

740

Alcohol abuse, main dg, excluding more controls

185

2055

0.90

0.75

2.2

3.2

61.35

52.11

u/ml

0.11

175

1996

Pyoderma gangrenosum

176

1.39

0.75

3.5

2.8

40.98

51.29

u/ml

0.16

167

Sensorineural hearing loss

1904

13103

0.97

0.75

3.4

3.9

58.44

61.42

u/ml

0.12

1830

12667

Tick-borne viral encephalitis, including avohilmo

109

0.54

0.74

2.0

2.7

37.93

65.80

u/ml

—

104

AV-block

246

2299

0.91

0.74

2.7

4.3

51.65

90.45

u/ml

1.40

235

2210

Dental caries, including avohilmo

2044

10132

1.03

0.74

3.4

3.8

55.53

65.99

u/ml

0.60

1944

9860

Kela reimbursement Agammaglobulinemia (D80-84)

194

1.37

0.74

1.9

2.4

45.81

46.62

u/ml

0.02

187

Other diseases of gallbladder

109

951

1.16

0.74

3.8

48.63

81.45

u/ml

0.66

104

910

Other (seronegative) rheumatoid arthritis, wide

470

5008

0.94

0.74

3.5

3.9

47.48

76.32

u/ml

2.13

451

4828

Degenerative macular diseases

223

2448

0.91

0.74

4.5

4.3

73.02

89.87

u/ml

0.27

216

2347

Other and unspecified syphilis

2.04

0.73

1.0

3.9

24.80

29.96

u/ml

—

Injury of muscle and tendon at forearm level

237

1.32

0.73

4.4

2.7

26.40

55.02

u/ml

1.08

227

Coxarthrosis [arthrosis of hip](FG)

1354

9673

0.96

0.73

3.3

4.2

54.78

66.68

u/ml

0.50

1306

9352

Acute epiglottitis

230

0.69

0.73

2.5

2.7

22.06

37.60

u/ml

0.71

223

Other Crohn's disease

149

1328

1.13

0.73

2.0

3.0

30.48

57.27

u/ml

1.66

143

1283

Plantar fascial fibromatosis

323

2993

1.09

0.72

3.0

3.8

68.51

60.46

u/ml

0.07

307

2898

Panniculitis, unspecified

212

1.34

0.72

2.3

2.7

135.07

105.89

u/ml

0.11

205

Senile cataract

1447

9121

0.96

0.72

3.8

4.2

48.90

64.44

u/ml

1.37

1398

8836

Tooth eruption problems

333

2980

1.08

0.72

2.4

33.14

36.72

u/ml

0.22

320

2874

Other predominantly sexually transmitted diseases, not elsewhere classified

514

4841

1.07

0.72

2.0

2.9

27.84

43.33

u/ml

2.95

495

4696

Acute suppurative otitis media

638

5630

1.06

0.72

2.3

2.7

30.84

41.96

u/ml

1.78

607

5455

Vitreous haemorrhage

189

1709

1.11

0.71

3.2

3.8

49.07

79.73

u/ml

0.98

179

1649

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

106

926

1.15

0.71

3.2

3.5

193.90

66.84

u/ml

0.49

101

897

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

1.94

0.71

2.6

1.7

23.00

20.18

u/ml

—

Lichen nitidus

1.96

0.71

4.6

3.9

14.80

12.66

u/ml

—

Other enthesopathies

953

9123

1.05

0.71

3.2

3.8

54.70

56.71

u/ml

0.05

912

8832

Poisoning by medicine, drug-induced

262

0.71

0.70

6.1

2.6

28.04

38.99

u/ml

0.43

253

Shock, not elsewhere classified

118

1.46

0.70

1.3

2.5

72.18

47.89

u/ml

0.19

112

Other and unspecified visual disturbances

277

2554

1.09

0.70

3.5

3.6

49.89

65.61

u/ml

0.35

270

2461

Pre-eclampsia or poor fetal growth

1203

12432

0.96

0.70

2.8

3.0

35.96

43.46

u/ml

0.77

1172

12048

Complications of anaesthesia during the puerperium

111

1.50

0.69

4.5

2.3

11.89

29.18

u/ml

3.08

105

Burn and corrosion of wrist and hand

565

1.19

0.69

3.0

2.4

67.36

56.94

u/ml

0.11

546

Otalgia

234

2143

1.10

0.69

2.1

3.6

33.41

64.01

u/ml

1.25

227

2075

Other specified/unspecified arthritis

766

7302

1.05

0.69

3.2

4.0

49.00

65.57

u/ml

0.96

736

7076

Chronic periodontitis, complicated

1349

13618

0.96

0.69

3.5

3.8

45.41

59.84

u/ml

2.08

1295

13171

Haemorrhage in early pregnancy

1219

11409

1.04

0.68

2.7

3.3

31.33

47.67

u/ml

4.06

1184

11073

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

303

1.27

0.68

5.1

2.9

39.57

83.24

u/ml

0.51

293

Chronic lower respiratory diseases

3647

18769

1.02

0.68

2.9

3.4

44.35

53.46

u/ml

1.04

3506

18181

Atopic dermatitis, strict definition with reimbursement

863

8662

0.95

0.68

2.7

3.0

27.92

42.56

u/ml

4.76

832

8376

Budesonide

376

3514

1.07

0.68

2.3

3.6

45.26

57.22

u/ml

0.38

361

3395

Fracture of spine, level unspecified

1.84

0.67

3.4

2.7

82.40

97.37

u/ml

—

Glomerular disorders in diseases classified elsewhere

172

1554

1.11

0.67

2.2

3.5

40.97

71.17

u/ml

2.13

163

1502

Keratitis

867

9057

0.96

0.67

2.5

3.5

51.72

59.39

u/ml

0.19

835

8756

Pemphigoid

406

0.78

0.67

3.0

3.3

134.93

110.38

u/ml

0.08

393

Malignant neoplasm of nasopharynx, including Hilmo

1.81

0.66

2.0

1.3

48.60

13.43

u/ml

—

Pre-eclampsia

767

8026

0.95

0.66

3.2

41.49

44.21

u/ml

0.14

743

7762

Polyarthropathies

1904

11860

1.03

0.66

3.1

3.6

46.60

54.99

u/ml

0.82

1840

11509

Complications of labour and delivery

2715

15454

0.97

0.66

3.3

3.6

46.12

50.28

u/ml

0.27

2636

14968

Iodine-deficiency-related thyroid disorders and allied conditions

1.84

0.66

1.4

3.8

20.60

65.67

u/ml

—

Other mosquito-borne viral fevers, including avohilmo

154

0.64

0.66

5.7

2.4

53.80

51.90

u/ml

—

148

Fracture of lower leg, including ankle

1506

15268

0.97

0.66

3.4

3.7

51.46

59.57

u/ml

0.56

1451

14761

Other and unspecified disorders of sclera

1.80

0.65

1.8

3.5

14.46

48.23

u/ml

—

Olecranon bursitis

458

1.21

0.65

2.3

3.7

30.91

92.81

u/ml

1.40

442

Injury of muscle and tendon at wrist and hand level

227

2083

1.09

0.65

3.9

3.4

39.04

54.89

u/ml

0.82

217

2008

Other and unspecified disorders of globe

1.78

0.65

1.4

5.4

25.40

78.21

u/ml

—

Cardiomyopathy

252

2322

1.09

0.64

2.7

4.1

81.19

81.31

u/ml

0.00

243

2248

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

296

2753

1.08

0.64

3.2

2.7

29.37

35.84

u/ml

0.49

284

2676

Other disorders of cornea

198

2166

0.91

0.64

2.1

3.8

54.85

72.30

u/ml

0.25

187

2088

Stenosis and insufficiency of lacrimal passages

264

2444

1.09

0.63

3.3

4.1

32.07

76.98

u/ml

5.97

254

2351

Congenital malformations of the respiratory system

306

1.26

0.63

3.8

2.8

33.53

87.55

u/ml

0.73

295

Other specified/unspecified disorders of bone/cartilage

424

1.21

0.63

1.9

2.9

37.87

55.74

u/ml

0.51

409

Meniscus derangement

1384

9495

0.97

0.63

3.3

3.9

53.21

61.43

u/ml

0.34

1338

9199

Anterior Iridocyclitis

478

4516

1.06

0.63

3.3

3.7

33.26

61.73

u/ml

5.59

457

4364

Atypical facial pain

157

1421

1.11

0.62

2.1

3.7

20.50

65.16

u/ml

4.54

148

1376

Disorders of tooth development and eruption

422

3646

0.94

0.62

3.1

3.6

33.62

67.62

u/ml

2.31

406

3550

Pedal cyclist injured in collision with motor vehicle

544

0.82

0.62

2.3

2.7

37.98

71.11

u/ml

0.53

525

IBD patients in KELA-register

516

4888

1.06

0.62

2.1

3.3

44.51

46.56

u/ml

0.07

498

4730

Preterm labour and delivery

998

10359

0.96

0.62

3.0

3.5

45.34

48.92

u/ml

0.16

963

10051

Migraine with aura, drug-induced

277

0.74

0.61

2.9

2.6

15.98

54.99

u/ml

1.65

264

306

3278

0.93

0.61

2.3

21.97

31.92

u/ml

2.08

297

3174

Yaws

0.00

0.61

0.0

2.5

—

18.29

—

Non-rheumatic valve diseases

1014

7517

0.96

0.61

3.2

4.2

48.80

69.27

u/ml

1.75

959

7284

Type 2 diabetes, definitions combined, including avohilmo

3018

17048

1.02

0.61

3.1

3.5

53.84

51.40

u/ml

0.20

2899

16515

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.61

0.0

4.6

—

30.16

—

Intentional self-harm by jumping or lying before moving object

0.00

0.61

0.0

1.4

—

31.44

—

Autoimmune hepatitis, wide definition

115

1024

1.13

0.61

4.1

3.8

34.09

82.59

u/ml

2.54

108

990

Profound mental retardation

0.00

0.61

0.0

4.2

—

31.57

—

Impacted maxillary molar

139

1251

1.12

0.61

1.7

2.1

21.22

29.59

u/ml

1.82

130

1208

Dengue fever [classical dengue]

0.00

0.60

0.0

1.7

—

65.68

—

Contact with nonpowered hand tool

367

0.79

0.60

3.2

2.3

20.28

76.36

u/ml

1.02

349

Actinic keratosis

837

7300

1.04

0.60

3.7

4.2

94.60

79.99

u/ml

0.31

809

7019

Hyperkinetic disorders (excl. ADHD)

206

0.71

0.60

1.5

1.8

43.00

33.69

u/ml

0.23

199

Other eating disorders

136

1224

1.12

0.59

1.8

2.4

22.32

42.95

u/ml

1.35

129

1186

Other disorders of optic disc

273

1.26

0.59

3.1

2.6

41.83

44.33

u/ml

0.04

260

Inflammatory bowel disease, strict (require KELA)

516

4895

1.06

0.59

2.1

3.3

44.51

46.56

u/ml

0.07

498

4740

Other and unspecified mononeuropathies of upper limb

557

1.18

0.59

2.4

3.5

20.74

80.97

u/ml

2.00

538

Conductive and sensorineural hearing loss

2046

13939

0.97

0.59

3.4

3.9

60.88

59.50

u/ml

0.06

1970

13483

Single delivery by caesarean section

721

4300

0.95

0.59

2.2

3.0

23.93

40.05

u/ml

5.53

700

4181

Injuries to the ankle and foot

2077

18190

0.97

0.59

2.8

3.3

44.84

49.18

u/ml

0.24

1990

17616

Other diseases of arteries and capillaries

185

1693

1.10

0.59

3.5

3.8

41.61

76.52

u/ml

2.31

177

1637

Persistent delusional disorders

136

1506

0.90

0.58

2.5

3.5

71.59

75.22

u/ml

0.04

128

1453

Other hearing loss

557

5669

0.95

0.58

3.2

4.0

60.11

82.98

u/ml

0.74

534

5450

Allergic asthma (mode), excluding more controls

685

6390

1.05

0.58

2.4

3.0

38.46

47.39

u/ml

0.60

663

6195

Unspecified visual impairment (binocular)

275

0.76

0.58

3.0

2.9

14.46

76.35

u/ml

2.46

266

Hyperkinetic disorders, excluding more controls

296

2576

1.07

0.58

2.1

31.94

32.61

u/ml

0.05

287

2499

Malignant neoplasm of lip

1.73

0.58

5.5

1.6

30.83

42.06

u/ml

—

Calcific tendinitis

195

0.71

0.57

1.9

2.6

24.97

47.67

u/ml

0.71

189

Benign neoplasm: Short bones of upper limb

330

0.78

0.57

2.3

2.4

29.40

81.67

u/ml

0.79

316

Complications predominantly related to the puerperium

1002

10385

0.96

0.57

2.8

3.3

31.97

46.62

u/ml

2.49

974

10074

Lichen ruber planus, wide definition including periferal and oral lichen planus

661

6320

1.05

0.57

3.1

4.0

36.36

67.82

u/ml

3.92

632

6104

Secondary polycythaemia

292

1.24

0.57

2.9

2.7

22.23

81.32

u/ml

0.83

279

Graves disease, strict definition

329

3087

1.07

0.57

3.4

48.54

51.27

u/ml

0.07

317

2991

Crossbite

134

1112

1.11

0.57

2.9

25.74

58.43

u/ml

1.95

128

1073

Cerebrovascular diseases (FINNGEN)

841

5659

1.04

0.56

2.8

3.3

105.52

43.73

u/ml

1.00

815

5490

Congenital hypothyroidism without goiter

125

0.62

0.56

1.8

3.1

11.41

42.42

u/ml

—

119

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

604

5767

1.05

0.56

1.9

2.8

29.22

41.20

u/ml

1.92

581

5596

Contusion of other and unspecified parts of foot

118

1059

1.12

0.56

2.0

2.7

27.70

53.14

u/ml

1.16

111

1024

Injury of nerves at ankle and foot level

122

0.65

0.56

1.3

2.7

15.50

56.77

u/ml

—

117

Other pulmonary heart/vessel disease

677

0.85

0.56

3.1

3.4

169.37

71.73

u/ml

0.92

656

Orchitis and epididymitis

1.46

0.56

1.4

1.5

24.38

170.78

u/ml

—

Superficial injury of thorax

299

2797

1.07

0.56

2.9

3.5

36.28

66.17

u/ml

2.66

286

2696

Impacted teeth

458

3723

1.06

0.56

1.9

2.3

23.51

36.91

u/ml

3.03

443

3590

Other and unspecified haemorrhagic conditions

303

1.24

0.55

4.3

2.7

31.38

47.79

u/ml

0.57

289

Ventricular septal defect, a heart condition

320

1.22

0.55

2.5

24.44

31.41

u/ml

0.58

306

Other and unspecified injuries of ankle and foot

862

1.13

0.55

1.6

2.8

88.23

64.85

u/ml

0.21

832

Diseases of oral cavity, salivary glands and jaws

1506

7528

1.03

0.55

3.4

3.9

63.99

70.86

u/ml

0.21

1436

7327

Pathological resorption of teeth

674

1.15

0.54

2.8

2.7

33.54

70.09

u/ml

1.12

653

Personal history of medical treatment

193

0.72

0.54

3.1

2.7

82.93

47.61

u/ml

0.36

185

Lichen planus

357

3365

1.06

0.54

3.1

4.1

30.22

70.11

u/ml

6.49

343

3241

Other disorders of breast and lactation associated with childbirth

512

0.83

0.54

1.5

2.1

25.88

37.80

u/ml

0.84

491

Flat foot [pes planus] (acquired)

282

3012

0.93

0.54

2.6

4.3

29.98

79.26

u/ml

3.00

272

2907

Other sexually transmitted chlamydial diseases

140

1271

1.11

0.54

1.8

2.2

30.33

32.05

u/ml

0.07

133

1237

Type 2 diabetes

3108

17620

1.02

0.54

3.0

3.5

58.89

51.27

u/ml

0.61

2986

17074

Internal derangement of knee

980

9365

1.04

0.53

2.9

3.8

51.06

56.69

u/ml

0.15

935

9082

Crowding of teeth, including avohilmo

185

1408

1.09

0.53

1.9

2.4

25.47

42.03

u/ml

1.13

177

1351

Azathioprine

345

3250

1.06

0.53

2.1

3.6

39.78

56.33

u/ml

1.54

329

3145

Posteruptive colour changes of dental hard tissues

1.45

0.53

1.9

2.6

22.56

67.35

u/ml

—

Other bursitis, not elsewhere classified

170

1.31

0.52

1.5

3.0

13.32

65.92

u/ml

1.98

162

Viral pneumonia

243

2263

1.08

0.52

4.0

3.4

39.65

69.34

u/ml

2.35

232

2183

Allergic contact dermatitis due to drugs in contact with skin

490

1.17

0.52

3.7

2.8

40.06

73.41

u/ml

0.66

472

ILD medications: immunosuppressive drugs

1887

16660

1.03

0.52

2.5

3.5

42.26

53.99

u/ml

1.98

1813

16133

Glaucoma

1456

12012

1.03

0.52

3.6

4.0

83.23

64.67

u/ml

0.36

1399

11596

Erythema nodosum

734

1.14

0.52

2.3

3.2

52.26

77.51

u/ml

0.41

709

Pre-eclampsia or eclampsia

839

8700

0.96

0.52

3.1

3.3

41.64

48.86

u/ml

0.45

814

8415

Congenital malformations of the respiratory system, including avohilmo

342

1.21

0.52

3.6

2.9

31.93

83.07

u/ml

0.78

329

Coxarthrosis

1209

8048

0.97

0.52

3.3

4.2

55.46

67.05

u/ml

0.42

1169

7788

Vasomotor and allergic rhinitis

1093

11026

0.97

0.52

2.8

3.3

47.17

51.87

u/ml

0.14

1057

10673

Valvular heart disease excluding rheumatic fever

1022

7546

0.97

0.51

3.2

4.2

48.98

69.13

u/ml

1.72

967

7311

Antepartum haemorrhage, not elsewhere classified

336

3171

1.07

0.51

1.7

2.6

30.31

34.63

u/ml

0.38

323

3074

Myocardial infarction, with ST-elevation

144

1578

0.91

0.51

3.9

3.6

40.26

94.59

u/ml

4.10

135

1515

Foreign body in respiratory tract

110

990

1.12

0.51

2.0

3.3

24.53

66.28

u/ml

2.47

101

959

Diabetes mellitus

3205

18145

1.02

0.51

3.0

3.4

57.65

50.58

u/ml

0.58

3083

17581

ILD medications: azathioprine

345

3256

1.06

0.51

2.1

3.7

39.78

55.78

u/ml

1.47

329

3152

Complications of internal orthopaedic prosthetic devices, implants and grafts

516

4923

1.05

0.51

2.7

3.9

67.41

77.55

u/ml

0.31

497

4725

ILD, hospital admission 2, with pulmonary infections

133

1461

0.91

0.51

3.7

4.0

82.53

86.20

u/ml

0.05

128

1405

Allergic asthma (mode)

685

6419

1.04

0.50

2.4

3.0

38.46

46.99

u/ml

0.57

663

6220

Memory loss

157

1710

0.91

0.50

3.3

4.0

68.81

100.49

u/ml

0.70

146

1637

Pregnancy with abortive outcome

3037

15512

1.02

0.50

3.2

3.5

48.15

56.59

u/ml

0.76

2939

15021

Contracture of joint

216

1.26

0.50

2.5

2.9

48.26

91.43

u/ml

0.32

209

Skin changes due to chronic exposure to nonionizing radiation

870

7596

1.04

0.50

3.6

4.2

100.19

77.76

u/ml

0.53

841

7302

633

5212

1.04

0.50

3.6

4.3

106.50

88.40

u/ml

0.31

598

5019

Orthopaedic devices associated with adverse incidents

334

0.80

0.50

1.9

3.9

25.24

114.94

u/ml

1.69

324

Eosinophilia

268

0.78

0.50

1.6

2.9

27.71

50.09

u/ml

0.73

255

Insulin, fast-acting or short human

665

6919

0.96

0.49

2.6

3.5

69.19

62.44

u/ml

0.13

643

6673

Degeneration of macula and posterior pole

1072

8535

0.97

0.49

3.7

4.3

83.37

77.47

u/ml

0.14

1020

8228

Gingivitis and periodontal diseases

2908

14718

1.02

0.49

3.1

3.5

46.11

59.61

u/ml

1.68

2787

14269

Ganglion

636

6621

0.96

0.48

2.7

3.6

42.65

54.45

u/ml

0.75

617

6412

Meningitis, viral

111

1.38

0.48

4.5

2.4

18.63

59.85

u/ml

1.12

105

Other external causes of accidental injury

2578

12646

1.02

0.48

3.2

3.5

47.12

55.64

u/ml

0.83

2495

12285

Other otitis externa (chronic)

151

1387

1.09

0.48

2.9

3.5

56.02

65.16

u/ml

0.14

141

1338

Bitten or struck by other mammals

307

2896

1.06

0.48

2.9

3.0

24.94

48.17

u/ml

4.31

291

2807

Carcinoma in situ of skin of other and unspecified parts of face

156

1435

1.09

0.48

3.7

4.2

110.52

112.93

u/ml

0.02

151

1378

Carcinoma in situ of skin

172

1590

1.09

0.47

3.6

3.9

87.38

88.41

u/ml

0.01

164

1534

Coxarthrosis, primary

1425

12143

0.97

0.47

3.3

4.1

53.76

68.98

u/ml

0.77

1372

11708

Other abnormal findings in urine

227

1.24

0.47

3.8

3.1

32.04

47.66

u/ml

0.40

220

Other maltreatment syndromes

383

1.18

0.47

2.3

2.6

72.72

37.58

u/ml

0.43

368

Disorders in reading

199

0.75

0.47

1.7

2.1

18.67

33.79

u/ml

1.37

190

Juvenile cataract

1.46

0.47

1.9

2.5

183.82

42.53

u/ml

0.57

Lymphangioma, anys site

138

1.32

0.46

3.4

2.6

37.11

38.18

u/ml

0.02

133

Other and unspecified vascular occlusions

173

1601

1.08

0.46

3.5

4.1

54.21

110.69

u/ml

2.10

162

1539

Sequelae of injuries of lower limb

201

1872

1.08

0.46

2.6

3.3

34.84

57.85

u/ml

1.35

193

1805

Autoimmune diseases excluding thyroid diseases

2934

15599

1.02

0.46

3.0

3.4

47.00

51.51

u/ml

0.34

2829

15096

Pregnancy, childbirth and the puerperium

1110

5969

0.97

0.45

3.3

3.7

78.99

68.97

u/ml

0.29

1069

5764

Discitis, unspecified

201

1.25

0.45

3.6

3.0

35.87

141.86

u/ml

0.99

192

Caries of dentine, including avohilmo

2226

11136

1.02

0.45

3.3

3.7

60.24

62.76

u/ml

0.10

2119

10830

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

220

1.24

0.44

1.7

3.0

64.74

85.71

u/ml

0.14

213

Other abnormal products of conception

1435

9176

1.03

0.44

2.6

2.9

34.24

36.43

u/ml

0.19

1396

8914

Disorders of lens

1633

10370

0.98

0.44

3.6

4.0

45.29

59.81

u/ml

1.51

1581

10045

Sudden idiopathic hearing loss

184

1977

0.93

0.44

2.5

3.9

29.11

76.39

u/ml

5.23

173

1905

Poisoning by drugs, medicaments and biological substances

556

5790

0.96

0.44

2.7

3.1

36.45

46.47

u/ml

0.98

534

5613

Routine general health check-up of defined subpopulation

536

1.15

0.44

4.2

3.3

39.87

85.19

u/ml

0.95

516

Supernumerary ureter

1.66

0.44

1.4

1.9

18.00

28.17

u/ml

—

Complications specific to multiple gestation

139

0.70

0.44

1.2

2.1

30.20

48.91

u/ml

—

133

Respiratory tuberculosis, bacteriologically and histologically confirmed

211

1.24

0.44

2.7

2.8

143.29

61.44

u/ml

0.41

203

Eccrine sweat disorders

1.47

0.44

5.1

2.8

14.26

22.46

u/ml

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1128

10823

1.03

0.44

2.7

3.1

37.73

47.44

u/ml

0.88

1078

10472

Unspecified threat to breathing

196

0.76

0.44

2.1

2.3

41.87

48.27

u/ml

0.11

189

Cerebral palsy and other paralytic syndromes

229

2148

1.07

0.44

3.1

3.3

40.60

63.60

u/ml

1.44

221

2073

Need for immunization against other single viral diseases

257

1.22

0.43

2.5

3.0

30.54

44.03

u/ml

0.45

248

5-aminosalicylic acid

498

4772

1.05

0.43

2.0

3.4

40.29

53.33

u/ml

0.63

483

4615

Ovarian dysfunction: estrogen excess

1.62

0.43

2.0

1.8

24.80

52.52

u/ml

—

Meralgia paraesthetica

726

1.12

0.43

1.7

3.7

27.07

75.62

u/ml

1.84

703

Statin medication

2084

11975

0.98

0.43

2.8

3.5

48.47

52.68

u/ml

0.32

2010

11634

Central nervous system disorder causing precocious puberty

1.59

0.43

1.2

1.3

25.00

20.58

u/ml

—

Open bite that required surgery (Lefort1 or BSSO)

217

0.77

0.42

1.6

2.0

19.42

36.14

u/ml

0.88

207

Hyperfunction of pituitary gland

130

1196

1.09

0.42

2.2

2.8

22.20

57.66

u/ml

2.54

125

1153

Other and unspecified disorders of refraction

0.00

0.42

0.0

1.5

—

18.11

—

Exophthalmic conditions

231

1.23

0.42

3.8

2.7

82.94

111.29

u/ml

0.18

225

Entropion and trichiasis of eyelid

143

1320

1.09

0.42

3.9

4.3

50.63

93.28

u/ml

1.35

138

1271

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.42

0.0

2.2

—

83.72

—

Fracture of femur

558

4833

1.04

0.42

3.1

4.1

89.23

93.08

u/ml

0.08

535

4647

Compression of brain

0.00

0.42

0.0

4.7

—

15.56

—

Choroidal detachment

1.54

0.42

5.6

3.2

28.00

61.40

u/ml

—

Early lumbar disc prolapse, operated

218

2046

1.07

0.42

2.1

2.7

33.08

35.63

u/ml

0.16

211

1994

Ulcerative colitis (strict definition, all Crohn cases excluded)

282

2668

1.06

0.42

2.3

3.1

46.37

53.14

u/ml

0.15

275

2576

Accidental poisoning by and exposure to alcohol

228

0.78

0.42

1.4

2.1

21.78

42.77

u/ml

1.04

217

Spinal enthesopathy

313

1.18

0.41

1.9

2.5

328.49

148.91

u/ml

0.53

303

Hereditary corneal dystrophies

783

0.89

0.41

1.9

4.2

99.66

87.54

u/ml

0.05

756

Injuries to the knee and lower leg

3622

19267

1.02

0.41

3.1

3.4

43.01

53.83

u/ml

1.93

3481

18655

Pediculosis, acariasis and other infestations, including avohilmo

393

3752

1.05

0.41

2.5

2.9

28.22

47.44

u/ml

2.99

375

3635

Horner syndrome

238

0.79

0.41

6.5

2.9

24.37

45.42

u/ml

0.83

229

Poisoning by medicine

503

5236

0.96

0.41

2.7

3.1

30.71

46.07

u/ml

2.29

483

5074

Other strabismus

568

5447

1.04

0.41

2.6

3.3

44.95

49.51

u/ml

0.25

552

5273

Schizoaffective disorder

146

1575

0.92

0.41

2.2

3.0

29.37

56.09

u/ml

1.68

131

1527

Injury of blood vessels at ankle and foot level

0.00

0.41

0.0

4.6

—

29.39

—

Focal brain injury

786

1.11

0.40

3.1

4.0

51.89

92.83

u/ml

0.85

766

Continuous positive airway pressure

393

3126

1.05

0.40

3.4

4.4

35.62

54.17

u/ml

2.56

375

3042

Secondary right heart disease

624

0.88

0.40

3.1

3.5

177.12

75.87

u/ml

0.89

608

Toxic effect of ethanol

540

1.13

0.40

1.7

2.4

36.50

37.36

u/ml

0.02

517

Injury of eye and orbit

238

2244

1.06

0.40

2.4

3.2

31.75

62.62

u/ml

3.35

233

2164

Biological medicines for asthma

442

0.85

0.39

1.4

2.7

20.31

64.91

u/ml

1.02

428

Glaucoma secondary to eye inflammation

148

0.73

0.39

5.1

3.2

30.61

38.05

u/ml

0.21

143

Dental operations

1583

7955

1.02

0.39

3.4

3.8

64.06

68.33

u/ml

0.15

1517

7753

Contact with other hot fluids

506

0.86

0.39

1.6

2.4

128.28

65.52

u/ml

0.34

486

Other disorders of conjunctiva

315

2997

1.05

0.39

2.8

4.1

51.51

76.15

u/ml

0.99

299

2884

Other extrapyramidal and movement disorders in other diseases

637

6155

1.04

0.39

2.6

3.9

48.06

70.67

u/ml

1.26

602

5935

Bullous pemphigoid

280

0.82

0.39

2.7

3.5

179.00

123.46

u/ml

0.13

270

Mixed and other personality disorders

160

1715

0.93

0.38

2.2

2.9

29.72

49.26

u/ml

1.52

153

1655

Insulin, fast-acting

662

6840

0.97

0.38

2.6

3.6

69.41

62.36

u/ml

0.14

640

6606

Gingival hyperplasia

571

1.13

0.38

2.0

3.2

45.52

85.47

u/ml

0.78

551

Acquired clawhand, clubhand, clawfoot and clubfoot

107

1.33

0.38

2.1

27.99

52.90

u/ml

0.55

102

Other disorders of the musculoskeletal system and connective tissue

339

3235

1.05

0.38

2.6

3.8

71.49

68.39

u/ml

0.03

323

3114

Pregnancy hypertension

1747

15917

0.98

0.38

2.9

3.2

37.47

46.91

u/ml

1.38

1690

15432

Emotionally unstable personality disorder

336

3208

1.05

0.37

2.1

2.6

28.36

41.31

u/ml

1.49

324

3112

Unspecified fall

1236

12418

0.98

0.37

3.2

3.6

41.29

62.38

u/ml

3.57

1192

11991

Melanoma in situ of lower limb, including hip

180

1.24

0.37

3.9

3.1

18.23

38.95

u/ml

1.51

173

Other specified and unspecified personality disorders

206

1941

1.06

0.37

2.2

2.9

175.63

51.75

u/ml

0.41

200

1873

Cardiac murmurs and other cardiac sounds

235

2197

1.06

0.37

2.6

3.3

59.73

63.95

u/ml

0.08

227

2117

Trigeminal neuralgia

162

1515

1.07

0.37

2.4

3.7

33.07

70.54

u/ml

2.40

153

1464

928

8118

1.03

0.37

3.5

4.1

96.58

76.00

u/ml

0.52

896

7809

Mixed conductive and sensorineural hearing loss

260

2467

1.06

0.37

3.1

4.1

75.17

75.39

u/ml

0.00

249

2376

Complications of anaesthesia during labour and delivery

117

1.31

0.37

2.9

2.1

30.91

59.86

u/ml

0.67

109

Ankylosing spondylitis, ICD10

164

1534

1.07

0.37

3.0

3.1

52.61

58.91

u/ml

0.17

157

1479

Maternal care for other known or suspected fetal problems

929

5985

0.97

0.36

2.3

2.5

24.69

34.26

u/ml

3.88

903

5818

Intracranial injury

1413

13450

0.98

0.36

2.7

3.5

46.01

59.99

u/ml

1.25

1360

12988

Status epilepticus

545

1.12

0.36

1.7

3.4

42.43

101.25

u/ml

1.51

533

Substance use, excluding alcohol

398

3818

1.04

0.36

2.9

3.5

36.42

49.57

u/ml

1.06

387

3691

Open wound of wrist and hand

850

8443

0.97

0.36

2.3

3.2

33.15

48.30

u/ml

2.20

823

8159

Aphakia

180

1.23

0.36

5.7

3.4

50.68

101.29

u/ml

0.58

171

Other arterial embolism and thrombosis

319

1.17

0.36

2.9

3.4

47.98

110.99

u/ml

0.88

308

Unspecified parasitic disease, including avohilmo

124

0.72

0.36

2.4

2.2

118.89

43.30

u/ml

—

119

Blepharochalasis

873

8496

1.03

0.36

2.9

4.2

45.17

73.99

u/ml

2.27

840

8209

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

237

2248

1.06

0.35

2.8

2.4

25.37

34.45

u/ml

0.80

232

2183

Other disorders of pigmentation

114

1054

1.09

0.35

3.6

3.7

22.78

73.44

u/ml

3.59

106

1022

Other symptoms and signs involving general sensations and perceptions

775

1.10

0.35

2.3

3.8

37.08

77.96

u/ml

1.76

755

Cerebral atherosclerosis

156

0.76

0.35

1.3

3.2

30.07

61.50

u/ml

0.78

149

Ankyloglossia

167

0.77

0.35

4.1

2.0

19.05

30.20

u/ml

0.77

159

Family history of other specific disorders

311

1.17

0.35

2.3

21.23

42.71

u/ml

0.94

297

Other acute disseminated demyelination

246

1.19

0.35

1.6

2.1

40.93

42.77

u/ml

0.03

234

COPD-related respiratory insufficiency

151

1411

1.07

0.35

2.2

3.9

53.71

91.73

u/ml

1.64

143

1366

Dyshidrosis [pompholyx]

351

0.85

0.35

2.6

2.7

22.47

83.68

u/ml

1.05

335

Wet age-related macular degeneration

321

3236

0.95

0.35

3.5

4.2

89.30

97.48

u/ml

0.13

300

3091

Superficial injury of head

582

5623

1.04

0.35

2.6

3.6

54.03

68.50

u/ml

0.74

562

5409

Accidents

2566

12646

1.02

0.34

3.1

3.5

45.69

55.64

u/ml

1.14

2482

12285

Hydrocephalus in other diseases

127

1.28

0.34

5.2

3.3

35.31

45.03

u/ml

0.25

121

Donors of organs and tissues

246

1.19

0.34

3.6

2.3

62.63

35.49

u/ml

0.23

241

Enteritis due to Yersinia enterocolitica

1.34

0.34

1.4

2.7

57.35

56.09

u/ml

0.01

Polymyalgia rheumatica

288

2747

1.05

0.34

3.6

4.3

51.92

98.01

u/ml

2.60

278

2638

Diabetes, varying definitions

3174

18131

1.02

0.34

3.1

3.4

58.05

50.57

u/ml

0.62

3052

17569

Thyrotoxicosis with diffuse goitre

482

4652

1.04

0.34

3.3

3.6

45.66

54.14

u/ml

0.38

464

4510

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

112

1037

1.08

0.34

2.3

3.4

320.54

57.17

u/ml

0.48

107

1002

Burns and corrosions confined to eye and internal organs

393

0.86

0.34

3.4

2.5

40.99

35.52

u/ml

0.09

379

Exposure to unspecified factor

3009

20158

1.02

0.34

2.9

3.4

42.69

53.32

u/ml

1.88

2897

19505

Benign neoplasm: Lip

340

1.15

0.34

3.7

3.4

19.12

100.21

u/ml

1.50

326

Superficial injury of lower leg

738

7173

1.03

0.34

2.4

3.5

40.52

63.62

u/ml

2.15

708

6926

Iridocyclitis

542

5242

1.04

0.33

3.2

3.7

33.33

60.44

u/ml

6.19

518

5070

Mouth breathing

773

7505

1.03

0.33

2.9

3.6

62.74

56.97

u/ml

0.12

744

7243

Spontaneous abortion

2008

13671

0.98

0.33

3.1

3.5

36.57

50.71

u/ml

2.19

1937

13259

Psoriatic and enteropathic arthropathies

256

2687

0.95

0.33

2.4

3.9

27.17

59.85

u/ml

3.30

250

2591

Lesion of plantar nerve

164

1742

0.94

0.33

3.6

4.3

41.50

70.84

u/ml

1.35

157

1681

Other and unspecified vaccines and biological substances

154

0.77

0.33

1.5

2.6

25.78

37.00

u/ml

0.46

148

Atopic dermatitis, strict definition

829

8319

0.97

0.33

2.7

2.9

27.46

41.49

u/ml

4.61

800

8044

Maternal care for cervical incompetence

131

1224

1.08

0.33

3.2

3.5

33.86

61.84

u/ml

1.49

123

1179

Metatarsalgia

303

2900

1.05

0.33

3.2

3.9

78.51

59.85

u/ml

0.18

284

2813

Benign neoplasm: Pituitary gland, craniopharyngeal duct

110

1020

1.08

0.33

2.7

3.1

307.03

69.98

u/ml

0.40

103

989

Other congenital malformations of intestine, including avohilmo

192

1.21

0.33

2.3

3.0

40.78

111.73

u/ml

0.55

185

Abnormal involuntary movements

304

2909

1.05

0.32

2.5

3.7

67.64

66.40

u/ml

0.02

289

2810

Arthrosis

1950

10869

0.98

0.32

3.1

3.7

47.09

57.51

u/ml

0.93

1882

10546

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

185

1749

1.06

0.32

2.8

4.2

39.03

78.26

u/ml

1.97

178

1692

Abrasion of teeth

1162

11370

1.02

0.32

3.2

3.6

32.97

55.35

u/ml

3.57

1120

11009

Toxic effect of alcohol

252

0.83

0.32

2.0

2.4

16.91

46.92

u/ml

1.90

239

Acute appendicitis, with complications

397

3822

1.04

0.32

3.7

45.79

58.79

u/ml

0.53

388

3688

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

159

1687

0.94

0.32

3.0

3.9

30.16

60.04

u/ml

2.22

154

1627

Hordeolum and other deep inflammation of eyelid

141

1322

1.07

0.32

3.5

3.4

27.46

63.72

u/ml

2.76

135

1277

Viral pneumonia (unknown virus, not influenza)

115

1070

1.08

0.31

3.0

34.67

72.44

u/ml

1.97

108

1034

Other blood glucose lowering drugs, excl. Insulins

285

2978

0.96

0.31

2.8

4.4

68.42

84.00

u/ml

0.50

277

2867

Bacterial pneumonia, not elsewhere classified

798

7186

0.97

0.31

3.4

3.6

44.59

65.24

u/ml

2.30

770

6931

Bacterial pneumoniae

846

7611

0.97

0.31

3.4

3.5

43.81

64.20

u/ml

2.45

817

7351

Disease of hard tissues of teeth, NOS

1453

7457

1.02

0.30

3.1

3.9

42.69

70.62

u/ml

2.03

1386

7264

Dislocation, sprain and strain of joints and ligaments of elbow

130

1387

0.93

0.30

3.2

3.1

23.72

55.97

u/ml

2.79

124

1344

Presbycusis

225

2333

0.95

0.30

3.2

4.2

94.32

102.85

u/ml

0.08

213

2226

Other and unspecified mononeuropathies of lower limb

630

0.90

0.30

2.1

3.7

263.68

79.83

u/ml

0.36

613

Carcinoma in situ of vulva

288

1.16

0.30

2.4

3.0

29.95

66.23

u/ml

1.05

276

Other and unspecified vasculitis limited to skin

410

1.13

0.30

2.6

3.3

47.11

88.58

u/ml

0.65

397

Type 2 diabetes, definitions combined

2972

17054

1.01

0.30

3.1

3.5

55.40

51.75

u/ml

0.31

2857

16516

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1244

9948

0.98

0.30

3.2

4.1

63.12

67.79

u/ml

0.24

1201

9602

Amputation of ankle bones

196

0.81

0.30

5.7

3.1

36.75

65.45

u/ml

0.63

186

Calculus of lower urinary tract

334

1.14

0.30

1.5

3.2

168.07

92.66

u/ml

0.22

319

Other and unspecified injuries of neck

152

0.78

0.30

1.0

2.3

13.83

43.05

u/ml

1.24

147

Obstructed labour due to maternal pelvic abnormality

606

5892

1.03

0.30

3.7

49.85

48.69

u/ml

0.02

582

5713

Burn and corrosion confined to eye and adnexa

335

0.86

0.30

3.6

2.3

45.36

38.66

u/ml

0.10

324

Vertical strabismus

659

1.10

0.30

2.5

3.4

67.36

77.38

u/ml

0.10

638

Respiratory insufficiency

124

1157

1.07

0.29

3.1

4.2

50.23

83.76

u/ml

1.28

116

1118

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

299

2871

1.05

0.29

3.2

2.9

34.11

45.41

u/ml

0.61

289

2782

Strabismus

665

6453

1.03

0.29

2.7

3.4

53.13

52.32

u/ml

0.03

642

6237

Other and unspecified disorders of adult personality and behaviour

107

0.74

0.29

5.4

2.4

21.63

44.72

u/ml

—

102

Other papulosquamous disorders

213

1.18

0.29

4.7

2.8

18.66

44.97

u/ml

1.39

203

Achilles tendinitis

215

2257

0.95

0.29

3.2

4.1

57.38

63.20

u/ml

0.07

204

2185

Gender identity disorders

185

1.20

0.29

1.4

1.7

31.21

26.34

u/ml

0.31

179

Disturbance of activity and attention

292

2733

1.04

0.29

2.1

31.57

29.82

u/ml

0.13

283

2636

Erectile dysfunction

1.25

0.29

1.1

1.5

43.14

218.20

u/ml

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1966

17300

0.98

0.29

3.0

3.4

38.31

47.52

u/ml

1.39

1903

16757

Bronchiectasis

151

1600

0.94

0.29

2.8

4.3

58.67

96.68

u/ml

1.40

145

1545

Crushed, pushed or stepped on by crowd or human stampede

126

1181

1.07

0.29

2.1

2.5

26.46

54.71

u/ml

1.62

119

1138

L04AA Selective immunosuppressants

543

5593

0.97

0.29

2.6

3.6

44.84

61.42

u/ml

1.18

523

5399

Artificial joint operation, meniscal resection

2366

15339

0.99

0.29

3.3

3.8

56.73

59.44

u/ml

0.13

2281

14832

Autoimmune diseases excluding thyroid diseases, strict definition

2813

15091

1.01

0.29

3.0

3.4

48.17

51.44

u/ml

0.22

2711

14607

Inflammatory diseases of the central nervous system

170

1610

1.06

0.29

2.8

3.5

34.60

60.88

u/ml

1.81

165

1558

Other/unspecified synovitis and tenosynovitis

304

2922

1.04

0.28

3.2

3.8

43.13

59.09

u/ml

0.94

294

2830

Disorders of optic nerve and visual pathways

230

2197

1.05

0.28

2.8

3.2

53.88

57.17

u/ml

0.05

223

2120

Spinal osteochondrosis

151

0.79

0.28

1.8

2.3

175.33

58.89

u/ml

0.48

144

Cutaneous lupus erythematosus

585

0.90

0.28

2.8

3.3

112.67

78.90

u/ml

0.15

564

Artrosis, including avohilmo

2279

12653

0.98

0.28

3.0

3.6

48.42

55.55

u/ml

0.61

2205

12270

Pollen allergy

463

4710

0.97

0.28

2.5

2.8

29.12

42.40

u/ml

1.76

449

4567

Helminthiases, including avohilmo

922

1.08

0.28

1.8

2.7

30.16

60.33

u/ml

1.29

890

Mandibular prognathia

237

0.84

0.28

2.0

2.5

15.99

42.29

u/ml

1.66

227

Unspecified parasitic disease

116

0.77

0.28

2.4

2.2

118.89

37.39

u/ml

—

111

Combinations of oral blood glucose lowering drugs

448

4624

0.97

0.28

3.3

4.2

100.12

73.17

u/ml

0.40

433

4461

Contusion of toe(s) without damage to nail

567

1.10

0.27

1.6

2.4

76.65

42.44

u/ml

0.24

546

Deviated nasal septum

540

5242

1.03

0.27

3.0

3.7

26.45

59.08

u/ml

10.27

522

5065

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

488

4127

1.03

0.27

1.9

2.1

28.78

31.59

u/ml

0.37

473

3979

ILD-related respiratory insufficiency

385

1.12

0.27

2.8

3.4

47.97

111.32

u/ml

1.09

370

Reactive arthropathies

190

1810

1.05

0.27

3.3

3.9

36.13

62.83

u/ml

1.70

182

1745

Failed attempted abortion

367

1.13

0.27

1.7

2.0

46.14

36.36

u/ml

0.16

352

Gonarthrosis

1723

9886

0.98

0.27

3.1

3.9

37.69

60.17

u/ml

4.02

1657

9583

Maternal care for known or suspected disproportion

170

1617

1.06

0.26

2.6

2.5

26.40

35.53

u/ml

1.37

165

1569

Cardiomyopathy, Hypertrophic obstructive

257

0.85

0.26

1.5

3.8

28.77

112.73

u/ml

1.11

252

Specific development disorders of speech and language

752

0.92

0.26

3.2

2.6

33.43

68.56

u/ml

1.13

718

Infective dermatitis

232

2222

1.05

0.26

3.1

3.7

68.40

63.58

u/ml

0.11

226

2145

Rotator cuff syndrome

1707

11566

1.02

0.26

3.2

3.8

68.75

58.64

u/ml

0.21

1644

11197

Fracture of forearm

1803

15952

1.02

0.26

3.5

3.7

52.59

58.48

u/ml

0.43

1739

15409

Other fall from one level to another

371

3832

0.97

0.26

2.5

3.2

37.59

56.05

u/ml

1.72

359

3708

Tularaemia, including avohilmo

330

0.87

0.25

2.1

2.6

31.10

50.76

u/ml

0.57

319

Other cataract

1078

7857

1.02

0.25

3.7

4.2

51.69

68.38

u/ml

1.16

1033

7610

Calcific tendinitis of shoulder

163

1551

1.05

0.25

2.5

3.8

30.73

57.97

u/ml

1.79

156

1502

Juvenile arthritis (FINNGEN)

104

976

1.07

0.25

1.5

2.6

46.09

53.24

u/ml

0.13

945

Pleural plaque without asbestos

311

1.13

0.25

4.4

3.8

26.49

127.30

u/ml

1.70

301

Occlusion and stenosis of arteries, not leading to stroke

148

0.81

0.24

1.8

2.9

13.97

39.64

u/ml

2.02

140

Presence of other functional implants

1441

10020

0.98

0.24

3.3

4.0

41.57

69.91

u/ml

5.21

1378

9681

Outcome of delivery

595

3743

0.97

0.24

2.4

2.6

22.31

36.95

u/ml

5.97

585

3643

Type 2 diabetes, strict (exclude DM1)

2977

17120

1.01

0.24

3.1

3.5

56.63

51.64

u/ml

0.45

2861

16581

Asymmetry of jaw

307

0.87

0.24

1.6

2.3

25.21

39.78

u/ml

0.77

295

Respiratory tuberculosis, confirmed

208

1.16

0.24

2.7

2.8

153.94

62.08

u/ml

0.44

200

Respiratory tuberculosis, confirmed, including avohilmo

208

1.16

0.24

2.7

2.8

153.94

62.08

u/ml

0.44

200

Benign neoplasm of eye and adnexa

245

2357

1.04

0.24

3.0

3.8

41.60

69.80

u/ml

1.33

237

2271

Polyglandular dysfunction

1.37

0.24

2.2

2.1

15.20

31.65

u/ml

—

severe traumatic brain injury, does not include concussion

297

3075

0.96

0.24

3.1

3.8

78.23

82.39

u/ml

0.06

283

2946

Abnormal findings on antenatal screening of mother

290

2801

1.04

0.24

2.2

24.02

32.53

u/ml

2.35

277

2720

Toxic effects of substances chiefly nonmedicinal as to source

210

2014

1.04

0.24

2.6

3.1

30.40

58.25

u/ml

2.14

203

1940

Personality disorders, excluding more controls

694

6772

1.02

0.23

2.5

3.0

71.59

41.77

u/ml

0.31

668

6572

Typhoid and paratyphoid fevers, including avohilmo

134

1.21

0.23

3.6

2.9

83.06

62.85

u/ml

0.17

128

Vasculitis limited to skin, not elsewhere classified

476

1.10

0.23

3.5

3.4

47.77

87.43

u/ml

0.72

459

Injury of muscle and tendon at hip and thigh level

181

1892

0.95

0.23

2.2

3.3

38.07

57.25

u/ml

0.65

174

1824

Other mycoses, not elsewhere classified/unspecified, including avohilmo

342

1.12

0.23

4.0

2.6

120.26

92.03

u/ml

0.12

329

Unequal limb length (acquired)

125

0.79

0.23

1.9

2.8

27.60

46.53

u/ml

—

118

Choroidal haemorrhage and rupture

1.29

0.23

1.4

2.1

32.28

73.26

u/ml

—

Biguanides

2856

17418

0.99

0.23

3.2

3.6

60.79

52.47

u/ml

0.64

2742

16870

Type 2 diabetes, wide definition

2187

13613

1.01

0.23

3.5

3.9

70.66

57.23

u/ml

0.88

2102

13176

Dissection of aorta

306

0.88

0.23

1.9

3.5

66.89

83.67

u/ml

0.18

298

Erosion of teeth , including avohilmo

720

7050

1.02

0.23

2.7

3.1

36.88

46.49

u/ml

0.68

693

6815

Other and unspecified injuries of head

150

1429

1.05

0.22

3.4

3.6

29.00

81.54

u/ml

4.49

140

1378

Other/unspecified reactive arthropathies

136

1293

1.05

0.22

3.4

3.2

33.11

65.10

u/ml

1.67

131

1251

Delta-beta thalassaemia

0.00

0.22

0.0

2.3

—

95.00

—

Maternal care for known or suspected malpresentation of fetus

766

5351

1.02

0.22

2.1

2.5

23.40

35.59

u/ml

5.93

742

5200

Pediculosis and phthiriasis, including avohilmo

116

1.22

0.22

1.2

2.4

15.11

25.96

u/ml

1.84

111

Radial styloid tenosynovitis [de Quervain]

164

1715

0.95

0.22

3.4

3.5

32.72

53.86

u/ml

1.22

158

1662

Complications following abortion and ectopic and molar pregnancy

117

1109

1.06

0.22

4.6

4.0

81.58

58.83

u/ml

0.25

106

1072

Cardiomyopathy, other and unspecified

124

1176

1.06

0.22

3.0

3.8

88.24

83.02

u/ml

0.07

119

1140

Hereditary factor XI deficiency

0.00

0.22

0.0

2.3

—

90.60

—

Other symptoms and signs involving cognitive functions and awareness

1096

9874

0.98

0.22

2.8

4.0

63.26

67.17

u/ml

0.10

1042

9547

Cardiodefibrillation

514

4999

1.03

0.22

3.2

4.2

100.52

87.09

u/ml

0.18

495

4799

Other and unspecified acne

248

1.14

0.22

1.4

2.4

17.87

44.89

u/ml

1.67

240

Hyperalimentation, other specified

0.00

0.22

0.0

1.5

—

18.16

—

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

0.22

0.0

2.7

—

17.83

—

Ulcer of lower limb, not elsewhere classified

214

2224

0.96

0.22

2.9

4.0

71.62

91.79

u/ml

0.44

206

2141

Hereditary factor IX deficiency

0.00

0.22

0.0

2.3

—

83.47

—

Haemolytic disease of fetus and newborn

0.00

0.22

0.0

1.5

—

16.60

—

Intentional self-harm by crashing of motor vehicle

0.00

0.22

0.0

1.8

—

21.29

—

Asphyxiation

0.00

0.22

0.0

2.3

—

141.60

—

Foreign body in genitourinary tract

239

1.14

0.21

2.0

2.8

28.48

42.82

u/ml

0.43

232

Enthesopathies of lower limb, excluding foot

662

6482

1.02

0.21

2.9

3.9

37.49

59.68

u/ml

1.33

646

6276

Habit and impulse disorders

220

0.86

0.21

2.1

2.2

19.93

36.57

u/ml

1.21

211

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

2.5

—

36.30

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

3.2

—

15.59

—

Postprocedural musculoskeletal disorders, not elsewhere classified

144

1509

0.95

0.21

2.6

3.8

30.94

82.68

u/ml

4.10

139

1454

Disorders of sexual preference

0.00

0.21

0.0

2.3

—

103.96

—

Open wound of ankle and foot

156

1632

0.95

0.21

3.2

129.25

62.77

u/ml

0.38

151

1578

Discharge from other and unspecified firearms

0.00

0.21

0.0

1.8

—

15.34

—

Other secondary gonarthrosis

1038

0.94

0.21

2.6

3.9

48.01

78.36

u/ml

0.80

1003

Niacin deficiency [pellagra]

0.00

0.21

0.0

2.5

—

89.42

—

Hyperparathyroidism

512

4944

1.03

0.21

3.1

4.0

69.58

88.77

u/ml

0.30

491

4748

Other and unspecified iridocyclitis

976

0.94

0.21

2.7

3.5

28.77

73.54

u/ml

2.34

941

Allergic contact dermatitis

425

4141

1.03

0.21

3.3

3.5

35.92

52.58

u/ml

1.46

410

4010

Diseases of the myoneural junction and muscle

203

2110

0.96

0.21

2.8

3.7

52.77

77.39

u/ml

0.81

198

2036

Tibial collateral bursitis [Pellegrini-Stieda]

249

1.13

0.21

2.6

2.2

41.32

106.78

u/ml

0.66

241

Early lumbar disc prolapse operation

219

2110

1.04

0.21

2.1

2.4

33.09

32.75

u/ml

0.02

212

2042

Desensitization to allergens

124

1179

1.05

0.21

1.8

2.3

31.04

32.88

u/ml

0.06

119

1139

Speech and linguistic disorders

122

1230

0.95

0.21

2.7

2.4

29.87

53.47

u/ml

1.30

115

1184

Aortic hypoplasia

0.00

0.21

0.0

2.5

—

15.86

—

Unspecified hairloss

0.00

0.21

0.0

3.3

—

14.02

—

Familial benign pemphigus (Hailey-Hailey disease)

1.30

0.21

5.5

3.6

34.50

65.32

u/ml

—

Congenital malformations of the nervous system

431

1.10

0.21

2.2

2.1

30.38

39.46

u/ml

0.41

414

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.7

—

88.70

—

Other disorders affecting eyelid function

164

1.17

0.21

1.7

2.5

40.36

74.31

u/ml

0.46

158

Abscess of external ear

240

0.87

0.20

1.7

2.5

22.97

34.32

u/ml

0.60

230

Other enthesopathy of foot (+metatarsalgia)

326

3166

1.03

0.20

3.3

3.9

74.44

60.04

u/ml

0.14

305

3068

Arnold-Chiari syndrome

202

1.15

0.20

2.7

2.1

21.45

47.56

u/ml

1.24

193

Antenatal screening

836

4764

0.98

0.20

2.4

2.7

26.90

39.41

u/ml

3.20

812

4633

Glaucoma secondary to drugs

1.26

0.20

1.0

5.3

14.83

72.90

u/ml

—

Retinal vascular disorders

209

2013

1.04

0.20

3.4

4.3

50.02

103.45

u/ml

2.65

197

1932

Abdominal aortic aneurysm (AAA)

363

0.90

0.20

2.7

3.3

68.03

131.98

u/ml

0.78

349

Amputation of ankle

0.00

0.20

0.0

5.6

—

78.93

—

Nonsuppurative otitis media, including avohilmo

789

6946

0.98

0.20

2.4

3.1

50.36

47.12

u/ml

0.07

751

6724

Other disorders of peripheral nervous system

113

0.79

0.20

5.7

2.9

11.44

45.56

u/ml

—

108

Mixed specific developmental disorders

163

0.85

0.20

1.9

2.2

27.93

38.54

u/ml

0.46

157

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

617

6043

1.02

0.20

2.8

3.6

31.57

62.43

u/ml

4.54

602

5833

Diabetes medication

3163

18632

0.99

0.20

3.0

3.4

58.82

50.86

u/ml

0.67

3039

18054

Simple and mucopurulent chronic bronchitis

562

0.92

0.20

1.9

3.6

25.68

94.48

u/ml

2.30

547

Premature separation of placenta [abruptio placentae]

767

0.93

0.20

3.3

2.7

29.54

37.53

u/ml

0.36

739

Other and unspecified disorders of skin and subcutaneous tissue

132

1382

0.95

0.20

2.6

3.7

108.29

73.92

u/ml

0.36

126

1338

Disorders of puberty, other/unspecified

1.18

0.19

2.0

1.8

18.00

61.26

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

299

2905

1.03

0.19

3.2

3.0

34.11

43.96

u/ml

0.53

289

2815

Thyroiditis, ILD-related definition

341

3502

0.97

0.19

2.9

3.6

61.38

56.25

u/ml

0.12

331

3386

Bacterial pneumonia (organism specified)

896

8243

0.98

0.19

3.4

3.6

57.05

67.54

u/ml

0.30

867

7946

Pedal cyclist injured in transport accident

471

4818

0.98

0.19

2.9

3.4

33.55

53.41

u/ml

1.54

459

4658

Thiazolidinediones

168

1747

0.96

0.19

3.6

4.3

71.09

85.88

u/ml

0.30

161

1688

Diseases caused by chlamydiae, including avohilmo

386

1.09

0.19

1.9

2.4

52.28

32.29

u/ml

0.36

368

Primary open-angle glaucoma

682

6681

0.98

0.19

3.6

4.2

74.04

79.17

u/ml

0.08

653

6431

Fall on same level involving ice and snow

1689

16684

1.01

0.18

3.3

3.6

49.22

57.47

u/ml

0.78

1629

16120

Retinal detachments and breaks

760

7733

0.98

0.18

3.2

4.0

43.38

71.32

u/ml

2.68

732

7459

Striking against or struck by other objects

627

6140

1.02

0.18

2.9

3.1

55.58

50.04

u/ml

0.10

594

5935

Atopic conjunctivitis

111

1058

1.05

0.18

2.4

3.2

28.81

65.40

u/ml

2.00

105

1023

Otitis media, unspecified

213

2028

0.97

0.18

2.3

2.9

29.99

53.42

u/ml

2.02

202

1967

Reactive arthropathies, FINNGEN

151

1450

1.04

0.18

3.4

3.5

31.92

61.75

u/ml

1.70

145

1400

Cysts of oral region, not elsewhere classified

103

980

1.05

0.18

2.9

3.1

66.71

71.90

u/ml

0.04

950

Previous suicide attempt

195

0.87

0.18

1.4

2.7

18.00

34.58

u/ml

1.44

189

Benign neoplasm: Skin of scalp and neck

455

1.08

0.17

3.1

2.8

23.64

81.61

u/ml

1.39

438

Dermatophytosis, including avohilmo

1700

16829

0.99

0.17

2.8

3.4

50.02

53.08

u/ml

0.12

1645

16283

Caught, crushed, jammed or pinched in or between objects

743

0.94

0.17

1.8

2.5

34.03

58.04

u/ml

0.67

713

Blepharospasm

205

1.13

0.17

3.7

3.0

39.17

43.61

u/ml

0.07

200

Oral lichen planus, including avohilmo , including avohilmo

202

1955

1.04

0.17

3.3

4.0

32.05

66.81

u/ml

2.33

192

1892

Fracture at wrist and hand level

708

7177

0.98

0.17

3.1

3.4

40.11

60.92

u/ml

1.54

677

6938

Hypermetropia

153

1471

1.04

0.17

3.6

3.3

56.43

63.73

u/ml

0.10

147

1422

Protein-energy malnutrition of moderate and mild degree

148

1.16

0.17

1.8

2.8

24.35

47.84

u/ml

1.47

143

Other disorders of nervous system

125

1198

1.05

0.17

2.8

3.8

50.76

73.12

u/ml

0.62

119

1158

Other and unspecified nerve root and plexus disorders, also in other diseases

494

5040

0.98

0.17

2.3

3.8

29.09

61.13

u/ml

4.31

473

4885

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

120

0.83

0.17

1.8

3.0

15.20

39.22

u/ml

—

114

Diabetic nephropathy

203

1940

1.03

0.17

2.8

2.9

65.92

65.79

u/ml

0.00

191

1857

Papulosquamous disorders

1004

10179

0.99

0.17

3.0

3.8

32.83

60.63

u/ml

6.49

970

9847

Polyhydramnios

163

1573

1.04

0.16

2.0

2.4

22.51

36.50

u/ml

3.47

157

1523

Restless leg syndrome

382

3735

1.02

0.16

2.9

3.8

36.52

65.09

u/ml

2.61

361

3603

Left bundle-branch block

133

1384

0.96

0.16

3.2

3.9

44.32

85.71

u/ml

1.98

126

1340

Hypertension, Pulmonary Arterial

158

1.15

0.16

2.9

2.7

96.63

129.88

u/ml

0.26

153

Acute alcohol intoxication ICD-9

319

0.91

0.16

2.7

3.0

49.67

89.22

u/ml

0.45

307

Impingement syndrome of shoulder

574

5637

1.02

0.16

3.1

4.2

40.03

61.96

u/ml

1.43

551

5458

Coeliac disease

294

2865

1.03

0.16

3.8

3.5

43.46

58.26

u/ml

0.53

287

2768

Hyperkinetic disorders

296

2812

1.03

0.16

2.1

31.94

29.59

u/ml

0.19

287

2715

Personal history of allergy to drugs, medicaments and biological substances

254

1.11

0.16

6.9

2.4

49.18

101.87

u/ml

0.46

246

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

317

3093

1.03

0.16

2.3

3.2

43.26

50.73

u/ml

0.19

309

2989

Cleft lip, lip and palate or palate

287

0.90

0.16

6.8

2.0

81.32

37.52

u/ml

0.53

272

Non-selective monoamine reuptake inhibitors

1049

10192

0.99

0.16

3.1

3.9

96.52

60.77

u/ml

0.57

1005

9883

Benign neoplasm: Pharynx, unspecified

149

1.15

0.16

1.9

2.8

60.18

45.94

u/ml

0.18

144

Other and unspecified bullous disorders

216

1.12

0.16

7.6

3.0

38.48

104.04

u/ml

0.60

210

Human immunodeficiency virus [HIV] disease, including avohilmo

168

1.13

0.16

1.5

2.4

20.89

34.86

u/ml

0.98

161

Other congenital malformations of skin, including avohilmo

197

1910

1.03

0.16

2.7

3.1

59.25

55.70

u/ml

0.03

191

1843

Infective bursitis

266

0.90

0.15

4.0

3.1

55.63

105.09

u/ml

0.41

255

Aortic aneurysm

184

1746

1.03

0.15

2.8

4.0

62.02

94.83

u/ml

1.25

179

1673

Speech and linguistic disorders, excluding more controls

121

1181

0.96

0.15

2.7

2.6

30.03

61.60

u/ml

1.84

114

1146

Superficial injury of shoulder and upper arm

251

2444

1.03

0.15

2.6

3.5

45.33

63.17

u/ml

0.67

244

2361

Heart failure and bmi 25plus

593

4020

0.98

0.15

3.0

4.2

96.65

74.08

u/ml

0.43

567

3855

Retrobulbar neuritis in diseases classified elsewhere

0.80

0.15

2.7

2.6

30.57

28.75

u/ml

—

Kyphosis

236

1.11

0.15

1.6

3.1

36.12

146.41

u/ml

1.28

228

Arteriovenous malformation of cerebral vessels

188

1.12

0.15

4.4

3.0

47.95

37.10

u/ml

0.17

177

Non-allergic asthma

165

1703

0.97

0.15

2.8

3.6

23.68

73.57

u/ml

5.59

159

1642

Non-allergic asthma (mode), excluding more controls

466

4531

1.02

0.15

2.6

3.4

28.15

56.32

u/ml

5.55

455

4387

Postpartum haemorrhage due to retained placenta

449

4407

1.02

0.15

2.3

2.5

27.71

30.58

u/ml

0.47

434

4270

Alopecia areata

674

1.06

0.15

2.5

2.9

87.39

69.10

u/ml

0.10

654

Open wound of thorax

171

0.87

0.15

3.3

3.0

17.20

51.20

u/ml

1.50

163

Normotensive glaucoma

191

1967

0.97

0.14

3.6

4.5

116.73

97.31

u/ml

0.10

182

1890

Pacemaker

568

5365

0.98

0.14

2.7

4.0

111.92

89.69

u/ml

0.29

542

5155

Other meningitis

326

0.92

0.14

1.7

2.6

29.80

87.93

u/ml

0.86

312

Maternal care for known or suspected abnormality of pelvic organs

1039

7095

0.99

0.14

2.2

2.8

23.78

39.33

u/ml

6.70

993

6886

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1285

8003

1.01

0.14

1.9

2.3

23.25

31.65

u/ml

5.76

1241

7769

Eosinophilic disease (BM)

233

0.90

0.14

1.6

2.8

27.71

94.83

u/ml

0.70

226

Increased muscle tone

141

1.14

0.14

5.3

2.5

33.25

45.54

u/ml

0.27

135

Unspecified nephritic syndrome

324

1.08

0.14

1.7

2.7

46.12

94.61

u/ml

0.63

311

Localized scleroderma [morphea]

373

1.08

0.14

2.3

3.5

23.17

79.82

u/ml

1.08

362

Glaucoma, exfoliation

200

2056

0.97

0.14

3.6

4.4

55.63

104.34

u/ml

1.23

191

1968

Lyme disease

938

9268

1.01

0.14

3.2

3.8

52.65

59.90

u/ml

0.20

909

8963

Lyme disease, including avohilmo

938

9268

1.01

0.14

3.2

3.8

52.65

59.90

u/ml

0.20

909

8963

Necrosis of pulp, including avohilmo

1630

16245

0.99

0.14

2.8

3.3

36.88

48.30

u/ml

1.63

1549

15747

Pre-eclampsia superimposed on chronic hypertension

180

1.12

0.13

1.8

2.0

25.58

39.47

u/ml

0.39

173

Fall on and from stairs and steps

634

6433

0.98

0.13

3.0

3.7

46.27

67.23

u/ml

1.72

615

6205

Maxillary retrognathism

286

1.09

0.13

1.7

2.1

25.02

39.86

u/ml

0.78

273

Retinal breaks without detachment

375

3679

1.02

0.13

3.1

4.0

41.97

62.41

u/ml

0.93

360

3546

MS-disease / Multiple Sclerosis

183

1882

0.97

0.13

1.8

2.8

29.98

51.58

u/ml

1.72

175

1822

Impacted cerumen

216

2105

1.03

0.13

3.9

4.0

33.84

81.37

u/ml

4.77

204

2026

Non-allergic asthma (mode)

466

4539

1.02

0.13

2.6

3.4

28.15

56.37

u/ml

5.97

455

4388

Varicella [chickenpox], including avohilmo

578

1.06

0.13

2.4

2.5

29.12

43.73

u/ml

0.87

556

Heart failure and hypertrophic cardiomyopathy

211

0.90

0.13

1.3

3.3

41.42

62.84

u/ml

0.45

203

Pneumonia derived septicemia

481

1.06

0.13

5.0

3.2

42.81

96.52

u/ml

1.16

461

Chronic myeloproliferative disease

190

0.89

0.13

2.4

3.5

16.49

59.23

u/ml

1.32

182

Congenital dislocation of hip, unilateral

142

1.14

0.13

2.5

2.3

16.66

38.51

u/ml

1.52

137

Disorders of eyelid in diseases classified elsewhere

713

0.95

0.13

2.1

3.4

23.40

80.46

u/ml

2.43

689

Other diseases caused by chlamydiae, including avohilmo

404

1.07

0.12

1.9

2.5

51.46

39.69

u/ml

0.19

386

Other necrotizing vasculopathies

146

1416

1.03

0.12

2.7

3.8

65.41

89.94

u/ml

0.30

141

1370

Viral infections of the central nervous system, including avohilmo

166

1614

1.03

0.12

2.9

3.3

27.14

60.13

u/ml

3.00

161

1562

Burns and corrosions of external body surface, specified by site

173

1683

1.03

0.12

2.4

3.1

65.04

60.21

u/ml

0.08

167

1632

Vasomotor rhinitis (mode)

161

1656

0.97

0.12

3.5

3.6

119.69

61.02

u/ml

0.32

155

1602

Macular hole

117

1210

0.97

0.12

3.4

4.3

42.48

94.00

u/ml

2.32

112

1164

Glaucoma secondary to other eye disorders

610

0.95

0.12

3.3

3.4

32.23

90.90

u/ml

1.97

590

Nonsuppurative otitis media

501

4279

1.02

0.12

2.4

2.9

60.15

50.29

u/ml

0.14

476

4129

Sequelae of injuries of upper limb

182

1868

0.97

0.12

2.6

3.5

27.22

59.97

u/ml

3.11

171

1801

Other congenital malformations of nervous system

220

1.10

0.12

2.6

2.2

21.30

46.69

u/ml

1.34

211

Bleeding

2071

14615

0.99

0.12

3.4

3.8

74.62

58.44

u/ml

0.51

1991

14133

Dystonia

140

1359

1.03

0.12

3.1

3.5

63.68

68.31

u/ml

0.05

135

1315

Other retinal artery occlusion

292

0.92

0.12

2.7

3.2

35.96

119.84

u/ml

1.23

284

Other respiratory disorders and diseases

323

3170

1.02

0.11

2.8

4.1

55.44

82.17

u/ml

1.52

307

3048

Other diseases of the respiratory system

323

3170

1.02

0.11

2.8

4.1

55.44

82.17

u/ml

1.52

307

3048

Eustachian salpingitis and obstruction

167

1715

0.97

0.11

2.1

2.7

42.26

46.16

u/ml

0.12

159

1664

Other forms of systemic lupus erythematosus

240

1.09

0.11

2.0

2.9

43.40

43.02

u/ml

0.01

229

Other respiratory diseases principally affecting the interstitium

284

2784

1.02

0.11

3.3

4.0

56.79

79.24

u/ml

0.95

273

2679

Palindromic rheumatism

209

0.90

0.11

2.1

3.3

34.26

122.06

u/ml

0.85

202

Bullous keratopathy

126

0.87

0.11

1.5

3.1

30.18

37.86

u/ml

0.17

121

Focal epilepsy, strict definition

374

3676

1.02

0.11

3.3

3.7

134.75

65.15

u/ml

0.41

363

3548

Spirochaetal infections, other/unspecified, including avohilmo

942

9325

1.01

0.11

3.2

3.8

52.52

59.86

u/ml

0.20

913

9017

Blindness, monocular

153

1.12

0.11

1.8

3.2

45.62

55.82

u/ml

0.16

148

Lateral epicondylitis

373

3669

1.02

0.11

2.5

3.7

39.44

53.21

u/ml

0.80

362

3560

Intrahepatic Cholestasis of Pregnancy (ICP)

237

2321

1.02

0.11

2.8

2.5

25.37

33.66

u/ml

1.32

232

2251

Infections of genitourinary tract in pregnancy

337

3313

1.02

0.11

2.7

3.4

39.10

50.95

u/ml

0.34

323

3210

Acute and subacute iridocyclitis

435

4285

1.02

0.11

3.4

3.7

33.89

62.22

u/ml

5.04

416

4144

Multifocal fibrosclerosis

134

1.13

0.11

1.9

3.2

19.48

63.32

u/ml

1.39

129

Sequelae of injuries, of poisoning and of other consequences of external causes

495

4882

1.01

0.11

2.5

3.6

30.55

55.88

u/ml

4.64

468

4718

Mental retardation, wide definition

572

0.95

0.11

2.5

2.7

37.27

64.20

u/ml

0.56

550

Focal epilepsy, mode (most common among epilepsy diagnosis)

359

3530

1.02

0.11

3.2

3.6

139.46

64.59

u/ml

0.43

348

3409

Isolated patent ductus arteriosus

123

1.13

0.10

5.2

3.0

28.86

36.70

u/ml

0.27

118

Other and unspecified disorders of psychological development

102

1.14

0.10

1.7

1.9

35.15

28.50

u/ml

0.23

Palmar fascial fibromatosis [Dupuytren]

167

1629

1.03

0.10

2.9

4.3

71.72

78.91

u/ml

0.10

159

1568

Benign neoplasm: Tongue

505

1.05

0.10

4.1

3.5

38.69

84.92

u/ml

0.79

489

Deep bite

223

1998

0.98

0.10

2.1

3.1

44.76

54.56

u/ml

0.21

208

1929

Superficial injury of hip and thigh

311

3056

1.02

0.10

2.8

3.7

37.45

76.80

u/ml

4.69

291

2936

Open wound of forearm

148

1518

0.97

0.10

2.5

3.2

27.90

71.90

u/ml

4.33

148

1459

Contracture of muscle

106

1.14

0.10

6.7

2.1

40.33

47.74

u/ml

0.11

100

Other keratitis

247

2424

1.02

0.10

2.5

3.3

29.95

61.11

u/ml

3.74

240

2341

Open wound of lower leg

302

3071

0.98

0.10

2.5

3.5

39.01

77.10

u/ml

4.05

286

2953

Pedal cyclist injured in noncollision transport accidents

217

2214

0.98

0.10

2.9

3.1

22.58

57.32

u/ml

5.59

212

2135

Intentional self-harm by unspecified means

232

1.08

0.10

1.6

2.0

22.40

39.34

u/ml

0.86

220

Dermatophytosis

238

2335

1.02

0.10

3.1

3.6

101.96

68.14

u/ml

0.24

231

2255

Other contact dermatitis

198

1939

1.02

0.10

2.1

3.4

25.98

54.46

u/ml

3.21

191

1878

Glaucoma-related operations

106

1092

0.97

0.09

3.5

4.0

57.42

97.94

u/ml

0.62

1055

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

354

3487

1.02

0.09

2.2

3.3

40.89

49.19

u/ml

0.25

342

3368

Retained placenta and membranes, without haemorrhage

459

4532

1.01

0.09

3.2

3.6

62.66

49.91

u/ml

0.41

445

4392

Other and unspecified hypertrophic disorders of skin

145

1.11

0.09

3.0

2.5

48.00

54.25

u/ml

0.06

139

Hypertensive Heart Disease

380

2923

0.99

0.09

3.5

4.3

88.75

87.41

u/ml

0.02

366

2826

Infection due to other mycobacteria

258

0.93

0.09

5.5

3.1

39.17

106.79

u/ml

0.78

249

Other (not insulin) diabetes medications

2996

17657

0.99

0.09

3.0

3.5

59.10

51.86

u/ml

0.55

2876

17102

Other injuries of upper limb, level unspecified

186

0.91

0.09

1.8

2.5

10.18

39.39

u/ml

3.58

179

Abnormalities of forces of labour

394

3993

0.99

0.09

2.9

3.0

28.28

40.26

u/ml

1.56

376

3878

Poor fetal growth

427

4325

0.99

0.09

2.1

2.4

25.68

31.98

u/ml

1.52

417

4187

L04AC Interleukin inhibitors

128

1313

0.97

0.09

1.6

3.0

24.14

58.49

u/ml

2.47

123

1273

Other congenital malformations of integument, including avohilmo

1.14

0.09

4.5

2.1

47.77

60.01

u/ml

—

Premature rupture of membranes

873

6156

1.01

0.09

2.2

2.8

27.60

39.47

u/ml

3.54

851

5975

Cholesteatoma of middle ear

746

0.96

0.09

3.7

3.6

36.17

88.24

u/ml

1.88

720

Symptoms and signs involving the nervous and musculoskeletal systems

1593

15822

1.01

0.09

2.6

3.6

44.14

58.84

u/ml

1.65

1533

15294

Other spirochaetal diseases

942

9344

1.01

0.09

3.2

3.8

52.53

59.86

u/ml

0.20

913

9038

Disorders of adult personality and behaviour

731

7377

0.99

0.08

2.4

3.0

68.04

42.26

u/ml

0.28

703

7137

Epilepsy

671

6624

1.01

0.08

3.1

3.7

104.36

61.50

u/ml

0.45

644

6407

Other diseases caused by chlamydiae

328

0.94

0.08

2.0

2.6

63.15

36.05

u/ml

0.37

313

Viral hepatitis, including avohilmo

126

1230

1.03

0.08

2.6

3.0

52.55

54.24

u/ml

0.03

118

1190

Hypertensive heart and/or renal disease

429

3170

0.99

0.08

3.6

4.2

87.27

86.06

u/ml

0.02

412

3056

Personality disorders

694

7001

0.99

0.08

2.5

3.1

71.59

42.83

u/ml

0.30

668

6783

Rheumatoid arthritis

926

8257

0.99

0.08

3.3

4.1

52.58

65.49

u/ml

0.83

894

7996

D07AA Corticosteroids, weak (group I)

349

3440

1.01

0.08

2.7

3.1

33.13

47.39

u/ml

1.47

338

3332

Other factor of the environment

215

1.07

0.07

4.3

2.7

136.28

42.09

u/ml

0.45

207

Congenital malformations of great arteries

251

0.94

0.07

4.3

2.5

30.97

34.92

u/ml

0.15

240

Behavioural disorders

266

0.94

0.07

1.8

1.9

33.56

35.72

u/ml

0.05

255

Trigger finger

426

4214

1.01

0.07

2.9

3.8

30.73

58.39

u/ml

2.38

412

4082

Adalimumab

225

2215

1.02

0.07

1.8

3.1

39.48

49.88

u/ml

0.38

215

2143

Behavioural disorders, excluding more controls

265

0.94

0.07

1.8

2.0

33.56

34.44

u/ml

0.02

255

Falls/tendency to fall

3262

16271

1.00

0.07

3.1

3.4

47.40

51.85

u/ml

0.41

3144

15781

Acute and transient psychotic disorders

245

2414

1.02

0.07

2.7

3.4

40.70

56.47

u/ml

0.76

234

2332

Other and unspecified paralytic syndromes

255

0.94

0.07

3.0

2.7

93.42

44.39

u/ml

0.48

244

Mumps, including avohilmo

442

1.04

0.07

1.9

3.0

74.48

69.70

u/ml

0.03

429

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

163

0.92

0.07

2.0

2.3

14.12

46.64

u/ml

1.46

156

Melanocytic naevi of eyelid, including canthus

214

0.93

0.07

5.6

2.9

25.76

35.61

u/ml

0.43

205

Juvenile Open Angle Glaucoma

0.86

0.07

6.4

2.6

22.25

40.08

u/ml

—

Pneumococcal septicemia

468

0.96

0.07

4.0

3.0

37.21

92.82

u/ml

1.23

450

Use of antiglaucoma preparations and miotics

144

1413

1.02

0.07

3.2

4.0

195.18

90.77

u/ml

0.49

136

1362

Neovascular glaucoma

599

0.97

0.06

3.3

3.2

32.23

95.29

u/ml

2.10

578

Diseases caused by chlamydiae

315

0.95

0.06

2.0

2.4

64.69

34.94

u/ml

0.39

300

Other bursal cyst

305

1.05

0.06

3.7

43.99

90.24

u/ml

0.47

294

Scabies, including avohilmo

326

3223

1.01

0.06

2.5

2.7

24.46

45.69

u/ml

3.70

310

3121

Cleft palate

193

0.93

0.06

6.3

2.1

66.08

31.83

u/ml

0.38

183

Focal epilepsy

409

4048

1.01

0.06

3.2

3.6

125.98

64.86

u/ml

0.39

397

3908

Raynaud syndrome

228

2311

0.99

0.06

2.4

3.2

30.11

55.76

u/ml

2.66

220

2233

Other and unspecified pemphigoid

148

1.09

0.06

4.3

3.0

25.56

46.52

u/ml

1.13

143

Disorders of parathyroid gland

579

5766

0.99

0.06

3.0

4.0

67.48

82.62

u/ml

0.26

552

5547

Varicella [chickenpox]

463

1.04

0.06

2.4

2.5

25.71

44.05

u/ml

0.99

442

All-cause Heart Failure

1127

7791

1.01

0.06

3.3

4.3

96.24

76.35

u/ml

0.70

1083

7506

Other and unspecified tonsillitis

717

5915

1.01

0.06

2.1

2.7

67.83

40.85

u/ml

0.28

684

5741

Other viral hepatitis, including avohilmo

103

1008

1.02

0.06

2.3

2.5

42.73

53.18

u/ml

0.29

975

Postpartum hemorraghe, all women as controls

1002

9826

0.99

0.06

2.4

2.7

28.69

36.71

u/ml

2.38

972

9524

Anorexia

355

1.05

0.06

3.8

2.5

49.32

38.25

u/ml

0.22

339

Ulcerative colitis (strict definition, require KELA)

324

3206

1.01

0.06

2.3

3.3

42.80

50.01

u/ml

0.19

316

3100

Disorders of sclera, cornea, iris and ciliary body

1478

14846

1.00

0.06

2.7

3.5

42.70

55.64

u/ml

0.71

1416

14355

Fracture of lumbar spine and pelvis

491

4857

1.01

0.06

3.1

3.8

49.78

87.13

u/ml

1.30

468

4658

Retinal vascular occlusion

201

1983

1.01

0.05

3.4

4.3

42.20

103.06

u/ml

4.00

189

1902

Burns and corrosions

218

2208

0.99

0.05

2.8

3.1

60.35

54.47

u/ml

0.12

211

2135

Other peripheral vascular diseases

190

1926

0.99

0.05

2.6

3.6

35.30

69.31

u/ml

2.58

184

1859

Melanocytic naevi of lip

208

1.06

0.05

2.8

3.0

21.68

41.16

u/ml

1.48

200

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

214

1517

0.99

0.05

3.3

5.2

47.73

85.52

u/ml

1.85

208

1488

Primary open-angle glaucoma, strict

567

5694

0.99

0.05

3.5

4.2

73.68

82.57

u/ml

0.13

543

5477

Other spirochaetal diseases, including avohilmo

951

9462

1.01

0.05

3.2

3.8

52.20

59.56

u/ml

0.21

921

9152

Other congenital malformations, not elsewhere classified

159

1.07

0.05

2.2

2.5

36.20

34.28

u/ml

0.06

152

Human immunodeficiency virus [HIV] disease

159

1.07

0.05

1.5

2.2

21.88

34.49

u/ml

0.77

152

Abnormalities of gait and mobility

209

2065

1.01

0.05

3.0

4.0

58.81

80.41

u/ml

0.58

201

1987

Left ventricular outflow tract obstruction (LVOTO), broad definition

131

1331

0.98

0.05

2.5

3.3

59.88

61.69

u/ml

0.03

124

1286

Postpartum haemorrhage due to anatomy

337

3400

0.99

0.05

2.0

2.2

29.00

28.88

u/ml

0.01

328

3292

Other specified/unspecified deforming dorsopathies

406

1.04

0.05

3.0

2.5

119.65

52.67

u/ml

0.39

394

Other bacterial agents as the cause of diseases classified to other chapters

179

1.06

0.05

1.8

3.0

87.95

35.54

u/ml

0.72

173

Psoriasis vulgaris

368

3650

1.01

0.05

2.6

3.7

35.91

60.47

u/ml

2.31

354

3519

Injury of nerves at shoulder and upper arm level

189

1.06

0.04

3.8

2.8

34.12

41.80

u/ml

0.16

180

Drug-induced hypoglycaemia without coma

191

0.94

0.04

1.9

2.7

36.54

51.57

u/ml

0.40

185

Childhood allergy (age < 16)

256

2089

1.01

0.04

1.5

1.9

21.49

28.82

u/ml

2.98

246

2006

Bell's palsy

255

2525

1.01

0.04

3.5

3.8

43.48

64.67

u/ml

1.28

242

2438

Infection due to other mycobacteria, including avohilmo

282

0.96

0.04

5.2

3.1

37.89

100.64

u/ml

0.80

273

ILD, hospital admissions 1, main diag only

208

2103

0.99

0.04

3.0

4.1

62.29

84.28

u/ml

0.65

200

2023

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

305

3076

0.99

0.04

3.9

3.7

38.28

54.96

u/ml

1.18

298

2974

Scleritis

302

0.96

0.04

2.0

2.7

17.07

47.02

u/ml

1.93

293

Demyelinating diseases of the central nervous system

217

2193

0.99

0.04

2.0

2.9

28.35

49.59

u/ml

2.15

209

2127

Dissection of cerebral arteries, nonruptured

150

0.93

0.04

2.7

2.5

24.61

51.01

u/ml

0.81

145

Fracture of foot, except ankle

633

6296

1.01

0.04

2.7

3.4

32.86

53.43

u/ml

4.04

610

6094

Other superficial mycoses, including avohilmo

233

2308

1.01

0.04

1.8

2.9

26.84

50.68

u/ml

2.73

223

2232

Conduct disorder

261

0.96

0.04

1.7

1.9

33.32

38.60

u/ml

0.14

250

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

380

3826

0.99

0.04

2.2

3.1

30.08

45.41

u/ml

1.71

364

3707

Other protozoal intestinal diseases

281

0.96

0.04

2.6

2.5

57.69

94.75

u/ml

0.28

269

Specific personality disorders

608

6111

0.99

0.04

2.4

3.0

75.71

42.03

u/ml

0.31

585

5916

Use of pramipexole

532

5348

0.99

0.03

3.2

3.9

38.55

79.88

u/ml

4.28

514

5158

Suppurative and unspecified otitis media

886

7874

1.00

0.03

2.3

2.9

34.94

44.41

u/ml

1.34

850

7617

Other hammer toe(s) (acquired)

548

5006

0.99

0.03

3.5

4.6

58.35

81.99

u/ml

0.47

525

4842

Medical abortion

2858

15436

1.00

0.03

3.2

3.5

48.46

56.64

u/ml

0.69

2754

14952

Injuries to the hip and thigh

1103

9854

1.00

0.03

2.8

3.7

64.61

69.05

u/ml

0.19

1055

9514

Polypectomy (DHB20)

773

0.98

0.03

2.6

3.2

25.88

85.99

u/ml

2.83

745

Residual foreign body in soft tissue

827

1.02

0.03

3.2

3.0

94.41

69.73

u/ml

0.18

800

Hallux rigidus

378

3801

0.99

0.03

3.8

4.7

32.97

80.25

u/ml

4.84

368

3674

Short stature, not elsewhere classified

177

1.05

0.03

2.3

2.2

56.25

34.13

u/ml

0.41

171

Sixth [abducent] nerve palsy

531

0.98

0.03

3.2

3.3

36.05

93.17

u/ml

1.18

513

ILD, hospital admissions

234

2323

1.01

0.03

3.3

4.0

59.44

82.28

u/ml

0.79

226

2228

Hypersensitivity pneumonitis due to organic dust

259

0.96

0.02

4.2

3.1

36.52

59.12

u/ml

0.60

249

Acute poliomyelitis

261

1.04

0.02

5.6

2.9

29.96

70.34

u/ml

1.16

254

Acute poliomyelitis, including avohilmo

261

1.04

0.02

5.6

2.9

29.96

70.34

u/ml

1.16

254

Prurigo nodularis

490

1.02

0.02

3.0

3.6

30.81

97.40

u/ml

1.71

473

Mental retardation, excluding more controls

511

1.02

0.02

2.5

3.0

37.46

71.62

u/ml

0.69

499

Heart failure, strict

1142

7913

1.00

0.02

3.2

4.3

95.58

75.70

u/ml

0.72

1098

7623

Hypotension due to drugs

162

1.05

0.02

5.3

3.1

31.01

74.77

u/ml

1.08

157

Disorders of puberty

162

1.05

0.02

1.5

2.1

21.76

44.96

u/ml

1.13

157

Persistent mood disorders

493

4911

1.00

0.02

2.7

3.7

55.72

54.50

u/ml

0.04

477

4761

Disorders of puberty, all

198

0.96

0.02

1.4

2.0

22.95

41.01

u/ml

1.01

190

UC patients in KELA-register (code 208), prior to 1994

720

0.99

0.02

2.7

3.4

29.33

75.51

u/ml

1.49

700

Postpartum hemorraghe, parous women as controls

1002

8396

1.00

0.02

2.4

2.7

28.69

34.38

u/ml

1.35

972

8132

Chronic periodontitis, including avohilmo

2899

18462

1.00

0.02

3.4

3.5

38.87

55.86

u/ml

4.64

2781

17893

Sleep apnoea

2747

17285

1.00

0.01

2.8

3.6

38.79

54.07

u/ml

3.04

2643

16743

Defect, injury or illness of neck

133

1.06

0.01

1.6

2.2

24.00

43.21

u/ml

0.74

127

Paralytic strabismus

120

1190

1.01

0.01

3.1

3.7

85.73

80.93

u/ml

0.03

113

1152

Other symptoms and signs involving the nervous and musculoskeletal systems

1167

11648

1.00

0.01

2.5

3.5

39.47

57.95

u/ml

2.01

1125

11265

Mumps

432

1.02

0.01

1.9

3.0

77.71

69.28

u/ml

0.06

421

Disorders of psychological development

187

1743

0.99

0.01

2.6

2.3

29.37

48.61

u/ml

1.53

178

1682

Prominent ears

177

0.96

0.01

2.8

2.0

88.41

48.87

u/ml

0.25

166

Other obstetric conditions, not elsewhere classified

1305

8242

1.00

0.01

1.8

2.4

23.32

31.71

u/ml

5.80

1261

7998

Speech disturbances, not elsewhere classified

164

1630

1.01

0.01

3.1

3.5

50.25

72.34

u/ml

0.73

155

1579

Caries in Clefts patients

193

1.04

0.01

5.8

2.1

100.66

44.97

u/ml

0.51

183

Periodontitis

2899

18477

1.00

0.01

3.4

3.5

39.08

56.01

u/ml

4.59

2781

17906

Corneal ulcer

401

4022

1.00

0.01

2.6

3.5

63.24

57.78

u/ml

0.06

384

3887

Other and unspecified injuries of lower leg

175

1759

0.99

0.01

3.0

3.1

23.15

58.62

u/ml

4.29

169

1697

Other disorders of ear

2634

17021

1.00

0.01

3.2

3.6

56.87

54.21

u/ml

0.12

2542

16473

Carcinoma in situ of skin of trunk

413

1.02

0.01

3.5

3.9

30.38

111.42

u/ml

1.75

401

Mental retardation

542

0.99

0.01

2.5

2.6

37.46

60.32

u/ml

0.43

520

Scissor bite

320

1.02

0.01

2.8

2.1

24.42

38.33

u/ml

0.74

308

Other viral hepatitis

947

0.99

0.01

2.3

2.6

43.79

52.27

u/ml

0.21

917

Lichen simplex chronicus and prurigo

132

1313

1.01

0.00

2.6

3.7

32.96

72.62

u/ml

2.38

126

1270

Injury of nerves at lower leg level

164

1.04

0.00

3.4

2.3

30.21

42.28

u/ml

0.23

157

Degenerative myopia

174

1.04

0.00

2.7

3.1

29.55

38.10

u/ml

0.37

167

Excessive earwax

1573

14253

1.00

0.00

3.2

3.7

43.83

63.57

u/ml

2.17

1514

13785

Other localized connective tissue disorders

486

0.99

0.00

2.1

3.6

27.85

73.29

u/ml

1.09

470

Aortic valve malfunction, age under 60 years

122

1222

1.00

0.00

2.6

3.3

62.92

64.66

u/ml

0.03

115

1178

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

145

1.04

0.00

1.5

2.2

21.47

33.80

u/ml

0.69

139

Disorder of lipoprotein metabolism, unspecified

207

2075

1.00

0.00

3.7

4.1

66.57

94.41

u/ml

0.69

201

1997

Viral hepatitis

116

1161

1.00

0.00

2.7

2.9

54.54

55.06

u/ml

0.01

109

1124

Other congenital malformations of ear

225

0.98

0.00

2.5

1.9

70.48

43.55

u/ml

0.21

212

Fracture of shoulder and upper arm

894

8923

1.00

0.00

3.0

3.9

55.81

71.05

u/ml

1.06

857

8616

Lifestyle-related condition

196

1.02

0.00

4.4

2.8

42.97

47.64

u/ml

0.05

187

Atypical mycobacterium lung infection

204

0.98

0.00

5.4

2.9

43.40

115.24

u/ml

0.64

199

Viral infections of the central nervous system

150

1497

1.00

0.00

3.1

3.4

24.20

62.83

u/ml

3.81

145

1450

Open wound of shoulder and upper arm

277

1.01

0.00

4.0

2.5

22.20

70.20

u/ml

1.64

267

Other and unspecified hydrocephalus

313

0.99

0.00

3.6

2.9

43.44

100.43

u/ml

0.77

301

Corticotropin deficiency

182

0.99

0.00

4.3

2.5

18.36

52.03

u/ml

1.61

174

Pulmonary eosinophilia, not elsewhere classified

218

1.01

0.00

2.0

3.2

18.18

111.30

u/ml

1.05

212

Failed induction of labour

195

1954

1.00

0.00

1.6

2.4

24.23

32.15

u/ml

1.38

180

1891

Other interstitial pulmonary diseases

235

2352

1.00

0.00

3.3

4.0

59.23

83.82

u/ml

0.88

227

2256

Certain conditions originating in the perinatal period

143

1266

1.00

0.00

3.0

2.3

25.70

47.19

u/ml

1.37

138

1219

Myositis

410

1.00

0.00

4.4

3.4

28.93

90.04

u/ml

1.28

394

Impacted maxillary canine

117

1.03

0.00

1.8

2.4

27.58

40.36

u/ml

0.31

112

Dacryoadenitis

175

0.97

0.00

3.5

2.8

47.00

56.87

u/ml

0.14

170

Ankle and foot

195

0.97

0.00

1.7

2.9

17.24

43.68

u/ml

1.26

186

Postprocedural disorders of ear and mastoid process, not elsewhere classified

124

0.97

0.00

1.8

2.8

14.98

38.66

u/ml

1.31

119

186

1.02

0.00

1.5

2.3

141.91

49.62

u/ml

0.32

180

Benign neoplasm: Uterine tubes and ligaments

188

1.01

0.00

1.3

3.3

16.68

39.32

u/ml

1.80

182

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms, including avohilmo

0.00

0.0

6.9

—

16.40

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.0

2.6

—

199.20

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

1.00

0.00

1.6

2.4

18.00

41.72

u/ml

—

Other infective (teno)synovitis

0.99

0.00

1.1

1.9

22.04

62.60

u/ml

—

Necrotizing fasciitis

0.99

0.00

1.6

2.5

27.63

58.65

u/ml

—

Lethal midline granuloma

0.00

0.0

1.6

—

17.57

—

Other neonatal haemorrhages

0.00

0.0

1.7

—

15.83

—

Microcephaly

0.00

0.0

2.2

—

215.67

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

1.4

—

207.60

—

Toxic effect of other inorganic substances

0.00

0.0

1.4

—

12.20

—

Rabies, including avohilmo

0.00

0.0

8.6

—

50.65

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

3.1

—

20.57

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

0.00

0.0

6.9

—

16.40

—

Drowning to ice

0.00

-0.00

0.0

1.6

—

142.25

—

Drowning and submersion, undetermined intent

0.00

-0.00

0.0

7.0

—

116.33

—

Choroidal degeneration

0.00

-0.00

0.0

7.2

—

24.22

—

Hypopituitarism after medical therapy

0.00

-0.00

0.0

1.6

—

15.20

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

4.1

—

127.02

—

Disorders of visual cortex

0.00

-0.00

0.0

1.8

—

12.09

—

Other protozoal intestinal diseases, including avohilmo

440

1.00

-0.00

3.6

2.6

45.63

70.42

u/ml

0.30

426

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

-0.00

0.0

1.0

—

14.12

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.3

—

28.40

—

Strongyloidiasis, including avohilmo

0.00

-0.00

0.0

2.0

—

127.62

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

9.7

—

24.95

—

Persistent hyperplasia of thymus

0.00

-0.00

0.0

1.3

—

12.80

—

Interstitial lung disease endpoints

235

2350

1.00

-0.00

3.3

4.0

59.23

83.82

u/ml

0.88

227

2254

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.6

—

23.18

—

Other fluke infections, including avohilmo

0.00

-0.00

0.0

10.0

—

29.67

—

Disseminated intravascular coagulation [defibrination syndrome]

0.93

-0.00

2.2

2.0

33.33

55.71

u/ml

—

Other and unspecified acantholytic disorders

0.00

-0.00

0.0

2.2

—

25.20

—

Other disorders of penis

0.94

-0.00

1.2

1.7

36.50

152.93

u/ml

—

Folliculitis ulerythematosa abscedens

0.00

-0.00

0.0

2.2

—

16.32

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

2.0

—

24.84

—

Sclerodactyly

0.00

-0.00

0.0

1.4

—

11.75

—

Miliaria crystallina

0.00

-0.00

0.0

2.2

—

11.00

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

140

1.00

-0.00

1.4

2.2

22.07

32.70

u/ml

0.53

134

Other disorders of kidney and ureter in diseases classified elsewhere

0.00

-0.00

0.0

2.5

—

164.83

—

Other fluke infections

0.00

-0.00

0.0

11.8

—

34.60

—

Other specified air transport accidents

0.00

-0.00

0.0

2.8

—

215.56

—

Interstitial lung disease

235

2350

1.00

-0.00

3.3

4.0

59.23

83.82

u/ml

0.88

227

2254

Drug-induced chorea

0.00

-0.00

0.0

2.8

—

192.80

—

Torsion of testis

0.00

-0.00

0.0

2.7

—

21.14

—

Inflammatory diseases of prostate (prostatitis)

0.95

-0.00

1.0

1.4

19.50

132.42

u/ml

—

Ectopic testis

0.00

-0.00

0.0

3.5

—

20.00

—

Diastrofic dysplasy

0.00

-0.00

0.0

2.1

—

188.14

—

Immunodeficiency associated with other specified major defects, or unspecified

0.00

-0.00

0.0

1.4

—

11.93

—

Androgen resistance syndrome

0.00

-0.00

0.0

1.8

—

12.80

—

Strongyloidiasis

0.00

-0.00

0.0

2.0

—

127.63

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

1.8

—

35.60

—

Rabies

0.00

-0.00

0.0

11.2

—

62.53

—

Congenital ectropion

0.00

-0.00

0.0

2.6

—

192.40

—

Taeniasis

0.00

-0.00

0.0

3.1

—

152.78

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.93

-0.00

1.3

3.3

855.83

70.78

u/ml

—

Unattended death

0.98

-0.00

5.9

3.3

129.75

51.61

u/ml

—

Traumatic amputation of forearm

0.00

-0.00

0.0

1.8

—

12.78

—

Trachoma

0.00

-0.00

0.0

3.0

—

165.83

—

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.5

—

16.37

—

Benign neoplasm: Lymph nodes

0.93

-0.00

2.0

3.2

18.33

61.84

u/ml

—

Trachoma, including avohilmo

0.00

-0.00

0.0

3.0

—

165.83

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.0

—

11.72

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

3.0

—

70.44

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

2.6

—

192.00

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

8.0

—

16.88

—

Disorders of accommodation

0.00

-0.00

0.0

1.2

—

11.27

—

Exposure to vibration

0.00

-0.00

0.0

9.7

—

32.77

—

Gastroenterology and urology devices associated with adverse incidents

0.00

-0.00

0.0

2.0

—

21.57

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

2.6

—

116.28

—

Otorhinolaryngological devices associated with adverse incidents

0.00

-0.00

0.0

2.6

—

193.20

—

Unspecified drowning and submersion

0.00

-0.00

0.0

4.6

—

11.82

—

Mosquito-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

1.6

—

17.64

—

Hypervitaminosis D

0.00

-0.00

0.0

1.6

—

19.75

—

Dietary calcium deficiency

0.00

-0.00

0.0

2.1

—

25.71

—

Myopathy due to other toxic agents

0.00

-0.00

0.0

2.0

—

22.80

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

7.5

—

20.83

—

Rat-bite fevers

0.00

-0.00

0.0

1.6

—

21.15

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

13.02

—

Copper deficiency

0.00

-0.00

0.0

2.0

—

30.12

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.4

—

21.13

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cancer Ag 125 [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS